disease,drug,phase,status,target,num_ev_strings
nephrotic syndrome,PREDNISONE,4,n/a,NR3C1,108
nephrotic syndrome,HYDROCHLOROTHIAZIDE,4,n/a,SLC12A3,100
chronic kidney disease,HYDROCHLOROTHIAZIDE,4,n/a,SLC12A3,98
nephrotic syndrome,FUROSEMIDE,4,n/a,SLC12A1,48
kidney disease,LOSARTAN,4,n/a,AGTR1,48
renal cell carcinoma,SUNITINIB,2,Completed,PDGFRB,23
renal cell carcinoma,SUNITINIB,2,Completed,PDGFRA,23
renal cell carcinoma,SUNITINIB,2,Completed,CSF1R,23
renal cell carcinoma,SUNITINIB,2,Completed,FLT1,23
renal cell carcinoma,SUNITINIB,2,Completed,FLT3,23
renal cell carcinoma,SUNITINIB,2,Completed,FLT4,23
nephrotic syndrome,BUMETANIDE,4,n/a,SLC12A1,23
renal cell carcinoma,SUNITINIB,2,Completed,KDR,23
renal cell carcinoma,SUNITINIB,2,Completed,KIT,23
kidney disease,BUMETANIDE,4,n/a,SLC12A1,23
renal cell carcinoma,SUNITINIB,2,Completed,RET,23
nephrotic syndrome,PREDNISOLONE,4,n/a,NR3C1,16
renal cell carcinoma,SORAFENIB,2,Completed,BRAF,13
renal cell carcinoma,SORAFENIB,2,Completed,RAF1,13
renal cell carcinoma,SORAFENIB,2,Completed,PDGFRB,13
diabetic nephropathy,CAPTOPRIL,4,n/a,ACE,13
renal cell carcinoma,SORAFENIB,2,Completed,KIT,13
renal cell carcinoma,SORAFENIB,2,Completed,RET,13
renal cell carcinoma,SORAFENIB,3,Completed,BRAF,13
renal cell carcinoma,SORAFENIB,3,Completed,FLT1,13
renal cell carcinoma,SORAFENIB,3,Completed,FLT3,13
renal cell carcinoma,SORAFENIB,3,Completed,FLT4,13
renal cell carcinoma,BEVACIZUMAB,2,Completed,VEGFA,13
renal cell carcinoma,SORAFENIB,3,Completed,KDR,13
renal cell carcinoma,SORAFENIB,3,Completed,KIT,13
renal cell carcinoma,SORAFENIB,3,Completed,PDGFRB,13
renal cell carcinoma,SORAFENIB,2,Completed,KDR,13
renal cell carcinoma,SORAFENIB,3,Completed,RET,13
renal cell carcinoma,SORAFENIB,2,Completed,FLT4,13
renal cell carcinoma,SORAFENIB,2,Completed,FLT3,13
renal cell carcinoma,SORAFENIB,2,Completed,FLT1,13
renal cell carcinoma,SORAFENIB,3,Completed,RAF1,13
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,POLE2,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,RRM1,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,PRIM2,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,PRIM1,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,POLE3,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,POLE,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,POLD4,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,POLD2,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,POLD1,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,POLA2,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,POLA1,12
transitional cell carcinoma of kidney,GEMCITABINE,2,Completed,POLD3,12
chronic kidney disease,CHLORTHALIDONE,4,n/a,SLC12A3,11
renal cell carcinoma,EVEROLIMUS,2,Completed,FKBP1A,10
renal cell carcinoma,PAZOPANIB,1,Completed,LCK,9
renal cell carcinoma,PAZOPANIB,1,Completed,KIT,9
diabetic nephropathy,IRBESARTAN,4,n/a,AGTR1,9
renal cell carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,9
chronic kidney disease,TACROLIMUS,4,Completed,FKBP1A,9
renal carcinoma,ALDESLEUKIN,2,Unknown status,IL2RA,9
renal cell carcinoma,SUNITINIB,1,Completed,CSF1R,9
renal cell carcinoma,PAZOPANIB,1,Completed,CSF1R,9
renal cell carcinoma,PAZOPANIB,1,Completed,FGFR1,9
renal cell carcinoma,PAZOPANIB,1,Completed,FGFR3,9
renal cell carcinoma,PAZOPANIB,1,Completed,FLT1,9
renal cell carcinoma,PAZOPANIB,1,Completed,FLT4,9
renal cell carcinoma,PAZOPANIB,1,Completed,ITK,9
renal cell carcinoma,PAZOPANIB,1,Completed,KDR,9
renal carcinoma,ALDESLEUKIN,2,Unknown status,IL2RB,9
chronic kidney disease,PARICALCITOL,4,n/a,VDR,9
renal cell carcinoma,SUNITINIB,1,Completed,FLT1,9
renal cell carcinoma,SUNITINIB,1,Completed,FLT3,9
renal cell carcinoma,SUNITINIB,1,Completed,FLT4,9
renal cell carcinoma,SUNITINIB,1,Completed,KIT,9
renal cell carcinoma,SUNITINIB,1,Completed,KDR,9
renal cell carcinoma,SUNITINIB,1,Completed,PDGFRA,9
renal cell carcinoma,SUNITINIB,1,Completed,PDGFRB,9
renal cell carcinoma,SUNITINIB,1,Completed,RET,9
renal cell carcinoma,PAZOPANIB,1,Completed,PDGFRB,9
renal cell carcinoma,PAZOPANIB,1,Completed,PDGFRA,9
renal cell carcinoma,SORAFENIB,2,Terminated,RAF1,8
renal cell carcinoma,SORAFENIB,2,Terminated,FLT3,8
renal cell carcinoma,SORAFENIB,2,Terminated,FLT4,8
renal cell carcinoma,SORAFENIB,2,Terminated,KDR,8
renal cell carcinoma,SORAFENIB,2,Terminated,KIT,8
renal cell carcinoma,SORAFENIB,2,Terminated,PDGFRB,8
chronic kidney disease,EPOETIN ALFA,3,Completed,EPOR,8
renal cell carcinoma,SUNITINIB,2,"Active, not recruiting",RET,8
renal cell carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRB,8
renal cell carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRA,8
renal cell carcinoma,SUNITINIB,2,"Active, not recruiting",KIT,8
renal cell carcinoma,SUNITINIB,2,"Active, not recruiting",KDR,8
renal cell carcinoma,SUNITINIB,2,"Active, not recruiting",FLT4,8
renal cell carcinoma,SUNITINIB,2,"Active, not recruiting",FLT3,8
renal cell carcinoma,SUNITINIB,2,"Active, not recruiting",FLT1,8
renal cell carcinoma,SORAFENIB,2,Terminated,RET,8
renal cell carcinoma,SUNITINIB,2,"Active, not recruiting",CSF1R,8
renal cell carcinoma,SORAFENIB,2,Terminated,FLT1,8
chronic kidney disease,DARBEPOETIN ALFA,3,Completed,EPOR,8
renal cell carcinoma,SORAFENIB,2,Terminated,BRAF,8
renal cell carcinoma,SUNITINIB,3,"Active, not recruiting",PDGFRB,8
renal cell carcinoma,SUNITINIB,3,"Active, not recruiting",KIT,8
chronic kidney disease,CALCITRIOL,4,n/a,VDR,8
renal cell carcinoma,SUNITINIB,3,"Active, not recruiting",CSF1R,8
renal cell carcinoma,SUNITINIB,3,"Active, not recruiting",FLT1,8
renal cell carcinoma,SUNITINIB,3,"Active, not recruiting",FLT3,8
renal cell carcinoma,SUNITINIB,3,"Active, not recruiting",FLT4,8
renal cell carcinoma,SUNITINIB,3,"Active, not recruiting",PDGFRA,8
renal cell carcinoma,SUNITINIB,3,"Active, not recruiting",KDR,8
renal cell carcinoma,SUNITINIB,3,"Active, not recruiting",RET,8
renal cell carcinoma,SUNITINIB,2,Terminated,FLT4,7
renal cell carcinoma,SUNITINIB,2,Terminated,CSF1R,7
renal cell carcinoma,SUNITINIB,2,Terminated,FLT3,7
chronic kidney disease,PARICALCITOL,3,Completed,VDR,7
renal cell carcinoma,SUNITINIB,2,Terminated,KDR,7
renal cell carcinoma,SUNITINIB,2,Terminated,KIT,7
renal cell carcinoma,SUNITINIB,2,Terminated,PDGFRA,7
renal cell carcinoma,SUNITINIB,2,Terminated,RET,7
renal cell carcinoma,SUNITINIB,2,Terminated,PDGFRB,7
renal cell carcinoma,SUNITINIB,2,Terminated,FLT1,7
renal cell carcinoma,EVEROLIMUS,1,Completed,FKBP1A,7
lupus nephritis,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH1,6
renal cell carcinoma,GEMCITABINE,2,Completed,PRIM2,6
renal cell carcinoma,PAZOPANIB,2,Completed,FGFR1,6
renal cell carcinoma,PAZOPANIB,2,Completed,FGFR3,6
renal cell carcinoma,PAZOPANIB,2,Completed,FLT1,6
renal cell carcinoma,PAZOPANIB,2,Completed,FLT4,6
renal cell carcinoma,PAZOPANIB,2,Completed,ITK,6
renal cell carcinoma,PAZOPANIB,2,Completed,KDR,6
renal cell carcinoma,PAZOPANIB,2,Completed,KIT,6
renal cell carcinoma,PAZOPANIB,2,Completed,LCK,6
renal cell carcinoma,PAZOPANIB,2,Completed,PDGFRA,6
renal cell carcinoma,PAZOPANIB,2,Completed,PDGFRB,6
Autosomal dominant polycystic kidney disease,TOLVAPTAN,2,Completed,AVPR2,6
renal cell carcinoma,GEMCITABINE,2,Completed,RRM1,6
renal cell carcinoma,GEMCITABINE,2,Completed,PRIM1,6
lupus nephritis,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH2,6
renal cell carcinoma,GEMCITABINE,2,Completed,POLE3,6
renal cell carcinoma,GEMCITABINE,2,Completed,POLA1,6
renal cell carcinoma,GEMCITABINE,2,Completed,POLE2,6
renal cell carcinoma,GEMCITABINE,2,Completed,POLA2,6
renal cell carcinoma,GEMCITABINE,2,Completed,POLD1,6
renal cell carcinoma,GEMCITABINE,2,Completed,POLD2,6
renal cell carcinoma,GEMCITABINE,2,Completed,POLD3,6
renal cell carcinoma,GEMCITABINE,2,Completed,POLD4,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB,6
renal cell carcinoma,GEMCITABINE,2,Completed,POLE,6
kidney failure,TACROLIMUS,3,Completed,FKBP1A,6
renal cell carcinoma,PAZOPANIB,2,Completed,CSF1R,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB1,6
Autosomal dominant polycystic kidney disease,TOLVAPTAN,3,Completed,AVPR2,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB4A,6
renal cell carcinoma,IPILIMUMAB,2,Recruiting,CTLA4,6
chronic kidney disease,CYCLOSPORINE,4,Completed,PPIA,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB8,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB6,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB4B,6
renal carcinoma,ALDESLEUKIN,3,Completed,IL2RA,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB3,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB2A,6
renal carcinoma,ALDESLEUKIN,3,Completed,IL2RB,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB2B,6
renal cell carcinoma,SUNITINIB,3,Completed,FLT4,5
chronic kidney disease,PARICALCITOL,2,Completed,VDR,5
renal cell carcinoma,SUNITINIB,3,Completed,RET,5
renal cell carcinoma,SORAFENIB,1,Completed,FLT3,5
renal cell carcinoma,SUNITINIB,3,Completed,CSF1R,5
renal cell carcinoma,SUNITINIB,3,Completed,FLT1,5
renal cell carcinoma,SUNITINIB,3,Completed,FLT3,5
renal cell carcinoma,SUNITINIB,3,Completed,KIT,5
renal cell carcinoma,SUNITINIB,3,Completed,KDR,5
renal cell carcinoma,SUNITINIB,3,Completed,PDGFRA,5
renal cell carcinoma,SORAFENIB,1,Completed,FLT1,5
renal cell carcinoma,SUNITINIB,3,Completed,PDGFRB,5
renal cell carcinoma,SORAFENIB,1,Completed,RET,5
renal cell carcinoma,SORAFENIB,1,Completed,BRAF,5
chronic kidney disease,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH1,5
renal cell carcinoma,BEVACIZUMAB,1,Completed,VEGFA,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,POLA2,5
renal cell carcinoma,SORAFENIB,1,Completed,RAF1,5
renal cell carcinoma,SORAFENIB,1,Completed,FLT4,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,PRIM1,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,PRIM2,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,RRM1,5
renal cell carcinoma,SORAFENIB,1,Completed,KDR,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,POLE2,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,POLE,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,POLD4,5
renal cell carcinoma,ALDESLEUKIN,2,Terminated,IL2RB,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,POLA1,5
renal cell carcinoma,ALDESLEUKIN,2,Terminated,IL2RA,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,POLD3,5
renal cell carcinoma,SORAFENIB,1,Completed,KIT,5
renal cell carcinoma,SORAFENIB,1,Completed,PDGFRB,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,POLD2,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,POLD1,5
transitional cell carcinoma of kidney,GEMCITABINE,1,Completed,POLE3,5
renal cell carcinoma,SUNITINIB,2,Recruiting,CSF1R,5
chronic kidney disease,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH2,5
renal carcinoma,SUNITINIB,2,Completed,PDGFRA,5
renal carcinoma,SUNITINIB,2,Completed,FLT3,5
clear cell renal carcinoma,BEVACIZUMAB,1,Completed,VEGFA,5
renal carcinoma,SUNITINIB,2,Completed,RET,5
renal carcinoma,SUNITINIB,2,Completed,PDGFRB,5
renal cell carcinoma,SUNITINIB,2,Recruiting,RET,5
renal carcinoma,SUNITINIB,2,Completed,KIT,5
renal carcinoma,SUNITINIB,2,Completed,KDR,5
renal cell carcinoma,SUNITINIB,2,Recruiting,FLT1,5
renal cell carcinoma,SUNITINIB,2,Recruiting,PDGFRB,5
renal carcinoma,SUNITINIB,2,Completed,FLT4,5
renal carcinoma,SUNITINIB,2,Completed,FLT1,5
renal carcinoma,SUNITINIB,2,Completed,CSF1R,5
renal cell carcinoma,SUNITINIB,2,Recruiting,PDGFRA,5
renal cell carcinoma,SUNITINIB,2,Recruiting,KIT,5
renal cell carcinoma,SUNITINIB,2,Recruiting,KDR,5
renal cell carcinoma,SUNITINIB,2,Recruiting,FLT4,5
renal cell carcinoma,SUNITINIB,2,Recruiting,FLT3,5
chronic kidney disease,DARBEPOETIN ALFA,4,Completed,EPOR,5
renal cell carcinoma,SUNITINIB,1,Terminated,KDR,4
renal cell carcinoma,SUNITINIB,1,Terminated,KIT,4
renal cell carcinoma,SUNITINIB,1,Terminated,PDGFRA,4
renal cell carcinoma,SUNITINIB,1,Terminated,PDGFRB,4
renal cell carcinoma,SUNITINIB,1,Terminated,RET,4
renal carcinoma,GEMCITABINE,2,Completed,POLE2,4
renal cell carcinoma,SUNITINIB,2,Unknown status,FLT1,4
renal cell carcinoma,SUNITINIB,2,Unknown status,CSF1R,4
renal cell carcinoma,TEMSIROLIMUS,2,Completed,FKBP1A,4
renal carcinoma,EVEROLIMUS,2,Terminated,FKBP1A,4
renal cell carcinoma,SUNITINIB,1,Terminated,FLT3,4
chronic kidney disease,CHOLECALCIFEROL,4,Completed,VDR,4
renal cell carcinoma,SUNITINIB,1,Terminated,FLT4,4
renal cell carcinoma,SUNITINIB,1,Terminated,CSF1R,4
renal cell carcinoma,SUNITINIB,1,Terminated,FLT1,4
renal carcinoma,GEMCITABINE,2,Completed,POLE3,4
renal carcinoma,GEMCITABINE,2,Completed,PRIM1,4
renal carcinoma,GEMCITABINE,2,Completed,PRIM2,4
renal cell carcinoma,SUNITINIB,2,Withdrawn,CSF1R,4
renal carcinoma,GEMCITABINE,2,Completed,POLE,4
renal carcinoma,GEMCITABINE,2,Completed,POLD4,4
renal carcinoma,GEMCITABINE,2,Completed,RRM1,4
renal cell carcinoma,SUNITINIB,2,Withdrawn,FLT1,4
renal carcinoma,GEMCITABINE,2,Completed,POLD3,4
renal carcinoma,GEMCITABINE,2,Completed,POLD2,4
renal cell carcinoma,SUNITINIB,2,Withdrawn,FLT3,4
renal cell carcinoma,SUNITINIB,2,Withdrawn,FLT4,4
renal cell carcinoma,SUNITINIB,2,Withdrawn,KDR,4
renal carcinoma,GEMCITABINE,2,Completed,POLD1,4
renal cell carcinoma,SUNITINIB,2,Withdrawn,KIT,4
renal cell carcinoma,SUNITINIB,2,Withdrawn,PDGFRA,4
renal cell carcinoma,SUNITINIB,2,Withdrawn,PDGFRB,4
renal cell carcinoma,SUNITINIB,2,Withdrawn,RET,4
renal cell carcinoma,SUNITINIB,2,Unknown status,RET,4
renal cell carcinoma,SUNITINIB,2,Unknown status,PDGFRB,4
renal carcinoma,BEVACIZUMAB,2,Completed,VEGFA,4
renal cell carcinoma,SUNITINIB,2,Unknown status,PDGFRA,4
renal cell carcinoma,SUNITINIB,2,Unknown status,KIT,4
renal carcinoma,GEMCITABINE,2,Completed,POLA1,4
renal cell carcinoma,SUNITINIB,2,Unknown status,KDR,4
renal cell carcinoma,SUNITINIB,2,Unknown status,FLT4,4
renal cell carcinoma,SUNITINIB,2,Unknown status,FLT3,4
chronic kidney disease,DOXERCALCIFEROL,4,n/a,VDR,4
renal carcinoma,GEMCITABINE,2,Completed,POLA2,4
nephrotic syndrome,CHLOROTHIAZIDE,4,n/a,SLC12A3,4
renal carcinoma,ALDESLEUKIN,2,Completed,IL2RB,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",KDR,4
renal cell carcinoma,AXITINIB,2,Completed,KDR,4
renal cell carcinoma,BEVACIZUMAB,2,Terminated,VEGFA,4
renal cell carcinoma,CAPECITABINE,2,Completed,TYMS,4
renal cell carcinoma,ALDESLEUKIN,2,Completed,IL2RB,4
diabetic nephropathy,MT-3995,2,Completed,NR3C2,4
renal cell carcinoma,ALDESLEUKIN,2,Completed,IL2RA,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",LCK,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",KIT,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",ITK,4
renal cell carcinoma,AXITINIB,2,Completed,FLT1,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT4,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT1,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,4
renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,4
chronic kidney disease,ROXADUSTAT,2,Completed,EGLN1,4
chronic kidney disease,ROXADUSTAT,2,Completed,EGLN2,4
chronic kidney disease,ROXADUSTAT,2,Completed,EGLN3,4
chronic kidney disease,ROXADUSTAT,2,Completed,P4HTM,4
renal carcinoma,ALDESLEUKIN,2,Completed,IL2RA,4
renal cell carcinoma,AXITINIB,2,Completed,FLT4,4
lupus nephritis,TACROLIMUS,3,Completed,FKBP1A,4
renal cell carcinoma,PAZOPANIB,3,Completed,PDGFRB,4
renal cell carcinoma,PAZOPANIB,3,Completed,FLT1,4
renal cell carcinoma,PAZOPANIB,3,Completed,FLT4,4
renal cell carcinoma,PAZOPANIB,3,Completed,ITK,4
renal cell carcinoma,PAZOPANIB,3,Completed,FGFR1,4
renal cell carcinoma,PAZOPANIB,3,Completed,KDR,4
renal cell carcinoma,PAZOPANIB,3,Completed,CSF1R,4
renal cell carcinoma,PAZOPANIB,3,Completed,KIT,4
renal cell carcinoma,PAZOPANIB,3,Completed,LCK,4
renal cell carcinoma,PAZOPANIB,3,Completed,PDGFRA,4
renal cell carcinoma,PAZOPANIB,3,Completed,FGFR3,4
clear cell renal carcinoma,AXITINIB,2,Recruiting,FLT4,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,POLE3,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,PRIM1,3
renal cell carcinoma,SUNITINIB,3,Recruiting,RET,3
clear cell renal carcinoma,AXITINIB,2,Recruiting,KDR,3
clear cell renal carcinoma,NIVOLUMAB,1,"Active, not recruiting",PDCD1,3
clear cell renal carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,3
renal cell carcinoma,EVEROLIMUS,4,Completed,FKBP1A,3
renal cell carcinoma,AXITINIB,1,"Active, not recruiting",FLT1,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,POLE2,3
renal cell carcinoma,EVEROLIMUS,2,"Active, not recruiting",FKBP1A,3
clear cell renal carcinoma,AXITINIB,2,Recruiting,FLT1,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,POLE,3
renal carcinoma,TACROLIMUS,2,Completed,FKBP1A,3
renal carcinoma,SUNITINIB,2,Unknown status,RET,3
renal carcinoma,SUNITINIB,2,Unknown status,PDGFRB,3
renal carcinoma,SUNITINIB,2,Unknown status,PDGFRA,3
renal carcinoma,SUNITINIB,2,Unknown status,KIT,3
renal carcinoma,SUNITINIB,2,Unknown status,KDR,3
renal carcinoma,SUNITINIB,2,Unknown status,FLT4,3
renal carcinoma,SUNITINIB,2,Unknown status,FLT3,3
renal carcinoma,SUNITINIB,2,Unknown status,FLT1,3
renal carcinoma,SUNITINIB,2,Unknown status,CSF1R,3
chronic kidney disease,TOLVAPTAN,2,Completed,AVPR2,3
renal cell carcinoma,INTERFERON ALFA-2A,3,Completed,IFNAR1,3
renal cell carcinoma,EVEROLIMUS,2,Terminated,FKBP1A,3
clear cell renal carcinoma,SORAFENIB,2,Completed,FLT4,3
renal cell carcinoma,EVEROLIMUS,1,Terminated,FKBP1A,3
renal cell carcinoma,SUNITINIB,3,Recruiting,KIT,3
renal cell carcinoma,AXITINIB,2,"Active, not recruiting",FLT4,3
renal cell carcinoma,AXITINIB,2,"Active, not recruiting",KDR,3
renal cell carcinoma,SUNITINIB,3,Recruiting,CSF1R,3
renal cell carcinoma,SUNITINIB,3,Recruiting,FLT1,3
renal cell carcinoma,SUNITINIB,3,Recruiting,FLT3,3
renal cell carcinoma,AXITINIB,2,Terminated,FLT1,3
renal cell carcinoma,AXITINIB,2,Terminated,FLT4,3
renal cell carcinoma,AXITINIB,2,Terminated,KDR,3
renal cell carcinoma,SUNITINIB,3,Recruiting,FLT4,3
renal cell carcinoma,SUNITINIB,3,Recruiting,KDR,3
renal cell carcinoma,SUNITINIB,3,Recruiting,PDGFRA,3
renal cell carcinoma,ERLOTINIB,2,Completed,EGFR,3
clear cell renal carcinoma,SORAFENIB,2,Completed,RET,3
clear cell renal carcinoma,SORAFENIB,2,Completed,RAF1,3
renal cell carcinoma,INTERFERON ALFA-2A,3,Completed,IFNAR2,3
renal cell carcinoma,SUNITINIB,3,Recruiting,PDGFRB,3
clear cell renal carcinoma,SORAFENIB,2,Completed,KIT,3
clear cell renal carcinoma,SORAFENIB,2,Completed,KDR,3
renal cell carcinoma,AXITINIB,2,"Active, not recruiting",FLT1,3
clear cell renal carcinoma,SORAFENIB,2,Completed,FLT3,3
clear cell renal carcinoma,SORAFENIB,2,Completed,FLT1,3
clear cell renal carcinoma,SORAFENIB,2,Completed,BRAF,3
clear cell renal carcinoma,SORAFENIB,2,Completed,PDGFRB,3
renal cell carcinoma,NIVOLUMAB,2,"Active, not recruiting",PDCD1,3
kidney disease,DARBEPOETIN ALFA,3,Completed,EPOR,3
renal carcinoma,SUNITINIB,2,"Active, not recruiting",RET,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,FGFR3,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,FLT1,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,FLT4,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,ITK,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,KDR,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,KIT,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,LCK,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,PDGFRA,3
kidney failure,TACROLIMUS,2,Completed,FKBP1A,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,PDGFRB,3
renal cell carcinoma,PAZOPANIB,2,Terminated,CSF1R,3
renal cell carcinoma,PAZOPANIB,2,Terminated,FGFR1,3
renal cell carcinoma,PAZOPANIB,2,Terminated,FGFR3,3
renal cell carcinoma,PAZOPANIB,2,Terminated,FLT1,3
renal cell carcinoma,PAZOPANIB,2,Terminated,FLT4,3
renal cell carcinoma,PAZOPANIB,2,Terminated,ITK,3
renal cell carcinoma,PAZOPANIB,2,Terminated,KDR,3
renal cell carcinoma,PAZOPANIB,2,Terminated,KIT,3
renal cell carcinoma,PAZOPANIB,2,Terminated,LCK,3
renal cell carcinoma,PAZOPANIB,2,Terminated,PDGFRA,3
renal cell carcinoma,PAZOPANIB,2,Terminated,PDGFRB,3
chronic kidney disease,MYCOPHENOLIC ACID,4,Completed,IMPDH2,3
chronic kidney disease,MYCOPHENOLIC ACID,4,Completed,IMPDH1,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,POLD3,3
chronic kidney disease,METHYLPREDNISOLONE,4,Completed,NR3C1,3
renal carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,3
renal cell carcinoma,AXITINIB,1,"Active, not recruiting",KDR,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,FGFR1,3
renal cell carcinoma,PAZOPANIB,2,Recruiting,CSF1R,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,RRM1,3
chronic kidney disease,RITUXIMAB,1,Completed,MS4A1,3
renal carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRB,3
renal carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRA,3
renal carcinoma,SUNITINIB,2,"Active, not recruiting",KIT,3
renal carcinoma,SUNITINIB,2,"Active, not recruiting",KDR,3
renal carcinoma,SUNITINIB,2,"Active, not recruiting",FLT4,3
renal carcinoma,SUNITINIB,2,"Active, not recruiting",FLT3,3
renal carcinoma,SUNITINIB,2,"Active, not recruiting",FLT1,3
chronic kidney disease,CHOLECALCIFEROL,2,Completed,VDR,3
renal carcinoma,SUNITINIB,2,"Active, not recruiting",CSF1R,3
renal cell carcinoma,NIVOLUMAB,1,Recruiting,PDCD1,3
renal cell carcinoma,NIVOLUMAB,3,Recruiting,PDCD1,3
chronic kidney disease,CINACALCET,2,Completed,CASR,3
kidney disease,SIROLIMUS,1,Completed,FKBP1A,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,PRIM2,3
chronic kidney disease,PREDNISONE,4,Completed,NR3C1,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",CSF1R,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",FGFR1,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",FGFR3,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",FLT1,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",FLT4,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",ITK,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",KDR,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",KIT,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",LCK,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",PDGFRA,3
renal cell carcinoma,PAZOPANIB,1,"Active, not recruiting",PDGFRB,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,POLD4,3
renal cell carcinoma,AXITINIB,1,"Active, not recruiting",FLT4,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,POLD2,3
transitional cell carcinoma of kidney,SUNITINIB,2,Completed,PDGFRB,3
lupus nephritis,PREDNISONE,2,Completed,NR3C1,3
lupus nephritis,PREDNISONE,3,Completed,NR3C1,3
transitional cell carcinoma of kidney,SUNITINIB,2,Completed,CSF1R,3
transitional cell carcinoma of kidney,SUNITINIB,2,Completed,FLT1,3
transitional cell carcinoma of kidney,SUNITINIB,2,Completed,FLT4,3
transitional cell carcinoma of kidney,SUNITINIB,2,Completed,KDR,3
transitional cell carcinoma of kidney,SUNITINIB,2,Completed,KIT,3
transitional cell carcinoma of kidney,SUNITINIB,2,Completed,PDGFRA,3
transitional cell carcinoma of kidney,SUNITINIB,2,Completed,RET,3
renal cell carcinoma,TEMSIROLIMUS,1,Completed,FKBP1A,3
lupus nephritis,TACROLIMUS,4,Completed,FKBP1A,3
nephrotic syndrome,TACROLIMUS,4,Completed,FKBP1A,3
nephrotic syndrome,TACROLIMUS,3,Completed,FKBP1A,3
renal cell carcinoma,TIVOZANIB,2,Completed,KDR,3
renal cell carcinoma,TIVOZANIB,2,Completed,FLT4,3
renal cell carcinoma,TIVOZANIB,2,Completed,FLT1,3
renal carcinoma,ERLOTINIB,2,Completed,EGFR,3
renal carcinoma,EVEROLIMUS,1,Completed,FKBP1A,3
renal carcinoma,BORTEZOMIB,2,Completed,PSMB5,3
renal carcinoma,BEVACIZUMAB,2,Terminated,VEGFA,3
transitional cell carcinoma of kidney,DOXORUBICIN,1,Completed,TOP2A,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,POLD1,3
renal carcinoma,ALDESLEUKIN,1,Completed,IL2RB,3
renal carcinoma,ALDESLEUKIN,1,Completed,IL2RA,3
lupus nephritis,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH1,3
lupus nephritis,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH2,3
lupus nephritis,MYCOPHENOLATE MOFETIL,2,Terminated,IMPDH1,3
lupus nephritis,MYCOPHENOLATE MOFETIL,2,Terminated,IMPDH2,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB1,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB2A,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB2B,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB3,3
lupus nephritis,AZATHIOPRINE,3,Completed,PPAT,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB4A,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB4B,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB6,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB8,3
transitional cell carcinoma of kidney,FILGRASTIM,1,Completed,CSF3R,3
renal cell carcinoma,TEMSIROLIMUS,3,Completed,FKBP1A,3
transitional cell carcinoma of kidney,SUNITINIB,2,Completed,FLT3,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLD3,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLE,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,PRIM2,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,PRIM1,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLE3,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLE2,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,POLA1,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Unknown status,POLA2,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,RRM1,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLD4,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLA1,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLD2,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLD1,3
renal carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLA2,3
chronic kidney disease,PROPOFOL,4,Completed,GABRB3,2
chronic kidney disease,PROPOFOL,4,Completed,GABRA1,2
chronic kidney disease,PROPOFOL,4,Completed,GABRB1,2
chronic kidney disease,PROPOFOL,4,Completed,GABRA6,2
chronic kidney disease,PROPOFOL,4,Completed,GABRA5,2
chronic kidney disease,PROPOFOL,4,Completed,GABRA4,2
chronic kidney disease,PROPOFOL,4,Completed,GABRA3,2
chronic kidney disease,PROPOFOL,4,Completed,GABRA2,2
chronic kidney disease,PROPOFOL,4,Completed,GABRD,2
chronic kidney disease,PROPOFOL,4,Completed,GABRB2,2
chronic kidney disease,PREDNISOLONE,4,Completed,NR3C1,2
chronic kidney disease,PREDNISONE,3,Completed,NR3C1,2
chronic kidney disease,PROPOFOL,4,Completed,GABRG1,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB3,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB4A,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB4B,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB6,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB8,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,CSF1R,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,FGFR1,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,FGFR3,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,FLT1,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,FLT4,2
renal cell carcinoma,BEVACIZUMAB,1,Recruiting,VEGFA,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,ITK,2
renal cell carcinoma,BEVACIZUMAB,1,Terminated,VEGFA,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,KIT,2
renal cell carcinoma,BEVACIZUMAB,2,"Active, not recruiting",VEGFA,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,LCK,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,PDGFRA,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,PDGFRB,2
kidney disease,TACROLIMUS,1,Completed,FKBP1A,2
chronic kidney disease,PROPOFOL,4,Completed,GABRE,2
renal cell carcinoma,CABOZANTINIB,3,Recruiting,MET,2
chronic kidney disease,PROPOFOL,4,Completed,GABRG2,2
chronic kidney disease,ROXADUSTAT,3,Completed,EGLN3,2
renal carcinoma,SORAFENIB,2,Completed,KIT,2
renal carcinoma,SORAFENIB,2,Completed,KDR,2
renal carcinoma,SORAFENIB,2,Completed,FLT4,2
renal cell carcinoma,BEVACIZUMAB,3,Completed,VEGFA,2
renal carcinoma,SORAFENIB,2,Completed,FLT3,2
renal carcinoma,SORAFENIB,2,Completed,FLT1,2
renal carcinoma,SORAFENIB,2,Completed,BRAF,2
Autosomal dominant polycystic kidney disease,LANREOTIDE,3,"Active, not recruiting",SSTR5,2
renal cell carcinoma,NIVOLUMAB,1,"Active, not recruiting",PDCD1,2
renal cell carcinoma,NIVOLUMAB,4,"Active, not recruiting",PDCD1,2
renal cell carcinoma,OLAPARIB,2,Not yet recruiting,PARP1,2
renal cell carcinoma,OLAPARIB,2,Not yet recruiting,PARP2,2
renal cell carcinoma,OLAPARIB,2,Not yet recruiting,PARP3,2
chronic kidney disease,ROXADUSTAT,3,Completed,P4HTM,2
chronic kidney disease,ROXADUSTAT,3,Completed,EGLN2,2
chronic kidney disease,PROPOFOL,4,Completed,GABRG3,2
chronic kidney disease,ROXADUSTAT,3,Completed,EGLN1,2
renal carcinoma,SORAFENIB,1,Completed,RET,2
renal carcinoma,SORAFENIB,1,Completed,RAF1,2
renal carcinoma,SORAFENIB,1,Completed,PDGFRB,2
renal carcinoma,SORAFENIB,1,Completed,KIT,2
renal carcinoma,SORAFENIB,1,Completed,KDR,2
renal carcinoma,SORAFENIB,1,Completed,FLT4,2
renal carcinoma,SORAFENIB,1,Completed,FLT3,2
chronic kidney disease,RAMIPRIL,2,Completed,ACE,2
renal carcinoma,SORAFENIB,1,Completed,FLT1,2
renal carcinoma,SORAFENIB,1,Completed,BRAF,2
chronic kidney disease,PROPOFOL,4,Completed,GABRQ,2
chronic kidney disease,PROPOFOL,4,Completed,GABRP,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB2A,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB2B,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB1,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",PDGFRB,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,POLD2,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,POLD3,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,POLD4,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,POLE,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,POLE2,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,POLE3,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,PRIM1,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",PDGFRA,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",CSF1R,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",LCK,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",KIT,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",KDR,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",ITK,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",FLT4,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",FLT1,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",FGFR3,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,POLD1,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,POLA2,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,POLA1,2
chronic kidney disease,PARICALCITOL,4,Completed,VDR,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,2
chronic kidney disease,METHYLPREDNISOLONE HEMISUCCINATE,4,Completed,NR3C1,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT1,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT4,2
chronic kidney disease,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH1,2
chronic kidney disease,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH2,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",ITK,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",KDR,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",KIT,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",LCK,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,2
renal carcinoma,PEGINTERFERON ALFA-2B,2,Terminated,IFNAR1,2
renal carcinoma,PEGINTERFERON ALFA-2B,2,Terminated,IFNAR2,2
lupus nephritis,METHYLPREDNISOLONE,2,"Active, not recruiting",NR3C1,2
renal cell carcinoma,PAZOPANIB,3,"Active, not recruiting",FGFR1,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,PDGFRB,2
renal carcinoma,SORAFENIB,2,Completed,RAF1,2
renal cell carcinoma,AXITINIB,3,"Active, not recruiting",FLT4,2
lupus nephritis,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH2,2
lupus nephritis,MYCOPHENOLATE MOFETIL,4,Recruiting,IMPDH1,2
lupus nephritis,MYCOPHENOLATE MOFETIL,4,Recruiting,IMPDH2,2
renal cell carcinoma,AXITINIB,2,Recruiting,FLT1,2
renal cell carcinoma,AXITINIB,2,Recruiting,FLT4,2
renal cell carcinoma,AXITINIB,2,Recruiting,KDR,2
renal cell carcinoma,AXITINIB,3,"Active, not recruiting",FLT1,2
renal cell carcinoma,AXITINIB,3,"Active, not recruiting",KDR,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,PDGFRA,2
renal cell carcinoma,AXITINIB,4,n/a,FLT1,2
renal cell carcinoma,AXITINIB,4,n/a,FLT4,2
renal cell carcinoma,AXITINIB,4,n/a,KDR,2
Autosomal dominant polycystic kidney disease,LANREOTIDE,3,"Active, not recruiting",SSTR2,2
kidney disease,TACROLIMUS,4,Unknown status,FKBP1A,2
kidney disease,TACROLIMUS,4,Completed,FKBP1A,2
kidney disease,TACROLIMUS,3,Completed,FKBP1A,2
lupus nephritis,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH1,2
lupus nephritis,MYCOPHENOLATE MOFETIL,3,Terminated,IMPDH2,2
lupus nephritis,MYCOPHENOLATE MOFETIL,3,Terminated,IMPDH1,2
nephrotic syndrome,DEXAMETHASONE PHOSPHORIC ACID,4,n/a,NR3C1,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,LCK,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,KIT,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,KDR,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,ITK,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,FLT4,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,FLT1,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,FGFR3,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,FGFR1,2
renal cell carcinoma,PAZOPANIB,2,Unknown status,CSF1R,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,PRIM2,2
transitional cell carcinoma of kidney,GEMCITABINE,2,Unknown status,RRM1,2
Autosomal dominant polycystic kidney disease,SIROLIMUS,2,Terminated,FKBP1A,2
diabetic nephropathy,CCX140,2,Completed,CCR2,2
nephrotic syndrome,CORTISONE ACETATE,4,n/a,NR3C1,2
nephrotic syndrome,DEXAMETHASONE,4,n/a,NR3C1,2
renal carcinoma,SORAFENIB,2,Completed,PDGFRB,2
kidney disease,EVEROLIMUS,4,Unknown status,FKBP1A,2
renal carcinoma,SORAFENIB,2,Completed,RET,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC1,2
clear cell renal carcinoma,SORAFENIB,2,Terminated,KIT,2
clear cell renal carcinoma,SORAFENIB,2,Terminated,PDGFRB,2
clear cell renal carcinoma,SORAFENIB,2,Terminated,RAF1,2
clear cell renal carcinoma,SORAFENIB,2,Terminated,RET,2
clear cell renal carcinoma,SUNITINIB,1,Completed,CSF1R,2
clear cell renal carcinoma,SUNITINIB,1,Completed,FLT1,2
clear cell renal carcinoma,SUNITINIB,1,Completed,FLT3,2
clear cell renal carcinoma,SUNITINIB,1,Completed,FLT4,2
clear cell renal carcinoma,SUNITINIB,1,Completed,KDR,2
clear cell renal carcinoma,SUNITINIB,1,Completed,KIT,2
clear cell renal carcinoma,SUNITINIB,1,Completed,PDGFRA,2
clear cell renal carcinoma,SUNITINIB,1,Completed,PDGFRB,2
clear cell renal carcinoma,SUNITINIB,1,Completed,RET,2
renal cell carcinoma,CABOZANTINIB,1,Recruiting,MET,2
diabetic nephropathy,FINERENONE,2,Completed,NR3C2,2
clear cell renal carcinoma,SORAFENIB,2,Terminated,KDR,2
clear cell renal carcinoma,SORAFENIB,2,Terminated,FLT4,2
clear cell renal carcinoma,SORAFENIB,2,Terminated,FLT3,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC6,2
renal cell carcinoma,ERLOTINIB,1,Terminated,EGFR,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB1,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC9,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC8,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC7,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC5,2
clear cell renal carcinoma,SORAFENIB,2,Terminated,FLT1,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC4,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC3,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC2,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC11,2
renal cell carcinoma,ENTINOSTAT,2,Recruiting,HDAC10,2
clear cell renal carcinoma,SORAFENIB,2,Terminated,BRAF,2
diabetic nephropathy,FINERENONE,3,"Active, not recruiting",NR3C2,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB2A,2
kidney disease,LOSARTAN,4,Completed,AGTR1,2
renal cell carcinoma,DURVALUMAB,2,Not yet recruiting,CD274,2
renal cell carcinoma,CABOZANTINIB,3,Recruiting,KDR,2
renal cell carcinoma,ALDESLEUKIN,1,Recruiting,IL2RA,2
renal cell carcinoma,ALDESLEUKIN,1,Recruiting,IL2RB,2
diabetic nephropathy,MT-3995,1,Completed,NR3C2,2
renal cell carcinoma,ALDESLEUKIN,2,Recruiting,IL2RA,2
renal cell carcinoma,ALDESLEUKIN,2,Recruiting,IL2RB,2
diabetic nephropathy,LOSARTAN,4,Completed,AGTR1,2
nephrotic syndrome,OFATUMUMAB,2,Recruiting,MS4A1,2
renal cell carcinoma,ALDESLEUKIN,3,Completed,IL2RA,2
renal cell carcinoma,ALDESLEUKIN,3,Completed,IL2RB,2
renal cell carcinoma,CEDIRANIB,2,Completed,PDGFRB,2
renal cell carcinoma,CEDIRANIB,2,Completed,PDGFRA,2
renal cell carcinoma,CEDIRANIB,2,Completed,KIT,2
renal cell carcinoma,CEDIRANIB,2,Completed,KDR,2
renal cell carcinoma,CEDIRANIB,2,Completed,FLT4,2
clear cell renal carcinoma,SUNITINIB,2,Recruiting,RET,2
clear cell renal carcinoma,SUNITINIB,2,Recruiting,PDGFRB,2
clear cell renal carcinoma,SUNITINIB,2,Recruiting,PDGFRA,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB6,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB2B,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB3,2
renal cell carcinoma,DOXORUBICIN,2,Completed,TOP2A,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB4A,2
renal cell carcinoma,CABOZANTINIB,2,Recruiting,KDR,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB4B,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB8,2
clear cell renal carcinoma,SUNITINIB,2,Recruiting,KIT,2
clear cell renal carcinoma,SUNITINIB,2,Recruiting,CSF1R,2
clear cell renal carcinoma,SUNITINIB,2,Recruiting,FLT1,2
clear cell renal carcinoma,SUNITINIB,2,Recruiting,FLT3,2
clear cell renal carcinoma,SUNITINIB,2,Recruiting,FLT4,2
renal cell carcinoma,CABOZANTINIB,2,Recruiting,MET,2
clear cell renal carcinoma,SUNITINIB,2,Recruiting,KDR,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB8,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB6,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB4B,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB4A,2
kidney disease,DEXMEDETOMIDINE,4,Completed,ADRA2A,2
kidney disease,DARBEPOETIN ALFA,4,Completed,EPOR,2
renal cell carcinoma,IPILIMUMAB,3,Recruiting,CTLA4,2
kidney disease,ATORVASTATIN,4,Completed,HMGCR,2
chronic kidney disease,TICAGRELOR,3,Unknown status,P2RY12,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,2
renal cell carcinoma,INTERFERON ALFA-2A,2,Completed,IFNAR2,2
renal cell carcinoma,INTERFERON ALFA-2A,2,Completed,IFNAR1,2
chronic kidney disease,VONAPANITASE,1,Completed,ELN,2
chronic kidney disease,VONAPANITASE,3,"Active, not recruiting",ELN,2
nephrotic syndrome,SPIRONOLACTONE,4,n/a,NR3C2,2
nephrotic syndrome,RITUXIMAB,3,Completed,MS4A1,2
clear cell renal carcinoma,BEVACIZUMAB,2,Completed,VEGFA,2
renal cell carcinoma,GEMCITABINE,2,Terminated,RRM1,2
renal cell carcinoma,GEMCITABINE,2,Terminated,PRIM2,2
kidney disease,DEXMEDETOMIDINE,4,Completed,ADRA2B,2
kidney disease,DEXMEDETOMIDINE,4,Completed,ADRA2C,2
lupus nephritis,PREDNISONE,3,Terminated,NR3C1,2
chronic kidney disease,TACROLIMUS,2,Completed,FKBP1A,2
chronic kidney disease,SIROLIMUS,2,Completed,FKBP1A,2
chronic kidney disease,SIROLIMUS,4,Completed,FKBP1A,2
chronic kidney disease,SOMATROPIN,2,Completed,GHR,2
renal cell carcinoma,CEDIRANIB,2,Completed,FLT1,2
chronic kidney disease,SPIRONOLACTONE,3,Recruiting,NR3C2,2
chronic kidney disease,SPIRONOLACTONE,4,Completed,NR3C2,2
lupus nephritis,PREDNISOLONE,2,Completed,NR3C1,2
renal cell carcinoma,CABOZANTINIB,1,Recruiting,KDR,2
chronic kidney disease,TACROLIMUS,3,Recruiting,FKBP1A,2
renal cell carcinoma,LAPATINIB,1,Completed,ERBB2,2
chronic kidney disease,TACROLIMUS,4,Recruiting,FKBP1A,2
renal cell carcinoma,LAPATINIB,1,Completed,EGFR,2
lupus nephritis,PREDNISONE,2,"Active, not recruiting",NR3C1,2
renal cell carcinoma,BEVACIZUMAB,3,Withdrawn,VEGFA,2
renal cell carcinoma,GEMCITABINE,2,Terminated,PRIM1,2
renal cell carcinoma,GEMCITABINE,2,Terminated,POLE3,2
renal cell carcinoma,GEMCITABINE,2,Terminated,POLE2,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,PDGFRA,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,FLT1,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,FLT4,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,ITK,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,KDR,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,KIT,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,LCK,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,PDGFRB,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,FGFR1,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB1,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB2A,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB2B,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB3,2
renal cell carcinoma,EVEROLIMUS,2,Recruiting,FKBP1A,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,FGFR3,2
clear cell renal carcinoma,PAZOPANIB,2,Completed,CSF1R,2
renal cell carcinoma,GEMCITABINE,2,Terminated,POLE,2
renal carcinoma,TRETINOIN,2,Completed,RARA,2
renal cell carcinoma,GEMCITABINE,2,Terminated,POLD4,2
renal cell carcinoma,GEMCITABINE,2,Terminated,POLD3,2
renal cell carcinoma,GEMCITABINE,2,Terminated,POLD2,2
renal cell carcinoma,GEMCITABINE,2,Terminated,POLD1,2
renal cell carcinoma,GEMCITABINE,2,Terminated,POLA2,2
renal cell carcinoma,GEMCITABINE,2,Terminated,POLA1,2
renal carcinoma,TRETINOIN,2,Completed,RARB,2
clear cell renal carcinoma,NIVOLUMAB,1,Recruiting,PDCD1,2
renal carcinoma,TRETINOIN,2,Completed,RARG,2
focal segmental glomerulosclerosis,DEXAMETHASONE,3,Completed,NR3C1,2
clear cell renal carcinoma,EVEROLIMUS,2,"Active, not recruiting",FKBP1A,2
focal segmental glomerulosclerosis,CCX140,2,Recruiting,CCR2,2
clear cell renal carcinoma,INTERFERON ALFA-2B,2,Completed,IFNAR1,2
clear cell renal carcinoma,INTERFERON ALFA-2B,2,Completed,IFNAR2,2
renal carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,2
transitional cell carcinoma of kidney,PAZOPANIB,2,Completed,KDR,2
renal carcinoma,DOXORUBICIN,3,Completed,TOP2A,2
transitional cell carcinoma of kidney,BORTEZOMIB,2,Completed,PSMB5,2
Tuberous sclerosis,EVEROLIMUS,2,"Active, not recruiting",FKBP1A,2
Granulomatosis with Polyangiitis,RITUXIMAB,2,Completed,MS4A1,2
renal carcinoma,LENALIDOMIDE,2,Completed,CRBN,2
renal carcinoma,LENALIDOMIDE,2,Completed,CUL4A,2
renal carcinoma,LENALIDOMIDE,2,Completed,DDB1,2
renal carcinoma,LENALIDOMIDE,2,Completed,RBX1,2
transitional cell carcinoma of kidney,DOXORUBICIN,2,Completed,TOP2A,2
renal carcinoma,METHOTREXATE,2,Completed,DHFR,2
renal cell carcinoma,SORAFENIB,2,Recruiting,BRAF,2
chronic kidney disease,DESFLURANE,4,Completed,GABRB1,2
chronic kidney disease,DESFLURANE,4,Completed,GABRB2,2
renal cell carcinoma,SORAFENIB,2,Recruiting,FLT1,2
chronic kidney disease,HEPARIN SODIUM,3,Unknown status,SERPINC1,2
chronic kidney disease,DESFLURANE,4,Completed,GABRA5,2
Granulomatosis with Polyangiitis,PREDNISONE,3,Recruiting,NR3C1,2
chronic kidney disease,DESFLURANE,4,Completed,GABRA4,2
chronic kidney disease,DESFLURANE,4,Completed,GABRA3,2
chronic kidney disease,DESFLURANE,4,Completed,GABRB3,2
chronic kidney disease,DESFLURANE,4,Completed,GABRA2,2
renal carcinoma,ETOPOSIDE,3,Completed,TOP2A,2
chronic kidney disease,EVEROLIMUS,4,Completed,FKBP1A,2
renal cell carcinoma,SUNITINIB,1,Unknown status,RET,2
renal carcinoma,GEFITINIB,2,Completed,EGFR,2
renal carcinoma,FLUOROURACIL,3,Completed,TYMS,2
renal cell carcinoma,SUNITINIB,1,Unknown status,PDGFRB,2
chronic kidney disease,DESFLURANE,4,Completed,GABRE,2
chronic kidney disease,DESFLURANE,4,Completed,GABRG1,2
chronic kidney disease,DESFLURANE,4,Completed,GABRG2,2
transitional cell carcinoma of kidney,FILGRASTIM,2,Completed,CSF3R,2
renal carcinoma,GEMCITABINE,2,Terminated,POLE3,2
renal cell carcinoma,SUNITINIB,1,Unknown status,PDGFRA,2
chronic kidney disease,CLOPIDOGREL,3,Completed,P2RY12,2
IGA glomerulonephritis,METHYLPREDNISOLONE,3,Completed,NR3C1,2
renal carcinoma,CAPECITABINE,2,Completed,TYMS,2
renal carcinoma,EVEROLIMUS,2,"Active, not recruiting",FKBP1A,2
renal carcinoma,EVEROLIMUS,2,Completed,FKBP1A,2
chronic kidney disease,IRBESARTAN,3,Completed,AGTR1,2
lupus nephritis,AZATHIOPRINE,2,Completed,PPAT,2
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH2,2
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH1,2
Granulomatosis with Polyangiitis,METHYLPREDNISOLONE,2,Completed,NR3C1,2
Granulomatosis with Polyangiitis,ETANERCEPT,2,Completed,TNF,2
Granulomatosis with Polyangiitis,AZATHIOPRINE,3,Terminated,PPAT,2
chronic kidney disease,CINACALCET,3,Terminated,CASR,2
chronic kidney disease,CINACALCET,4,Completed,CASR,2
Granulomatosis with Polyangiitis,AZATHIOPRINE,2,Completed,PPAT,2
renal carcinoma,IPILIMUMAB,2,Recruiting,CTLA4,2
chronic kidney disease,BASILIXIMAB,4,Completed,IL2RA,2
chronic kidney disease,BASILIXIMAB,2,Terminated,IL2RA,2
renal carcinoma,FILGRASTIM,3,Completed,CSF3R,2
renal cell carcinoma,TIVOZANIB,3,Completed,FLT1,2
renal cell carcinoma,TIVOZANIB,3,Completed,FLT4,2
renal cell carcinoma,TIVOZANIB,3,Completed,KDR,2
chronic kidney disease,DESFLURANE,4,Completed,GABRA6,2
renal cell carcinoma,TREBANANIB,2,"Active, not recruiting",ANGPT1,2
renal cell carcinoma,TREBANANIB,2,"Active, not recruiting",ANGPT2,2
chronic kidney disease,HYDROCHLOROTHIAZIDE,4,Unknown status,SLC12A3,2
renal carcinoma,GEMCITABINE,2,Terminated,RRM1,2
renal carcinoma,GEMCITABINE,2,Terminated,PRIM2,2
renal carcinoma,GEMCITABINE,2,Terminated,PRIM1,2
chronic kidney disease,DESFLURANE,4,Completed,GABRG3,2
chronic kidney disease,DESFLURANE,4,Completed,GABRD,2
chronic kidney disease,ERGOCALCIFEROL,4,Completed,VDR,2
chronic kidney disease,DESFLURANE,4,Completed,GABRP,2
chronic kidney disease,DESFLURANE,4,Completed,GLRA1,2
renal cell carcinoma,PEMBROLIZUMAB,3,Recruiting,PDCD1,2
renal cell carcinoma,PEMBROLIZUMAB,3,"Active, not recruiting",PDCD1,2
renal cell carcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,2
renal cell carcinoma,SUNITINIB,3,Terminated,CSF1R,2
renal cell carcinoma,SUNITINIB,1,Unknown status,KIT,2
renal cell carcinoma,PEMBROLIZUMAB,1,Recruiting,PDCD1,2
renal cell carcinoma,SUNITINIB,3,Terminated,FLT3,2
renal cell carcinoma,SUNITINIB,3,Terminated,FLT4,2
chronic kidney disease,DESFLURANE,4,Completed,KCNK10,2
chronic kidney disease,DESFLURANE,4,Completed,KCNK18,2
chronic kidney disease,DESFLURANE,4,Completed,KCNK2,2
chronic kidney disease,DESFLURANE,4,Completed,KCNK3,2
chronic kidney disease,DESFLURANE,4,Completed,KCNK9,2
chronic kidney disease,DEXAMETHASONE,3,Completed,NR3C1,2
renal cell carcinoma,SUNITINIB,3,Terminated,KDR,2
renal cell carcinoma,SUNITINIB,3,Terminated,KIT,2
renal cell carcinoma,SUNITINIB,3,Terminated,PDGFRA,2
renal carcinoma,GEMCITABINE,2,Terminated,POLA1,2
renal cell carcinoma,SUNITINIB,3,Terminated,PDGFRB,2
renal cell carcinoma,SUNITINIB,3,Terminated,RET,2
chronic kidney disease,DOXERCALCIFEROL,4,Completed,VDR,2
IGA glomerulonephritis,VALSARTAN,4,Completed,AGTR1,2
renal carcinoma,GEMCITABINE,2,Terminated,POLA2,2
renal carcinoma,GEMCITABINE,2,Terminated,POLD1,2
renal carcinoma,GEMCITABINE,2,Terminated,POLD2,2
renal carcinoma,GEMCITABINE,2,Terminated,POLD3,2
renal carcinoma,GEMCITABINE,2,Terminated,POLD4,2
IGA glomerulonephritis,PREDNISONE,4,"Active, not recruiting",NR3C1,2
chronic kidney disease,DESFLURANE,4,Completed,GABRQ,2
renal cell carcinoma,SUNITINIB,3,Terminated,FLT1,2
renal carcinoma,ATEZOLIZUMAB,1,Recruiting,CD274,2
chronic kidney disease,EPOETIN ALFA,4,Completed,EPOR,2
renal carcinoma,CYCLOSPORINE,2,Unknown status,PPIA,2
renal cell carcinoma,SUNITINIB,1,Unknown status,FLT3,2
renal cell carcinoma,SORAFENIB,2,Recruiting,RET,2
renal cell carcinoma,SORAFENIB,2,Recruiting,RAF1,2
renal cell carcinoma,SORAFENIB,2,Recruiting,PDGFRB,2
renal cell carcinoma,SORAFENIB,2,Recruiting,KIT,2
renal cell carcinoma,SORAFENIB,2,Recruiting,KDR,2
chronic kidney disease,EPOETIN ALFA,1,Completed,EPOR,2
renal carcinoma,DOXORUBICIN,2,Unknown status,TOP2A,2
renal cell carcinoma,SUNITINIB,1,Unknown status,FLT4,2
renal cell carcinoma,SORAFENIB,2,Recruiting,FLT4,2
renal cell carcinoma,SUNITINIB,1,Unknown status,KDR,2
kidney failure,SIROLIMUS,4,Completed,FKBP1A,2
renal cell carcinoma,SORAFENIB,2,Recruiting,FLT3,2
chronic kidney disease,DESFLURANE,4,Completed,GABRA1,2
renal carcinoma,ETOPOSIDE,3,Completed,TOP2B,2
renal carcinoma,GEMCITABINE,2,Terminated,POLE,2
renal carcinoma,GEMCITABINE,2,Terminated,POLE2,2
renal cell carcinoma,SUNITINIB,1,Unknown status,FLT1,2
renal cell carcinoma,SUNITINIB,1,Unknown status,CSF1R,2
IGA glomerulonephritis,AZATHIOPRINE,3,Completed,PPAT,2
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB3,1
renal carcinoma,VATALANIB,1,Completed,KIT,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,1
renal carcinoma,DENILEUKIN DIFTITOX,0,Completed,IL2RB,1
renal carcinoma,VATALANIB,1,Completed,KDR,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLA1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLA2,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB2A,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB,1
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB8,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB2B,1
renal carcinoma,VATALANIB,1,Completed,PDGFRB,1
renal carcinoma,VATALANIB,1,Completed,PDGFRA,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB3,1
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB,1
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB6,1
renal carcinoma,DIPHENHYDRAMINE,2,"Active, not recruiting",HRH1,1
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB1,1
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB4B,1
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB2A,1
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB2B,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB1,1
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB4A,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLD1,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB4A,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB4B,1
renal carcinoma,VANDETANIB,2,Completed,EPHB3,1
renal carcinoma,VATALANIB,1,Completed,FLT4,1
renal carcinoma,VATALANIB,1,Completed,FLT1,1
renal carcinoma,TREMELIMUMAB,0,Recruiting,CTLA4,1
nephrotic syndrome,RITUXIMAB,2,Unknown status,MS4A1,1
nephrotic syndrome,RITUXIMAB,2,Recruiting,MS4A1,1
nephrotic syndrome,RITUXIMAB,2,Completed,MS4A1,1
nephrotic syndrome,PREDNISONE,4,Not yet recruiting,NR3C1,1
nephrotic syndrome,PREDNISONE,3,Completed,NR3C1,1
nephrotic syndrome,PREDNISOLONE,4,Unknown status,NR3C1,1
nephrotic syndrome,PREDNISOLONE,4,Completed,NR3C1,1
nephrotic syndrome,PREDNISOLONE,3,Recruiting,NR3C1,1
nephrotic syndrome,PREDNISOLONE,3,Completed,NR3C1,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE9A,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE8B,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE8A,1
renal carcinoma,UCN-01,2,Unknown status,CDK2,1
renal carcinoma,UCN-01,2,Unknown status,CDK4,1
renal carcinoma,UCN-01,2,Unknown status,CDK6,1
renal carcinoma,UCN-01,2,Unknown status,CHEK1,1
renal carcinoma,TINZAPARIN SODIUM,1,Unknown status,SERPINC1,1
renal carcinoma,THALIDOMIDE,3,Completed,RBX1,1
renal carcinoma,THALIDOMIDE,3,Completed,DDB1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLD3,1
renal carcinoma,TEMSIROLIMUS,2,Terminated,FKBP1A,1
renal carcinoma,THALIDOMIDE,2,Terminated,CRBN,1
renal carcinoma,THALIDOMIDE,2,Terminated,CUL4A,1
renal carcinoma,THALIDOMIDE,2,Terminated,DDB1,1
renal carcinoma,THALIDOMIDE,2,Terminated,RBX1,1
renal carcinoma,THALIDOMIDE,2,Unknown status,CRBN,1
renal carcinoma,THALIDOMIDE,2,Unknown status,CUL4A,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLD2,1
renal carcinoma,THALIDOMIDE,3,Completed,CUL4A,1
renal carcinoma,THALIDOMIDE,2,Unknown status,DDB1,1
renal carcinoma,THALIDOMIDE,2,Unknown status,RBX1,1
renal carcinoma,THALIDOMIDE,2,Withdrawn,CRBN,1
renal carcinoma,THALIDOMIDE,2,Withdrawn,CUL4A,1
renal carcinoma,THALIDOMIDE,2,Withdrawn,DDB1,1
renal carcinoma,THALIDOMIDE,2,Withdrawn,RBX1,1
renal carcinoma,THALIDOMIDE,3,Completed,CRBN,1
renal carcinoma,UCN-01,2,Unknown status,PDPK1,1
renal carcinoma,UCN-01,2,Unknown status,PRKCA,1
renal carcinoma,UCN-01,2,Unknown status,PRKCB,1
renal carcinoma,VANDETANIB,2,Completed,ERBB4,1
renal carcinoma,VANDETANIB,2,Completed,EPHB2,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB8,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE7A,1
renal carcinoma,VANDETANIB,2,Completed,EPHB4,1
renal carcinoma,VANDETANIB,2,Completed,EPHB6,1
renal carcinoma,VANDETANIB,2,Completed,ERBB2,1
renal carcinoma,VANDETANIB,2,Completed,ERBB3,1
renal carcinoma,VANDETANIB,2,Completed,FLT1,1
renal carcinoma,VANDETANIB,2,Completed,EPHB1,1
renal carcinoma,VANDETANIB,2,Completed,FLT4,1
renal carcinoma,VANDETANIB,2,Completed,KDR,1
renal carcinoma,VANDETANIB,2,Completed,PTK6,1
renal carcinoma,VANDETANIB,2,Completed,RET,1
renal carcinoma,VANDETANIB,2,Completed,SRC,1
renal carcinoma,VANDETANIB,2,Completed,TEK,1
renal carcinoma,VATALANIB,1,Completed,CSF1R,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE7B,1
renal carcinoma,VANDETANIB,2,Completed,EPHA8,1
renal carcinoma,UCN-01,2,Unknown status,PRKCD,1
renal carcinoma,UCN-01,2,Unknown status,PRKD3,1
renal carcinoma,UCN-01,2,Unknown status,PRKCE,1
renal carcinoma,UCN-01,2,Unknown status,PRKCG,1
renal carcinoma,UCN-01,2,Unknown status,PRKCH,1
renal carcinoma,UCN-01,2,Unknown status,PRKCI,1
renal carcinoma,UCN-01,2,Unknown status,PRKCQ,1
renal carcinoma,UCN-01,2,Unknown status,PRKCZ,1
renal carcinoma,UCN-01,2,Unknown status,PRKD1,1
renal carcinoma,VANDETANIB,2,Completed,EGFR,1
renal carcinoma,VANDETANIB,2,Completed,EPHA7,1
renal carcinoma,VANDETANIB,2,Completed,EPHA1,1
renal carcinoma,VANDETANIB,2,Completed,EPHA10,1
renal carcinoma,VANDETANIB,2,Completed,EPHA2,1
renal carcinoma,VANDETANIB,2,Completed,EPHA3,1
renal carcinoma,VANDETANIB,2,Completed,EPHA4,1
renal carcinoma,VANDETANIB,2,Completed,EPHA5,1
renal carcinoma,VANDETANIB,2,Completed,EPHA6,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB6,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB4B,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",PRIM1,1
renal cell carcinoma,ANLOTINIB,2,"Active, not recruiting",PDGFRB,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",POLD4,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",POLE,1
renal cell carcinoma,ANLOTINIB,2,Unknown status,FLT4,1
renal cell carcinoma,ANLOTINIB,2,Unknown status,KDR,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",POLE2,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",POLE3,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",PRIM2,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,POLE,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",RRM1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLA1,1
renal cell carcinoma,ANLOTINIB,2,Unknown status,KIT,1
renal cell carcinoma,ANLOTINIB,2,Unknown status,PDGFRB,1
renal cell carcinoma,APATINIB,2,Unknown status,KDR,1
renal cell carcinoma,APITOLISIB,2,Completed,MTOR,1
renal cell carcinoma,APITOLISIB,2,Completed,PIK3CA,1
nephrotic syndrome,MYCOPHENOLIC ACID,3,Completed,IMPDH1,1
renal cell carcinoma,ANLOTINIB,2,"Active, not recruiting",KIT,1
renal cell carcinoma,ANLOTINIB,2,"Active, not recruiting",KDR,1
renal cell carcinoma,ANLOTINIB,2,"Active, not recruiting",FLT4,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,ADORA2A,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,POLE3,1
renal cell carcinoma,ALDESLEUKIN,2,Unknown status,IL2RA,1
renal cell carcinoma,ALDESLEUKIN,2,Unknown status,IL2RB,1
renal cell carcinoma,ALDESLEUKIN,2,Withdrawn,IL2RA,1
renal cell carcinoma,ALDESLEUKIN,2,Withdrawn,IL2RB,1
nephrotic syndrome,MYCOPHENOLIC ACID,3,Completed,IMPDH2,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,PRIM1,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,PRIM2,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,RRM1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",POLA1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",POLA2,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",POLD1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",POLD2,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,"Active, not recruiting",POLD3,1
renal cell carcinoma,APITOLISIB,2,Completed,PIK3CB,1
renal cell carcinoma,APITOLISIB,2,Completed,PIK3CD,1
renal cell carcinoma,APITOLISIB,2,Completed,PIK3CG,1
renal cell carcinoma,ATEZOLIZUMAB,3,Withdrawn,CD274,1
renal cell carcinoma,AVELUMAB,1,"Active, not recruiting",CD274,1
nephrotic syndrome,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH1,1
nephrotic syndrome,MYCOPHENOLATE MOFETIL,3,Terminated,IMPDH2,1
nephrotic syndrome,MYCOPHENOLATE MOFETIL,3,Terminated,IMPDH1,1
nephrotic syndrome,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH2,1
nephrotic syndrome,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH1,1
nephrotic syndrome,DEXAMETHASONE,2,Completed,NR3C1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,PRIM2,1
renal cell carcinoma,AVELUMAB,1,Recruiting,CD274,1
renal cell carcinoma,AVELUMAB,2,Recruiting,CD274,1
nephrotic syndrome,CORTICOTROPIN,4,Completed,MC2R,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,RRM1,1
renal cell carcinoma,AVELUMAB,2,Withdrawn,CD274,1
renal cell carcinoma,AVELUMAB,3,"Active, not recruiting",CD274,1
nephrotic syndrome,CORTICOTROPIN,3,Completed,MC2R,1
renal cell carcinoma,ATORVASTATIN,2,Completed,HMGCR,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,PRIM1,1
renal cell carcinoma,APITOLISIB,2,Completed,PIK3R1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLE3,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLA2,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD1,1
renal cell carcinoma,APITOLISIB,2,Completed,PIK3R2,1
renal cell carcinoma,APITOLISIB,2,Completed,PIK3R3,1
renal cell carcinoma,APITOLISIB,2,Completed,PIK3R5,1
nephrotic syndrome,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH2,1
renal cell carcinoma,ATEZOLIZUMAB,1,Recruiting,CD274,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD2,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD3,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD4,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLE,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLE2,1
renal cell carcinoma,ATEZOLIZUMAB,2,Completed,CD274,1
renal cell carcinoma,ATEZOLIZUMAB,3,"Active, not recruiting",CD274,1
renal cell carcinoma,ATEZOLIZUMAB,3,Recruiting,CD274,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,POLE2,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,POLD4,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2A,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC11,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE4B,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE4A,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE3B,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE3A,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE2A,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE1C,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE1B,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC2,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,ADORA2B,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC3,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC4,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC5,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC6,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC7,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC8,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC9,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE4C,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE4D,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC10,1
renal carcinoma,ENTINOSTAT,1,Recruiting,HDAC1,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE6H,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2B,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB3,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4A,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE6G,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE6D,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE6C,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE6B,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4B,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB6,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE6A,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE5A,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB8,1
nephrotic syndrome,RITUXIMAB,3,Recruiting,MS4A1,1
renal carcinoma,DOXORUBICIN,3,Unknown status,TOP2A,1
renal carcinoma,ERLOTINIB,1,"Active, not recruiting",EGFR,1
renal carcinoma,ESTRAMUSTINE PHOSPHATE,2,Completed,ESR2,1
renal carcinoma,ETOPOSIDE,2,Unknown status,TOP2A,1
renal carcinoma,VINORELBINE,2,Completed,TUBB8,1
renal carcinoma,ZOLEDRONIC ACID,2,Terminated,FDPS,1
renal cell carcinoma,AFLIBERCEPT,2,Completed,PGF,1
renal cell carcinoma,AFLIBERCEPT,2,Completed,VEGFA,1
renal cell carcinoma,ALDESLEUKIN,1,"Active, not recruiting",IL2RA,1
renal cell carcinoma,ALDESLEUKIN,1,"Active, not recruiting",IL2RB,1
renal cell carcinoma,ALDESLEUKIN,1,Completed,IL2RA,1
renal cell carcinoma,ALDESLEUKIN,1,Completed,IL2RB,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,POLD2,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,POLD3,1
renal cell carcinoma,ALDESLEUKIN,1,Unknown status,IL2RA,1
renal cell carcinoma,ALDESLEUKIN,1,Unknown status,IL2RB,1
renal cell carcinoma,ALDESLEUKIN,1,Withdrawn,IL2RA,1
renal cell carcinoma,ALDESLEUKIN,1,Withdrawn,IL2RB,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE1A,1
nephrotic syndrome,PENTOXIFYLLINE,3,Completed,PDE10A,1
renal carcinoma,ZOLEDRONIC ACID,1,Completed,FDPS,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,POLD1,1
renal carcinoma,ETOPOSIDE,2,Unknown status,TOP2B,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,POLA2,1
renal carcinoma,ETOPOSIDE,3,Unknown status,TOP2A,1
renal carcinoma,ETOPOSIDE,3,Unknown status,TOP2B,1
renal carcinoma,EVEROLIMUS,3,"Active, not recruiting",FKBP1A,1
renal carcinoma,VINORELBINE,2,Completed,TUBB,1
renal carcinoma,VINORELBINE,2,Completed,TUBB1,1
renal carcinoma,VINORELBINE,2,Completed,TUBB2A,1
renal carcinoma,VINORELBINE,2,Completed,TUBB2B,1
renal carcinoma,VINORELBINE,2,Completed,TUBB3,1
renal carcinoma,VINORELBINE,2,Completed,TUBB4A,1
renal carcinoma,VINORELBINE,2,Completed,TUBB4B,1
renal carcinoma,VINORELBINE,2,Completed,TUBB6,1
renal carcinoma,FILGRASTIM,1,Completed,CSF3R,1
renal carcinoma,FILGRASTIM,1,Terminated,CSF3R,1
renal carcinoma,FILGRASTIM,2,Completed,CSF3R,1
renal carcinoma,FLUDARABINE PHOSPHATE,1,Terminated,POLA1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLD4,1
renal carcinoma,SUNITINIB,2,Terminated,FLT4,1
renal carcinoma,TEMSIROLIMUS,2,"Active, not recruiting",FKBP1A,1
renal carcinoma,MYCOPHENOLATE MOFETIL,2,Terminated,IMPDH1,1
papillary renal cell carcinoma,SUNITINIB,2,Recruiting,KDR,1
papillary renal cell carcinoma,SUNITINIB,2,Recruiting,FLT4,1
renal carcinoma,IMATINIB,2,Terminated,PDGFRB,1
renal carcinoma,IMATINIB,2,Terminated,KIT,1
renal carcinoma,IMATINIB,2,Terminated,ABL1,1
renal carcinoma,IMATINIB,2,Completed,PDGFRB,1
renal carcinoma,IMATINIB,2,Completed,KIT,1
renal carcinoma,IMATINIB,2,Completed,ABL1,1
renal carcinoma,ALDESLEUKIN,2,"Active, not recruiting",IL2RB,1
papillary renal cell carcinoma,SUNITINIB,2,Recruiting,FLT3,1
papillary renal cell carcinoma,SUNITINIB,2,Recruiting,FLT1,1
papillary renal cell carcinoma,SUNITINIB,2,Recruiting,CSF1R,1
papillary renal cell carcinoma,SORAFENIB,2,Terminated,RET,1
papillary renal cell carcinoma,SORAFENIB,2,Terminated,RAF1,1
papillary renal cell carcinoma,SORAFENIB,2,Terminated,PDGFRB,1
papillary renal cell carcinoma,SORAFENIB,2,Terminated,KIT,1
papillary renal cell carcinoma,SORAFENIB,2,Terminated,KDR,1
renal carcinoma,INTERFERON ALFA-2A,3,Completed,IFNAR1,1
renal carcinoma,INTERFERON ALFA-2A,3,Completed,IFNAR2,1
papillary renal cell carcinoma,SUNITINIB,2,Recruiting,KIT,1
renal carcinoma,ISOTRETINOIN,1,Completed,RARG,1
renal carcinoma,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH1,1
renal carcinoma,MUROMONAB-CD3,2,Unknown status,CD3E,1
renal carcinoma,METHOTREXATE,2,Unknown status,DHFR,1
renal carcinoma,MEDROXYPROGESTERONE ACETATE,3,Completed,PGR,1
renal carcinoma,ISOTRETINOIN,3,Completed,RARG,1
renal carcinoma,ISOTRETINOIN,3,Completed,RARB,1
renal carcinoma,ISOTRETINOIN,3,Completed,RARA,1
renal carcinoma,ISOTRETINOIN,1,Completed,RARB,1
renal carcinoma,INTERFERON ALFA-2B,2,Withdrawn,IFNAR1,1
renal carcinoma,ISOTRETINOIN,1,Completed,RARA,1
renal carcinoma,IPILIMUMAB,2,Completed,CTLA4,1
renal carcinoma,IPILIMUMAB,1,Not yet recruiting,CTLA4,1
renal carcinoma,IODINE I 124 GIRENTUXIMAB,2,Unknown status,CA9,1
renal carcinoma,INTERFERON ALFA-2B,2,Withdrawn,IFNAR2,1
papillary renal cell carcinoma,SUNITINIB,2,Recruiting,PDGFRB,1
papillary renal cell carcinoma,SUNITINIB,2,Recruiting,PDGFRA,1
papillary renal cell carcinoma,SORAFENIB,2,Terminated,FLT4,1
papillary renal cell carcinoma,SORAFENIB,2,Terminated,FLT3,1
renal carcinoma,HISTAMINE,2,Unknown status,HRH1,1
renal carcinoma,GEMCITABINE,2,Unknown status,POLA2,1
papillary renal cell carcinoma,SORAFENIB,1,Completed,FLT3,1
renal carcinoma,GEMCITABINE,2,Unknown status,POLE2,1
renal carcinoma,GEMCITABINE,2,Unknown status,POLE,1
renal carcinoma,GEMCITABINE,2,Unknown status,POLD4,1
renal carcinoma,GEMCITABINE,2,Unknown status,POLD3,1
renal carcinoma,GEMCITABINE,2,Unknown status,POLD2,1
renal carcinoma,GEMCITABINE,2,Unknown status,POLD1,1
renal carcinoma,GEMCITABINE,2,Unknown status,POLA1,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRA5,1
renal carcinoma,ALDESLEUKIN,2,Terminated,IL2RA,1
renal carcinoma,ALDESLEUKIN,2,Terminated,IL2RB,1
renal carcinoma,ALDESLEUKIN,4,Completed,IL2RA,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRA6,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRB1,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRB2,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRB3,1
papillary renal cell carcinoma,SORAFENIB,1,Completed,FLT4,1
renal carcinoma,GEMCITABINE,2,Unknown status,POLE3,1
renal carcinoma,GIRENTUXIMAB,3,Completed,CA9,1
papillary renal cell carcinoma,SORAFENIB,1,Completed,KDR,1
renal carcinoma,GEMCITABINE,2,Unknown status,RRM1,1
papillary renal cell carcinoma,SORAFENIB,2,Terminated,FLT1,1
papillary renal cell carcinoma,SORAFENIB,2,Terminated,BRAF,1
papillary renal cell carcinoma,SORAFENIB,1,Completed,RET,1
papillary renal cell carcinoma,SORAFENIB,1,Completed,RAF1,1
papillary renal cell carcinoma,SORAFENIB,1,Completed,PDGFRB,1
papillary renal cell carcinoma,SORAFENIB,1,Completed,KIT,1
renal carcinoma,SEMAXANIB,2,Completed,FLT4,1
renal carcinoma,GEMCITABINE,2,Unknown status,PRIM1,1
renal carcinoma,SEMAXANIB,2,Completed,KDR,1
renal carcinoma,SEMAXANIB,2,Completed,KIT,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRA1,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRA2,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRA3,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRA4,1
renal carcinoma,GEMCITABINE,2,Unknown status,PRIM2,1
renal carcinoma,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH2,1
renal carcinoma,MYCOPHENOLATE MOFETIL,2,Terminated,IMPDH2,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRE,1
renal carcinoma,MYCOPHENOLATE MOFETIL,2,Unknown status,IMPDH1,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB8,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB6,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB4B,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB4A,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB3,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB2B,1
renal carcinoma,PEGINTERFERON ALFA-2A,1,Completed,IFNAR1,1
renal carcinoma,PEGINTERFERON ALFA-2A,1,Completed,IFNAR2,1
renal carcinoma,PEGINTERFERON ALFA-2B,1,Terminated,IFNAR1,1
renal carcinoma,PEGINTERFERON ALFA-2B,1,Terminated,IFNAR2,1
renal carcinoma,PEGINTERFERON ALFA-2B,2,Completed,IFNAR1,1
renal carcinoma,PEGINTERFERON ALFA-2B,2,Completed,IFNAR2,1
renal carcinoma,ALDESLEUKIN,0,Completed,IL2RB,1
renal carcinoma,ALDESLEUKIN,0,Completed,IL2RA,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB2A,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB1,1
renal carcinoma,PEMBROLIZUMAB,2,"Active, not recruiting",PDCD1,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB1,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB2A,1
renal carcinoma,PAZOPANIB,1,Completed,ITK,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB8,1
renal carcinoma,PANITUMUMAB,1,Completed,EGFR,1
renal carcinoma,PAZOPANIB,1,Completed,CSF1R,1
renal carcinoma,PAZOPANIB,1,Completed,FGFR1,1
renal carcinoma,PAZOPANIB,1,Completed,FGFR3,1
renal carcinoma,PAZOPANIB,1,Completed,FLT1,1
renal carcinoma,PAZOPANIB,1,Completed,FLT4,1
renal carcinoma,PAZOPANIB,1,Completed,KDR,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB2B,1
renal carcinoma,PAZOPANIB,1,Completed,KIT,1
renal carcinoma,PAZOPANIB,1,Completed,LCK,1
renal carcinoma,PAZOPANIB,1,Completed,PDGFRA,1
renal carcinoma,PAZOPANIB,1,Completed,PDGFRB,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB4A,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB3,1
renal carcinoma,ALDESLEUKIN,1,Terminated,IL2RA,1
renal carcinoma,PENTOSTATIN,1,Completed,ADA,1
renal carcinoma,PREDNISONE,2,Completed,NR3C1,1
renal carcinoma,PREDNISONE,2,Terminated,NR3C1,1
renal carcinoma,ORANTINIB,1,Unknown status,KDR,1
renal carcinoma,SARGRAMOSTIM,2,Terminated,CSF2RA,1
renal carcinoma,SARGRAMOSTIM,2,Unknown status,CSF2RA,1
renal carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K1,1
renal carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K2,1
renal carcinoma,SEMAXANIB,2,Completed,FLT1,1
papillary renal cell carcinoma,SUNITINIB,2,Recruiting,RET,1
renal carcinoma,ORANTINIB,1,Unknown status,PDGFRA,1
renal carcinoma,ORANTINIB,1,Unknown status,FGFR4,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRQ,1
renal carcinoma,ORANTINIB,1,Unknown status,FGFR3,1
renal carcinoma,ORANTINIB,1,Unknown status,FGFR2,1
renal carcinoma,ORANTINIB,1,Unknown status,FGFR1,1
renal carcinoma,ALDESLEUKIN,1,Terminated,IL2RB,1
renal carcinoma,ALDESLEUKIN,2,"Active, not recruiting",IL2RA,1
renal carcinoma,MYCOPHENOLATE MOFETIL,2,Withdrawn,IMPDH1,1
renal carcinoma,MYCOPHENOLATE MOFETIL,2,Unknown status,IMPDH2,1
renal carcinoma,SARGRAMOSTIM,2,Completed,CSF2RA,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRP,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRA1,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRA6,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRA2,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRA3,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRA4,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRA5,1
renal artery obstruction,ROSUVASTATIN,2,Completed,HMGCR,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB,1
renal carcinoma,ORANTINIB,1,Unknown status,PDGFRB,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRB1,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRG3,1
papillary renal cell carcinoma,TIVANTINIB,2,Completed,MET,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRB2,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRB3,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRD,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRE,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRG1,1
renal carcinoma,PROPOFOL,4,Recruiting,GABRG2,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRD,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRG1,1
renal carcinoma,TEMSIROLIMUS,1,Completed,FKBP1A,1
renal carcinoma,SORAFENIB,3,Completed,FLT4,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD3,1
papillary renal cell carcinoma,CRIZOTINIB,2,Recruiting,MET,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD2,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD1,1
papillary renal cell carcinoma,CRIZOTINIB,2,Recruiting,ALK,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA2,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA1,1
renal carcinoma,GEFITINIB,2,Terminated,EGFR,1
renal carcinoma,FLUOROURACIL,2,Unknown status,TYMS,1
renal carcinoma,FLUOROURACIL,1,Completed,TYMS,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,RRM1,1
papillary renal cell carcinoma,CAROTUXIMAB,2,Completed,ENG,1
papillary renal cell carcinoma,CAPMATINIB,2,Recruiting,MET,1
papillary renal cell carcinoma,CABOZANTINIB,2,Recruiting,MET,1
papillary renal cell carcinoma,CABOZANTINIB,2,Recruiting,KDR,1
papillary renal cell carcinoma,CABOZANTINIB,2,Not yet recruiting,MET,1
papillary renal cell carcinoma,CABOZANTINIB,2,Not yet recruiting,KDR,1
papillary renal cell carcinoma,ERLOTINIB,2,Completed,EGFR,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,1
renal carcinoma,SUNITINIB,1,Terminated,FLT3,1
renal carcinoma,SORAFENIB,3,Completed,KIT,1
renal carcinoma,SORAFENIB,3,Completed,PDGFRB,1
renal carcinoma,SORAFENIB,3,Completed,RAF1,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE3,1
renal carcinoma,SORAFENIB,3,Completed,RET,1
renal carcinoma,SUNITINIB,1,Terminated,CSF1R,1
renal carcinoma,SUNITINIB,1,Terminated,FLT1,1
renal carcinoma,SUNITINIB,1,Terminated,FLT4,1
renal carcinoma,SUNITINIB,1,Terminated,RET,1
renal carcinoma,SUNITINIB,1,Terminated,KDR,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE2,1
renal carcinoma,SUNITINIB,1,Terminated,KIT,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE,1
renal carcinoma,SUNITINIB,1,Terminated,PDGFRA,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD4,1
renal carcinoma,SUNITINIB,1,Terminated,PDGFRB,1
papillary renal cell carcinoma,BEVACIZUMAB,2,Completed,VEGFA,1
papillary renal cell carcinoma,BEVACIZUMAB,1,Completed,VEGFA,1
papillary renal cell carcinoma,AXITINIB,2,"Active, not recruiting",KDR,1
renal carcinoma,TACROLIMUS,2,Withdrawn,FKBP1A,1
renal carcinoma,DACTOLISIB,1,Terminated,PIK3R3,1
renal carcinoma,DACTOLISIB,1,Terminated,PIK3R5,1
papillary renal cell carcinoma,AXITINIB,2,"Active, not recruiting",FLT1,1
nephrotic syndrome,TRIAMTERENE,4,n/a,SCNN1A,1
nephrotic syndrome,TACROLIMUS,4,Recruiting,FKBP1A,1
renal carcinoma,DENILEUKIN DIFTITOX,0,Completed,EEF2,1
renal carcinoma,DENILEUKIN DIFTITOX,0,Completed,IL2RA,1
renal carcinoma,TANESPIMYCIN,1,Completed,HSP90AA1,1
renal carcinoma,DACTOLISIB,1,Terminated,PIK3R1,1
renal carcinoma,TANESPIMYCIN,1,Completed,HSP90AB1,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLE,1
nephrotic syndrome,RITUXIMAB,4,Recruiting,MS4A1,1
nephrotic syndrome,RITUXIMAB,3,Terminated,MS4A1,1
renal carcinoma,TANESPIMYCIN,2,Completed,HSP90AA1,1
renal carcinoma,TANESPIMYCIN,2,Completed,HSP90AB1,1
renal carcinoma,TEMSIROLIMUS,1,"Active, not recruiting",FKBP1A,1
renal carcinoma,DACTOLISIB,1,Terminated,PIK3R2,1
renal carcinoma,DACTOLISIB,1,Terminated,PIK3CG,1
papillary renal cell carcinoma,AXITINIB,2,"Active, not recruiting",FLT4,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLE3,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,PRIM2,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,PRIM1,1
renal carcinoma,SUNITINIB,2,Terminated,CSF1R,1
renal carcinoma,SUNITINIB,2,Terminated,FLT1,1
renal carcinoma,SUNITINIB,2,Terminated,FLT3,1
renal carcinoma,DACTOLISIB,1,Terminated,MTOR,1
renal carcinoma,DACTOLISIB,1,Terminated,PIK3CA,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB6,1
renal carcinoma,DACTOLISIB,1,Terminated,PIK3CD,1
renal carcinoma,SUNITINIB,2,Terminated,KDR,1
renal carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLE2,1
renal carcinoma,SUNITINIB,2,Terminated,KIT,1
renal carcinoma,SUNITINIB,2,Terminated,PDGFRA,1
renal carcinoma,SUNITINIB,2,Terminated,PDGFRB,1
renal carcinoma,SUNITINIB,2,Terminated,RET,1
renal carcinoma,DACTOLISIB,1,Terminated,PIK3CB,1
renal carcinoma,SORAFENIB,3,Completed,KDR,1
renal carcinoma,SORAFENIB,3,Completed,FLT3,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRG2,1
renal carcinoma,CYCLOSPORINE,2,Terminated,PPIA,1
renal carcinoma,SORAFENIB,0,Completed,BRAF,1
renal carcinoma,SORAFENIB,0,Completed,FLT1,1
renal carcinoma,SORAFENIB,0,Completed,FLT3,1
renal carcinoma,SORAFENIB,0,Completed,FLT4,1
renal carcinoma,SORAFENIB,0,Completed,KDR,1
renal carcinoma,SORAFENIB,0,Completed,KIT,1
renal carcinoma,SORAFENIB,0,Completed,PDGFRB,1
renal carcinoma,SORAFENIB,0,Completed,RAF1,1
renal carcinoma,SORAFENIB,0,Completed,RET,1
papillary renal cell carcinoma,SAVOLITINIB,2,Recruiting,MET,1
renal carcinoma,ATEZOLIZUMAB,2,Recruiting,CD274,1
renal carcinoma,ATRASENTAN,2,Completed,EDNRA,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",LCK,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",KIT,1
renal carcinoma,AXITINIB,2,"Active, not recruiting",FLT1,1
renal carcinoma,SILTUXIMAB,2,Withdrawn,IL6,1
renal carcinoma,SEVOFLURANE,4,Recruiting,KCNK9,1
renal carcinoma,SEVOFLURANE,4,Recruiting,KCNK3,1
renal carcinoma,ALDESLEUKIN,4,Completed,IL2RB,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRG3,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRP,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GABRQ,1
renal carcinoma,SEVOFLURANE,4,Recruiting,GLRA1,1
renal carcinoma,SEVOFLURANE,4,Recruiting,KCNK10,1
papillary renal cell carcinoma,SORAFENIB,1,Completed,FLT1,1
renal carcinoma,SEVOFLURANE,4,Recruiting,KCNK18,1
renal carcinoma,ALEMTUZUMAB,2,"Active, not recruiting",CD52,1
papillary renal cell carcinoma,SORAFENIB,1,Completed,BRAF,1
renal carcinoma,ALVOCIDIB,2,Completed,CDK1,1
renal carcinoma,ALVOCIDIB,2,Completed,CDK2,1
renal carcinoma,ALVOCIDIB,2,Completed,CDK4,1
renal carcinoma,ALVOCIDIB,2,Completed,CDK6,1
renal carcinoma,ALVOCIDIB,2,Completed,CDK7,1
renal carcinoma,ALVOCIDIB,2,Completed,CDK9,1
renal carcinoma,SEVOFLURANE,4,Recruiting,KCNK2,1
renal carcinoma,SORAFENIB,1,Terminated,BRAF,1
renal carcinoma,SORAFENIB,1,Terminated,FLT1,1
renal carcinoma,SORAFENIB,1,Terminated,FLT3,1
renal carcinoma,SORAFENIB,2,Terminated,KDR,1
renal carcinoma,CYCLOSPORINE,1,Completed,PPIA,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",RRM1,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM2,1
renal carcinoma,SORAFENIB,2,Terminated,BRAF,1
renal carcinoma,SORAFENIB,2,Terminated,FLT1,1
renal carcinoma,SORAFENIB,2,Terminated,FLT3,1
renal carcinoma,SORAFENIB,2,Terminated,FLT4,1
renal carcinoma,SORAFENIB,2,Terminated,KIT,1
renal carcinoma,BEVACIZUMAB,3,Completed,VEGFA,1
renal carcinoma,SORAFENIB,2,Terminated,PDGFRB,1
renal carcinoma,SORAFENIB,2,Terminated,RAF1,1
renal carcinoma,SORAFENIB,2,Terminated,RET,1
renal carcinoma,SORAFENIB,3,Completed,BRAF,1
renal carcinoma,SORAFENIB,3,Completed,FLT1,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,1
renal carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM1,1
renal carcinoma,CARFILZOMIB,2,Completed,PSMB5,1
renal carcinoma,BEVACIZUMAB,2,Unknown status,VEGFA,1
renal carcinoma,AXITINIB,2,"Active, not recruiting",FLT4,1
renal carcinoma,BEVACIZUMAB,2,"Active, not recruiting",VEGFA,1
renal carcinoma,AXITINIB,2,"Active, not recruiting",KDR,1
renal carcinoma,BECATECARIN,2,Completed,TOP1,1
renal carcinoma,SORAFENIB,1,Terminated,FLT4,1
renal carcinoma,SORAFENIB,1,Terminated,KDR,1
renal carcinoma,BECATECARIN,2,Completed,TOP2A,1
renal carcinoma,BECATECARIN,2,Completed,TOP2B,1
renal carcinoma,BEVACIZUMAB,1,Recruiting,VEGFA,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",KDR,1
renal carcinoma,BEVACIZUMAB,2,Recruiting,VEGFA,1
renal carcinoma,SORAFENIB,1,Terminated,KIT,1
renal carcinoma,SORAFENIB,1,Terminated,PDGFRB,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",ITK,1
renal carcinoma,SORAFENIB,1,Terminated,RAF1,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT4,1
renal carcinoma,SORAFENIB,1,Terminated,RET,1
papillary renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT1,1
renal carcinoma,MYCOPHENOLATE MOFETIL,2,Withdrawn,IMPDH2,1
Alport syndrome,BARDOXOLONE METHYL,2,"Active, not recruiting",IKBKB,1
renal cell carcinoma,AXITINIB,1,Completed,FLT1,1
renal cell carcinoma,SUNITINIB,4,Recruiting,FLT4,1
renal cell carcinoma,SUNITINIB,4,Completed,FLT3,1
renal cell carcinoma,SUNITINIB,4,Completed,FLT4,1
renal cell carcinoma,SUNITINIB,4,Completed,KDR,1
renal cell carcinoma,SUNITINIB,4,Completed,KIT,1
renal cell carcinoma,SUNITINIB,4,Completed,PDGFRA,1
renal cell carcinoma,SUNITINIB,4,Completed,PDGFRB,1
renal cell carcinoma,SUNITINIB,4,Completed,RET,1
renal cell carcinoma,SUNITINIB,4,Recruiting,CSF1R,1
renal cell carcinoma,SUNITINIB,4,Recruiting,FLT1,1
renal cell carcinoma,SUNITINIB,4,Recruiting,FLT3,1
renal cell carcinoma,SUNITINIB,4,Recruiting,KDR,1
renal cell carcinoma,SUNITINIB,4,Completed,CSF1R,1
renal cell carcinoma,SUNITINIB,4,Recruiting,KIT,1
renal cell carcinoma,SUNITINIB,4,Recruiting,PDGFRA,1
renal cell carcinoma,SUNITINIB,4,Recruiting,PDGFRB,1
renal cell carcinoma,SUNITINIB,4,Recruiting,RET,1
renal cell carcinoma,SUNITINIB,4,Terminated,CSF1R,1
renal cell carcinoma,SUNITINIB,4,Terminated,FLT1,1
renal cell carcinoma,SUNITINIB,4,Terminated,FLT3,1
renal cell carcinoma,SUNITINIB,4,Terminated,FLT4,1
renal cell carcinoma,SUNITINIB,4,Terminated,KDR,1
renal cell carcinoma,SUNITINIB,4,Terminated,KIT,1
renal cell carcinoma,SUNITINIB,4,Completed,FLT1,1
renal cell carcinoma,SUNITINIB,4,"Active, not recruiting",RET,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB3,1
renal cell carcinoma,SUNITINIB,3,Unknown status,KDR,1
renal cell carcinoma,SUNITINIB,1,Recruiting,FLT4,1
renal cell carcinoma,SUNITINIB,1,Recruiting,KDR,1
renal cell carcinoma,SUNITINIB,1,Recruiting,KIT,1
renal cell carcinoma,SUNITINIB,1,Recruiting,PDGFRA,1
renal cell carcinoma,SUNITINIB,1,Recruiting,PDGFRB,1
renal cell carcinoma,SUNITINIB,1,Recruiting,RET,1
renal cell carcinoma,SUNITINIB,3,Unknown status,CSF1R,1
renal cell carcinoma,SUNITINIB,3,Unknown status,FLT1,1
renal cell carcinoma,SUNITINIB,3,Unknown status,FLT3,1
renal cell carcinoma,SUNITINIB,3,Unknown status,FLT4,1
renal cell carcinoma,SUNITINIB,3,Unknown status,KIT,1
renal cell carcinoma,SUNITINIB,4,"Active, not recruiting",PDGFRB,1
renal cell carcinoma,SUNITINIB,3,Unknown status,PDGFRA,1
renal cell carcinoma,SUNITINIB,3,Unknown status,PDGFRB,1
renal cell carcinoma,SUNITINIB,3,Unknown status,RET,1
renal cell carcinoma,SUNITINIB,4,"Active, not recruiting",CSF1R,1
renal cell carcinoma,SUNITINIB,4,"Active, not recruiting",FLT1,1
renal cell carcinoma,SUNITINIB,4,"Active, not recruiting",FLT3,1
renal cell carcinoma,SUNITINIB,4,"Active, not recruiting",FLT4,1
renal cell carcinoma,SUNITINIB,4,"Active, not recruiting",KDR,1
renal cell carcinoma,SUNITINIB,4,"Active, not recruiting",KIT,1
renal cell carcinoma,SUNITINIB,4,"Active, not recruiting",PDGFRA,1
renal cell carcinoma,SUNITINIB,4,Terminated,PDGFRA,1
renal cell carcinoma,SUNITINIB,4,Terminated,PDGFRB,1
renal cell carcinoma,SUNITINIB,4,Terminated,RET,1
renal cell carcinoma,TOPOTECAN,1,Terminated,TOP1MT,1
renal cell carcinoma,TIVOZANIB,1,"Active, not recruiting",KDR,1
renal cell carcinoma,TIVOZANIB,1,Completed,FLT1,1
renal cell carcinoma,TIVOZANIB,1,Completed,FLT4,1
renal cell carcinoma,TIVOZANIB,1,Completed,KDR,1
renal cell carcinoma,TIVOZANIB,2,Withdrawn,FLT1,1
renal cell carcinoma,TIVOZANIB,2,Withdrawn,FLT4,1
renal cell carcinoma,TIVOZANIB,2,Withdrawn,KDR,1
renal cell carcinoma,TIVOZANIB,3,"Active, not recruiting",FLT1,1
renal cell carcinoma,TIVOZANIB,3,"Active, not recruiting",FLT4,1
renal cell carcinoma,TIVOZANIB,3,"Active, not recruiting",KDR,1
renal cell carcinoma,TRASTUZUMAB,1,Completed,ERBB2,1
renal cell carcinoma,SUNITINIB,4,n/a,CSF1R,1
renal cell carcinoma,TREBANANIB,2,Completed,ANGPT1,1
renal cell carcinoma,TREBANANIB,2,Completed,ANGPT2,1
renal cell carcinoma,TREMELIMUMAB,1,Completed,CTLA4,1
renal cell carcinoma,TREMELIMUMAB,1,Recruiting,CTLA4,1
renal cell carcinoma,TREMELIMUMAB,2,Not yet recruiting,CTLA4,1
renal cell carcinoma,TREMELIMUMAB,3,Recruiting,CTLA4,1
renal cell carcinoma,VARLILUMAB,1,Terminated,CD27,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB1,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB2A,1
renal cell carcinoma,TIVOZANIB,1,"Active, not recruiting",FLT4,1
renal cell carcinoma,TIVOZANIB,1,"Active, not recruiting",FLT1,1
renal cell carcinoma,THALIDOMIDE,2,Completed,RBX1,1
renal cell carcinoma,THALIDOMIDE,2,Completed,DDB1,1
renal cell carcinoma,SUNITINIB,4,n/a,FLT1,1
renal cell carcinoma,SUNITINIB,4,n/a,FLT3,1
renal cell carcinoma,SUNITINIB,4,n/a,FLT4,1
renal cell carcinoma,SUNITINIB,4,n/a,KDR,1
renal cell carcinoma,SUNITINIB,4,n/a,KIT,1
renal cell carcinoma,SUNITINIB,4,n/a,PDGFRA,1
renal cell carcinoma,SUNITINIB,4,n/a,PDGFRB,1
renal cell carcinoma,SUNITINIB,4,n/a,RET,1
renal cell carcinoma,SURAMIN,1,Completed,FGF1,1
renal cell carcinoma,TEMSIROLIMUS,1,Terminated,FKBP1A,1
renal cell carcinoma,TEMSIROLIMUS,2,"Active, not recruiting",FKBP1A,1
renal cell carcinoma,TEMSIROLIMUS,2,Terminated,FKBP1A,1
renal cell carcinoma,TEMSIROLIMUS,2,Unknown status,FKBP1A,1
renal cell carcinoma,TEMSIROLIMUS,4,n/a,FKBP1A,1
renal cell carcinoma,TESTOSTERONE UNDECANOATE,2,Recruiting,AR,1
renal cell carcinoma,THALIDOMIDE,1,Completed,CRBN,1
renal cell carcinoma,THALIDOMIDE,1,Completed,CUL4A,1
renal cell carcinoma,THALIDOMIDE,1,Completed,DDB1,1
renal cell carcinoma,THALIDOMIDE,1,Completed,RBX1,1
renal cell carcinoma,THALIDOMIDE,2,Completed,CRBN,1
renal cell carcinoma,THALIDOMIDE,2,Completed,CUL4A,1
renal cell carcinoma,SUNITINIB,1,Recruiting,FLT3,1
renal cell carcinoma,SUNITINIB,1,Recruiting,FLT1,1
renal cell carcinoma,SUNITINIB,1,Recruiting,CSF1R,1
renal cell carcinoma,SORAFENIB,1,"Active, not recruiting",RET,1
renal cell carcinoma,SILTUXIMAB,1,Completed,IL6,1
renal cell carcinoma,SIROLIMUS,2,Completed,FKBP1A,1
renal cell carcinoma,SORAFENIB,1,"Active, not recruiting",BRAF,1
renal cell carcinoma,SORAFENIB,1,"Active, not recruiting",FLT1,1
renal cell carcinoma,SORAFENIB,1,"Active, not recruiting",FLT3,1
renal cell carcinoma,SORAFENIB,1,"Active, not recruiting",FLT4,1
renal cell carcinoma,SORAFENIB,1,"Active, not recruiting",KDR,1
renal cell carcinoma,SORAFENIB,1,"Active, not recruiting",KIT,1
renal cell carcinoma,SORAFENIB,1,"Active, not recruiting",PDGFRB,1
renal cell carcinoma,SORAFENIB,1,"Active, not recruiting",RAF1,1
renal cell carcinoma,SORAFENIB,1,Terminated,BRAF,1
renal cell carcinoma,SORAFENIB,2,"Active, not recruiting",FLT4,1
renal cell carcinoma,SORAFENIB,1,Terminated,FLT1,1
renal cell carcinoma,SORAFENIB,1,Terminated,FLT3,1
renal cell carcinoma,SORAFENIB,1,Terminated,FLT4,1
renal cell carcinoma,SORAFENIB,1,Terminated,KDR,1
renal cell carcinoma,SORAFENIB,1,Terminated,KIT,1
renal cell carcinoma,SORAFENIB,1,Terminated,PDGFRB,1
renal cell carcinoma,SORAFENIB,1,Terminated,RAF1,1
renal cell carcinoma,SORAFENIB,1,Terminated,RET,1
renal cell carcinoma,SORAFENIB,2,"Active, not recruiting",BRAF,1
renal cell carcinoma,SORAFENIB,2,"Active, not recruiting",FLT1,1
renal cell carcinoma,SEMAXANIB,2,Terminated,KIT,1
renal cell carcinoma,SEMAXANIB,2,Terminated,KDR,1
renal cell carcinoma,SEMAXANIB,2,Terminated,FLT4,1
renal cell carcinoma,SEMAXANIB,2,Terminated,FLT1,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",FGFR1,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",FGFR2,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",FLT1,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",FLT4,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",FRK,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",KDR,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",KIT,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",MAPK11,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",PDGFRA,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",PDGFRB,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",RAF1,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",RET,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",TEK,1
renal cell carcinoma,RILOTUMUMAB,2,Completed,HGF,1
renal cell carcinoma,SAPANISERTIB,2,"Active, not recruiting",MTOR,1
renal cell carcinoma,SAPANISERTIB,2,Recruiting,MTOR,1
renal cell carcinoma,SARGRAMOSTIM,2,Completed,CSF2RA,1
renal cell carcinoma,SARGRAMOSTIM,2,Withdrawn,CSF2RA,1
renal cell carcinoma,SARGRAMOSTIM,3,Completed,CSF2RA,1
renal cell carcinoma,SAVOLITINIB,2,"Active, not recruiting",MET,1
renal cell carcinoma,SAVOLITINIB,3,"Active, not recruiting",MET,1
renal cell carcinoma,SORAFENIB,2,"Active, not recruiting",FLT3,1
renal cell carcinoma,SORAFENIB,2,"Active, not recruiting",KDR,1
renal cell carcinoma,SORAFENIB,4,n/a,RET,1
renal cell carcinoma,SORAFENIB,4,Terminated,KIT,1
renal cell carcinoma,SORAFENIB,3,Unknown status,KDR,1
renal cell carcinoma,SORAFENIB,3,Unknown status,KIT,1
renal cell carcinoma,SORAFENIB,3,Unknown status,PDGFRB,1
renal cell carcinoma,SORAFENIB,3,Unknown status,RAF1,1
renal cell carcinoma,SORAFENIB,3,Unknown status,RET,1
renal cell carcinoma,SORAFENIB,4,Terminated,BRAF,1
renal cell carcinoma,SORAFENIB,4,Terminated,FLT1,1
renal cell carcinoma,SORAFENIB,4,Terminated,FLT3,1
renal cell carcinoma,SORAFENIB,4,Terminated,FLT4,1
renal cell carcinoma,SORAFENIB,4,Terminated,KDR,1
renal cell carcinoma,SORAFENIB,4,Terminated,PDGFRB,1
renal cell carcinoma,SORAFENIB,2,"Active, not recruiting",KIT,1
renal cell carcinoma,SORAFENIB,4,Terminated,RAF1,1
renal cell carcinoma,SORAFENIB,4,Terminated,RET,1
renal cell carcinoma,SORAFENIB,4,n/a,BRAF,1
renal cell carcinoma,SORAFENIB,4,n/a,FLT1,1
renal cell carcinoma,SORAFENIB,4,n/a,FLT3,1
renal cell carcinoma,SORAFENIB,4,n/a,FLT4,1
renal cell carcinoma,SORAFENIB,4,n/a,KDR,1
renal cell carcinoma,SORAFENIB,4,n/a,KIT,1
renal cell carcinoma,SORAFENIB,4,n/a,PDGFRB,1
renal cell carcinoma,SORAFENIB,4,n/a,RAF1,1
renal cell carcinoma,SORAFENIB,3,Unknown status,FLT4,1
renal cell carcinoma,SORAFENIB,3,Unknown status,FLT3,1
renal cell carcinoma,SORAFENIB,3,Unknown status,FLT1,1
renal cell carcinoma,SORAFENIB,3,Unknown status,BRAF,1
renal cell carcinoma,SORAFENIB,2,"Active, not recruiting",PDGFRB,1
renal cell carcinoma,SORAFENIB,2,"Active, not recruiting",RAF1,1
renal cell carcinoma,SORAFENIB,2,"Active, not recruiting",RET,1
renal cell carcinoma,SORAFENIB,2,Unknown status,BRAF,1
renal cell carcinoma,SORAFENIB,2,Unknown status,FLT1,1
renal cell carcinoma,SORAFENIB,2,Unknown status,FLT3,1
renal cell carcinoma,SORAFENIB,2,Unknown status,FLT4,1
renal cell carcinoma,SORAFENIB,2,Unknown status,KDR,1
renal cell carcinoma,SORAFENIB,2,Unknown status,KIT,1
renal cell carcinoma,SORAFENIB,2,Unknown status,PDGFRB,1
renal cell carcinoma,SORAFENIB,2,Unknown status,RAF1,1
renal cell carcinoma,SORAFENIB,2,Unknown status,RET,1
renal cell carcinoma,SORAFENIB,3,"Active, not recruiting",BRAF,1
renal cell carcinoma,SORAFENIB,3,"Active, not recruiting",FLT1,1
renal cell carcinoma,SORAFENIB,3,"Active, not recruiting",FLT3,1
renal cell carcinoma,SORAFENIB,3,"Active, not recruiting",FLT4,1
renal cell carcinoma,SORAFENIB,3,"Active, not recruiting",KDR,1
renal cell carcinoma,SORAFENIB,3,"Active, not recruiting",KIT,1
renal cell carcinoma,SORAFENIB,3,"Active, not recruiting",PDGFRB,1
renal cell carcinoma,SORAFENIB,3,"Active, not recruiting",RAF1,1
renal cell carcinoma,SORAFENIB,3,"Active, not recruiting",RET,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB2B,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB4A,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",BRAF,1
transitional cell carcinoma of kidney,SUNITINIB,2,Unknown status,FLT1,1
transitional cell carcinoma of kidney,SORAFENIB,2,Terminated,BRAF,1
transitional cell carcinoma of kidney,SORAFENIB,2,Terminated,FLT1,1
transitional cell carcinoma of kidney,SORAFENIB,2,Terminated,FLT3,1
transitional cell carcinoma of kidney,SORAFENIB,2,Terminated,FLT4,1
transitional cell carcinoma of kidney,SORAFENIB,2,Terminated,KDR,1
transitional cell carcinoma of kidney,SORAFENIB,2,Terminated,KIT,1
transitional cell carcinoma of kidney,SORAFENIB,2,Terminated,PDGFRB,1
transitional cell carcinoma of kidney,SORAFENIB,2,Terminated,RAF1,1
transitional cell carcinoma of kidney,SORAFENIB,2,Terminated,RET,1
transitional cell carcinoma of kidney,SUNITINIB,2,Unknown status,CSF1R,1
transitional cell carcinoma of kidney,SUNITINIB,2,Unknown status,FLT3,1
transitional cell carcinoma of kidney,SORAFENIB,2,Completed,RAF1,1
transitional cell carcinoma of kidney,SUNITINIB,2,Unknown status,FLT4,1
transitional cell carcinoma of kidney,SUNITINIB,2,Unknown status,KDR,1
transitional cell carcinoma of kidney,SUNITINIB,2,Unknown status,KIT,1
transitional cell carcinoma of kidney,SUNITINIB,2,Unknown status,PDGFRA,1
transitional cell carcinoma of kidney,SUNITINIB,2,Unknown status,PDGFRB,1
transitional cell carcinoma of kidney,SUNITINIB,2,Unknown status,RET,1
transitional cell carcinoma of kidney,TEMSIROLIMUS,1,Completed,FKBP1A,1
transitional cell carcinoma of kidney,TIPIFARNIB,2,Completed,FNTA,1
transitional cell carcinoma of kidney,TIPIFARNIB,2,Completed,FNTB,1
transitional cell carcinoma of kidney,TRASTUZUMAB,1,Completed,ERBB2,1
transitional cell carcinoma of kidney,SORAFENIB,2,Completed,RET,1
transitional cell carcinoma of kidney,SORAFENIB,2,Completed,PDGFRB,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB4B,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC3,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB6,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB8,1
transitional cell carcinoma of kidney,PEGFILGRASTIM,2,Completed,CSF3R,1
transitional cell carcinoma of kidney,PEMETREXED,2,Completed,DHFR,1
transitional cell carcinoma of kidney,PEMETREXED,2,Completed,GART,1
transitional cell carcinoma of kidney,PEMETREXED,2,Completed,TYMS,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC1,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC10,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC11,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC2,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC4,1
transitional cell carcinoma of kidney,SORAFENIB,2,Completed,KIT,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC5,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC6,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC7,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC8,1
transitional cell carcinoma of kidney,ROMIDEPSIN,2,Terminated,HDAC9,1
transitional cell carcinoma of kidney,SORAFENIB,2,Completed,BRAF,1
transitional cell carcinoma of kidney,SORAFENIB,2,Completed,FLT1,1
transitional cell carcinoma of kidney,SORAFENIB,2,Completed,FLT3,1
transitional cell carcinoma of kidney,SORAFENIB,2,Completed,FLT4,1
transitional cell carcinoma of kidney,SORAFENIB,2,Completed,KDR,1
transitional cell carcinoma of kidney,TRASTUZUMAB,2,Completed,ERBB2,1
transitional cell carcinoma of kidney,TRASTUZUMAB,2,Terminated,ERBB2,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EGFR,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB2B,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB2A,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB2B,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB3,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB4A,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB4B,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB6,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB8,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB1,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB2A,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB3,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHA1,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB4A,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB4B,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB6,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB8,1
transitional cell carcinoma of kidney,VORINOSTAT,2,Terminated,HDAC1,1
transitional cell carcinoma of kidney,VORINOSTAT,2,Terminated,HDAC2,1
transitional cell carcinoma of kidney,VORINOSTAT,2,Terminated,HDAC3,1
transitional cell carcinoma of kidney,VORINOSTAT,2,Terminated,HDAC6,1
type 2 diabetes nephropathy,EMPAGLIFLOZIN,4,Withdrawn,SLC5A2,1
type 2 diabetes nephropathy,LINAGLIPTIN,4,Withdrawn,DPP4,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB1,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,TEK,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,SRC,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHA10,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHA2,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHA3,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHA4,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHA5,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHA6,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHA7,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHA8,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHB1,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHB2,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHB3,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHB4,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,EPHB6,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,ERBB2,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,ERBB3,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,ERBB4,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,FLT1,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,FLT4,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,KDR,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,PTK6,1
transitional cell carcinoma of kidney,VANDETANIB,2,Unknown status,RET,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB4B,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB4A,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB3,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB2A,1
renal osteodystrophy,RISEDRONIC ACID,1,Completed,FDPS,1
renal osteodystrophy,ZOLEDRONIC ACID,4,Completed,FDPS,1
renal pelvis carcinoma,VORINOSTAT,2,Terminated,HDAC1,1
renal pelvis carcinoma,VORINOSTAT,2,Terminated,HDAC2,1
renal pelvis carcinoma,VORINOSTAT,2,Terminated,HDAC3,1
renal pelvis carcinoma,VORINOSTAT,2,Terminated,HDAC6,1
transitional cell carcinoma of kidney,AFLIBERCEPT,2,Completed,PGF,1
transitional cell carcinoma of kidney,AFLIBERCEPT,2,Completed,VEGFA,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB1,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB2B,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB4B,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB3,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB4A,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB4B,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB6,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB8,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB1,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB2A,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB2B,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB3,1
renal cell carcinoma,ZOLEDRONIC ACID,2,Completed,FDPS,1
renal cell carcinoma,XL-999,2,Terminated,PDGFRB,1
renal cell carcinoma,XL-999,2,Terminated,PDGFRA,1
renal cell carcinoma,XL-999,2,Terminated,KIT,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB6,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB8,1
renal cell carcinoma,VOLOCIXIMAB,2,Terminated,ITGA5,1
renal cell carcinoma,VOLOCIXIMAB,2,Terminated,ITGB1,1
renal cell carcinoma,VORINOSTAT,1,Terminated,HDAC1,1
renal cell carcinoma,VORINOSTAT,1,Terminated,HDAC2,1
renal cell carcinoma,VORINOSTAT,1,Terminated,HDAC3,1
renal cell carcinoma,VORINOSTAT,1,Terminated,HDAC6,1
renal cell carcinoma,VORINOSTAT,2,Completed,HDAC1,1
renal cell carcinoma,VORINOSTAT,2,Completed,HDAC2,1
renal cell carcinoma,VORINOSTAT,2,Completed,HDAC3,1
renal cell carcinoma,VORINOSTAT,2,Completed,HDAC6,1
renal cell carcinoma,VORSETUZUMAB MAFODOTIN,1,Terminated,CD70,1
renal cell carcinoma,XL-999,2,Terminated,FGFR1,1
renal cell carcinoma,XL-999,2,Terminated,FGFR2,1
renal cell carcinoma,XL-999,2,Terminated,FGFR3,1
renal cell carcinoma,XL-999,2,Terminated,FGFR4,1
renal cell carcinoma,XL-999,2,Terminated,FLT1,1
renal cell carcinoma,XL-999,2,Terminated,FLT3,1
renal cell carcinoma,XL-999,2,Terminated,FLT4,1
renal cell carcinoma,XL-999,2,Terminated,KDR,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB4A,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB6,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB2B,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB4B,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,POLE3,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,PRIM1,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,PRIM2,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,RRM1,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB1,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB2A,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB2B,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB3,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB4A,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB6,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB8,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB8,1
transitional cell carcinoma of kidney,LAPATINIB,1,Completed,EGFR,1
transitional cell carcinoma of kidney,LAPATINIB,1,Completed,ERBB2,1
transitional cell carcinoma of kidney,LONAFARNIB,2,Completed,FNTA,1
transitional cell carcinoma of kidney,LONAFARNIB,2,Completed,FNTB,1
transitional cell carcinoma of kidney,METHOTREXATE,2,Completed,DHFR,1
transitional cell carcinoma of kidney,METHOTREXATE,3,Completed,DHFR,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB1,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB2A,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,POLE2,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,POLE,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,POLD4,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,POLD3,1
transitional cell carcinoma of kidney,DOXORUBICIN,3,Completed,TOP2A,1
transitional cell carcinoma of kidney,FILGRASTIM,2,Unknown status,CSF3R,1
transitional cell carcinoma of kidney,FLUOROURACIL,2,Completed,TYMS,1
transitional cell carcinoma of kidney,FLUOROURACIL,2,Unknown status,TYMS,1
transitional cell carcinoma of kidney,GEFITINIB,2,Completed,EGFR,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,POLA1,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,POLA2,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,POLD1,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,POLD2,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,POLD3,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,POLD4,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,POLE,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,POLE2,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,POLE3,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,PRIM1,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,PRIM2,1
transitional cell carcinoma of kidney,GEMCITABINE,2,Terminated,RRM1,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,POLA1,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,POLA2,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,POLD1,1
transitional cell carcinoma of kidney,GEMCITABINE,3,Completed,POLD2,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",DDR2,1
renal cell carcinoma,REGORAFENIB,2,"Active, not recruiting",ABL1,1
renal cell carcinoma,AXITINIB,1,Completed,FLT4,1
renal cell carcinoma,FORETINIB,2,Completed,KIT,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLE2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLE3,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,PRIM1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,PRIM2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,RRM1,1
renal cell carcinoma,FLUOROURACIL,1,Completed,TYMS,1
renal cell carcinoma,FORETINIB,2,Completed,FLT1,1
renal cell carcinoma,FORETINIB,2,Completed,FLT3,1
renal cell carcinoma,FORETINIB,2,Completed,FLT4,1
renal cell carcinoma,FORETINIB,2,Completed,KDR,1
renal cell carcinoma,FORETINIB,2,Completed,MET,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD4,1
renal cell carcinoma,FORETINIB,2,Completed,PDGFRA,1
renal cell carcinoma,FORETINIB,2,Completed,PDGFRB,1
renal cell carcinoma,FORETINIB,2,Completed,TEK,1
renal cell carcinoma,FRESOLIMUMAB,1,Completed,TGFB1,1
renal cell carcinoma,FRESOLIMUMAB,1,Completed,TGFB2,1
renal cell carcinoma,FRESOLIMUMAB,1,Completed,TGFB3,1
renal cell carcinoma,GEFITINIB,1,Completed,EGFR,1
renal cell carcinoma,GEMCITABINE,1,Completed,POLA1,1
renal cell carcinoma,GEMCITABINE,1,Completed,POLA2,1
renal cell carcinoma,GEMCITABINE,1,Completed,POLD1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLE,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD3,1
renal cell carcinoma,INTERFERON ALFA-2B,2,Completed,IFNAR1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLD2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",POLD4,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",POLE,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",POLE2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",POLE3,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",PRIM1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",PRIM2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",RRM1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLA1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLA2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLD1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLD3,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLD4,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLE,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLE2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLE3,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,PRIM1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,PRIM2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,RRM1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLA1,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLA2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD1,1
renal cell carcinoma,GEMCITABINE,1,Completed,POLD2,1
renal cell carcinoma,GEMCITABINE,1,Completed,POLD3,1
renal cell carcinoma,GEMCITABINE,1,Completed,POLD4,1
renal cell carcinoma,GEMCITABINE,4,Terminated,POLE2,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,PRIM1,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,PRIM2,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,RRM1,1
renal cell carcinoma,GEMCITABINE,4,Terminated,POLA1,1
renal cell carcinoma,GEMCITABINE,4,Terminated,POLA2,1
renal cell carcinoma,GEMCITABINE,4,Terminated,POLD1,1
renal cell carcinoma,GEMCITABINE,4,Terminated,POLD2,1
renal cell carcinoma,GEMCITABINE,4,Terminated,POLD3,1
renal cell carcinoma,GEMCITABINE,4,Terminated,POLD4,1
renal cell carcinoma,GEMCITABINE,4,Terminated,POLE,1
renal cell carcinoma,GEMCITABINE,4,Terminated,POLE3,1
renal cell carcinoma,GEMCITABINE,1,Completed,POLE,1
renal cell carcinoma,GEMCITABINE,4,Terminated,PRIM1,1
renal cell carcinoma,GEMCITABINE,4,Terminated,PRIM2,1
renal cell carcinoma,GEMCITABINE,4,Terminated,RRM1,1
renal cell carcinoma,GIRENTUXIMAB,1,Completed,CA9,1
renal cell carcinoma,HYDROXYCHLOROQUINE,1,"Active, not recruiting",TLR7,1
renal cell carcinoma,HYDROXYCHLOROQUINE,1,"Active, not recruiting",TLR9,1
renal cell carcinoma,HYDROXYCHLOROQUINE,1,Terminated,TLR7,1
renal cell carcinoma,HYDROXYCHLOROQUINE,1,Terminated,TLR9,1
renal cell carcinoma,IBRUTINIB,1,Recruiting,BTK,1
renal cell carcinoma,INTERFERON ALFA-2A,1,"Active, not recruiting",IFNAR1,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,POLE3,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,POLE,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,POLD4,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,POLD3,1
renal cell carcinoma,GEMCITABINE,1,Completed,POLE2,1
renal cell carcinoma,GEMCITABINE,1,Completed,POLE3,1
renal cell carcinoma,GEMCITABINE,1,Completed,PRIM1,1
renal cell carcinoma,GEMCITABINE,1,Completed,PRIM2,1
renal cell carcinoma,GEMCITABINE,1,Completed,RRM1,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,POLA1,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,POLA2,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,POLD1,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,POLD2,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,POLD3,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,POLD4,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,POLE,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,POLE2,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,POLE3,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,PRIM1,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,PRIM2,1
renal cell carcinoma,GEMCITABINE,2,Recruiting,RRM1,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,POLA1,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,POLA2,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,POLD1,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,POLD2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",POLD3,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",POLD2,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",POLD1,1
renal cell carcinoma,CEDIRANIB,2,Not yet recruiting,PDGFRA,1
renal cell carcinoma,CABOZANTINIB,3,"Active, not recruiting",KDR,1
renal cell carcinoma,CABOZANTINIB,3,"Active, not recruiting",MET,1
renal cell carcinoma,CAPECITABINE,1,Completed,TYMS,1
renal cell carcinoma,CAPECITABINE,2,Terminated,TYMS,1
renal cell carcinoma,CAPECITABINE,3,Terminated,TYMS,1
renal cell carcinoma,CAROTUXIMAB,1,"Active, not recruiting",ENG,1
renal cell carcinoma,CEDIRANIB,2,Not yet recruiting,FLT1,1
renal cell carcinoma,CEDIRANIB,2,Not yet recruiting,FLT4,1
renal cell carcinoma,CEDIRANIB,2,Not yet recruiting,KDR,1
renal cell carcinoma,CEDIRANIB,2,Not yet recruiting,KIT,1
renal cell carcinoma,CEDIRANIB,2,Not yet recruiting,PDGFRB,1
renal cell carcinoma,CYCLOSPORINE,1,"Active, not recruiting",PPIA,1
renal cell carcinoma,CELECOXIB,2,Completed,PTGS2,1
renal cell carcinoma,CG250 111IN,1,Completed,CA9,1
renal cell carcinoma,CG250 177LU,1,Completed,CA9,1
renal cell carcinoma,CM-082,1,Recruiting,FLT3,1
renal cell carcinoma,CM-082,1,Recruiting,KDR,1
renal cell carcinoma,CM-082,1,Recruiting,KIT,1
renal cell carcinoma,CM-082,1,Recruiting,PDGFRB,1
renal cell carcinoma,CM-082,2,Recruiting,FLT3,1
renal cell carcinoma,CM-082,2,Recruiting,KDR,1
renal cell carcinoma,CM-082,2,Recruiting,KIT,1
renal cell carcinoma,CABOZANTINIB,2,"Active, not recruiting",MET,1
renal cell carcinoma,CABOZANTINIB,2,"Active, not recruiting",KDR,1
renal cell carcinoma,BRIVANIB ALANINATE,2,Completed,KDR,1
renal cell carcinoma,BRIVANIB ALANINATE,2,Completed,FLT4,1
renal cell carcinoma,AXITINIB,1,Completed,KDR,1
renal cell carcinoma,AXITINIB,1,Recruiting,FLT1,1
renal cell carcinoma,AXITINIB,1,Recruiting,FLT4,1
renal cell carcinoma,AXITINIB,1,Recruiting,KDR,1
renal cell carcinoma,AXITINIB,2,Unknown status,FLT1,1
renal cell carcinoma,AXITINIB,2,Unknown status,FLT4,1
renal cell carcinoma,AXITINIB,2,Unknown status,KDR,1
renal cell carcinoma,AZACITIDINE,1,Terminated,DNMT1,1
renal cell carcinoma,AZACITIDINE,1,Terminated,DNMT3A,1
renal cell carcinoma,BEVACIZUMAB,1,"Active, not recruiting",VEGFA,1
renal cell carcinoma,BEVACIZUMAB,2,Recruiting,VEGFA,1
renal cell carcinoma,BEVACIZUMAB,2,Unknown status,VEGFA,1
renal cell carcinoma,BEVACIZUMAB,2,Withdrawn,VEGFA,1
renal cell carcinoma,BEVACIZUMAB,3,"Active, not recruiting",VEGFA,1
renal cell carcinoma,BEVACIZUMAB,4,n/a,VEGFA,1
renal cell carcinoma,BORTEZOMIB,1,"Active, not recruiting",PSMB5,1
renal cell carcinoma,BRIVANIB ALANINATE,2,Completed,FGFR1,1
renal cell carcinoma,BRIVANIB ALANINATE,2,Completed,FGFR2,1
renal cell carcinoma,BRIVANIB ALANINATE,2,Completed,FGFR3,1
renal cell carcinoma,BRIVANIB ALANINATE,2,Completed,FGFR4,1
renal cell carcinoma,BRIVANIB ALANINATE,2,Completed,FLT1,1
renal cell carcinoma,CM-082,2,Recruiting,PDGFRB,1
renal cell carcinoma,DALANTERCEPT,2,Completed,BMP10,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",POLA2,1
renal cell carcinoma,EVEROLIMUS,4,Terminated,FKBP1A,1
renal cell carcinoma,DURVALUMAB,3,Recruiting,CD274,1
renal cell carcinoma,ENZASTAURIN,2,Completed,PRKCB,1
renal cell carcinoma,EPACADOSTAT,3,"Active, not recruiting",IDO1,1
renal cell carcinoma,ETARACIZUMAB,1,Terminated,ITGAV,1
renal cell carcinoma,ETARACIZUMAB,1,Terminated,ITGB3,1
renal cell carcinoma,EVEROLIMUS,1,Not yet recruiting,FKBP1A,1
renal cell carcinoma,EVEROLIMUS,1,Recruiting,FKBP1A,1
renal cell carcinoma,EVEROLIMUS,3,"Active, not recruiting",FKBP1A,1
renal cell carcinoma,EVEROLIMUS,3,Completed,FKBP1A,1
renal cell carcinoma,EVEROLIMUS,3,Recruiting,FKBP1A,1
renal cell carcinoma,EVEROLIMUS,4,Unknown status,FKBP1A,1
renal cell carcinoma,DALANTERCEPT,2,Completed,GDF2,1
renal cell carcinoma,EVEROLIMUS,4,n/a,FKBP1A,1
renal cell carcinoma,FAMITINIB,2,Completed,FLT1,1
renal cell carcinoma,FAMITINIB,2,Completed,FLT3,1
renal cell carcinoma,FAMITINIB,2,Completed,FLT4,1
renal cell carcinoma,FAMITINIB,2,Completed,KDR,1
renal cell carcinoma,FAMITINIB,2,Completed,KIT,1
renal cell carcinoma,FAMITINIB,2,Completed,PDGFRA,1
renal cell carcinoma,FAMITINIB,2,Completed,PDGFRB,1
renal cell carcinoma,FILGRASTIM,2,Completed,CSF3R,1
renal cell carcinoma,FLUDARABINE PHOSPHATE,1,"Active, not recruiting",POLA1,1
renal cell carcinoma,DURVALUMAB,1,Recruiting,CD274,1
renal cell carcinoma,DOXORUBICIN,2,Recruiting,TOP2A,1
renal cell carcinoma,DOVITINIB,3,Completed,PDGFRB,1
renal cell carcinoma,DOVITINIB,3,Completed,PDGFRA,1
renal cell carcinoma,DALTEPARIN SODIUM,1,Completed,SERPINC1,1
renal cell carcinoma,DECITABINE,2,Terminated,DNMT1,1
renal cell carcinoma,DECITABINE,2,Terminated,DNMT3A,1
renal cell carcinoma,DENOSUMAB,2,Recruiting,TNFSF11,1
renal cell carcinoma,DENOSUMAB,3,Recruiting,TNFSF11,1
renal cell carcinoma,DEXAMETHASONE,2,Withdrawn,NR3C1,1
renal cell carcinoma,DIPHENHYDRAMINE,2,Completed,HRH1,1
renal cell carcinoma,DOVITINIB,1,Completed,FGFR3,1
renal cell carcinoma,DOVITINIB,1,Completed,FLT1,1
renal cell carcinoma,DOVITINIB,1,Completed,FLT3,1
renal cell carcinoma,DOVITINIB,1,Completed,FLT4,1
renal cell carcinoma,DOVITINIB,1,Completed,KDR,1
renal cell carcinoma,DOVITINIB,1,Completed,KIT,1
renal cell carcinoma,DOVITINIB,1,Completed,PDGFRA,1
renal cell carcinoma,DOVITINIB,1,Completed,PDGFRB,1
renal cell carcinoma,DOVITINIB,3,Completed,FGFR3,1
renal cell carcinoma,DOVITINIB,3,Completed,FLT1,1
renal cell carcinoma,DOVITINIB,3,Completed,FLT3,1
renal cell carcinoma,DOVITINIB,3,Completed,FLT4,1
renal cell carcinoma,DOVITINIB,3,Completed,KDR,1
renal cell carcinoma,DOVITINIB,3,Completed,KIT,1
renal cell carcinoma,INTERFERON ALFA-2A,1,"Active, not recruiting",IFNAR2,1
renal cell carcinoma,INTERFERON ALFA-2B,2,Completed,IFNAR2,1
renal cell carcinoma,RANITIDINE,2,Completed,HRH2,1
renal cell carcinoma,PAZOPANIB,3,Terminated,ITK,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,KDR,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,KIT,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,LCK,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,PDGFRA,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,PDGFRB,1
renal cell carcinoma,PAZOPANIB,3,Terminated,CSF1R,1
renal cell carcinoma,PAZOPANIB,3,Terminated,FGFR1,1
renal cell carcinoma,PAZOPANIB,3,Terminated,FGFR3,1
renal cell carcinoma,PAZOPANIB,3,Terminated,FLT1,1
renal cell carcinoma,PAZOPANIB,3,Terminated,FLT4,1
renal cell carcinoma,PAZOPANIB,3,Terminated,KDR,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,FLT4,1
renal cell carcinoma,PAZOPANIB,3,Terminated,KIT,1
renal cell carcinoma,PAZOPANIB,3,Terminated,LCK,1
renal cell carcinoma,PAZOPANIB,3,Terminated,PDGFRA,1
renal cell carcinoma,PAZOPANIB,3,Terminated,PDGFRB,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",CSF1R,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",FGFR1,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",FGFR3,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",FLT1,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",FLT4,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",ITK,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,ITK,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,FLT1,1
renal cell carcinoma,INTERFERON ALFA-2B,2,Terminated,IFNAR1,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,FGFR1,1
renal cell carcinoma,PAZOPANIB,0,Completed,FGFR3,1
renal cell carcinoma,PAZOPANIB,0,Completed,FLT1,1
renal cell carcinoma,PAZOPANIB,0,Completed,FLT4,1
renal cell carcinoma,PAZOPANIB,0,Completed,ITK,1
renal cell carcinoma,PAZOPANIB,0,Completed,KDR,1
renal cell carcinoma,PAZOPANIB,0,Completed,KIT,1
renal cell carcinoma,PAZOPANIB,0,Completed,LCK,1
renal cell carcinoma,PAZOPANIB,0,Completed,PDGFRA,1
renal cell carcinoma,PAZOPANIB,0,Completed,PDGFRB,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,CSF1R,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,FGFR3,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,FGFR3,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,FLT1,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,FLT4,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,ITK,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,KDR,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,KIT,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,LCK,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,PDGFRA,1
renal cell carcinoma,PAZOPANIB,1,Unknown status,PDGFRB,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,CSF1R,1
renal cell carcinoma,PAZOPANIB,3,Recruiting,FGFR1,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",KDR,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",KIT,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",LCK,1
renal cell carcinoma,PEGINTERFERON ALFA-2B,1,Terminated,IFNAR1,1
renal cell carcinoma,PAZOPANIB,4,n/a,FGFR3,1
renal cell carcinoma,PAZOPANIB,4,n/a,FLT1,1
renal cell carcinoma,PAZOPANIB,4,n/a,FLT4,1
renal cell carcinoma,PAZOPANIB,4,n/a,ITK,1
renal cell carcinoma,PAZOPANIB,4,n/a,KDR,1
renal cell carcinoma,PAZOPANIB,4,n/a,KIT,1
renal cell carcinoma,PAZOPANIB,4,n/a,LCK,1
renal cell carcinoma,PAZOPANIB,4,n/a,PDGFRA,1
renal cell carcinoma,PAZOPANIB,4,n/a,PDGFRB,1
renal cell carcinoma,PEGFILGRASTIM,2,Completed,CSF3R,1
renal cell carcinoma,PEGINTERFERON ALFA-2B,1,Terminated,IFNAR2,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",PDGFRA,1
renal cell carcinoma,PEMBROLIZUMAB,1,"Active, not recruiting",PDCD1,1
renal cell carcinoma,PEMBROLIZUMAB,1,Withdrawn,PDCD1,1
renal cell carcinoma,PEMBROLIZUMAB,2,"Active, not recruiting",PDCD1,1
renal cell carcinoma,PEMETREXED,2,Terminated,DHFR,1
renal cell carcinoma,PEMETREXED,2,Terminated,GART,1
renal cell carcinoma,PEMETREXED,2,Terminated,TYMS,1
renal cell carcinoma,PIDILIZUMAB,2,Terminated,PDCD1,1
renal cell carcinoma,PROPRANOLOL,2,Withdrawn,ADRB1,1
renal cell carcinoma,PROPRANOLOL,2,Withdrawn,ADRB2,1
renal cell carcinoma,RAMUCIRUMAB,2,Completed,KDR,1
renal cell carcinoma,PAZOPANIB,4,n/a,FGFR1,1
renal cell carcinoma,PAZOPANIB,4,n/a,CSF1R,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,PDGFRB,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,PDGFRA,1
renal cell carcinoma,PAZOPANIB,4,"Active, not recruiting",PDGFRB,1
renal cell carcinoma,PAZOPANIB,4,Completed,CSF1R,1
renal cell carcinoma,PAZOPANIB,4,Completed,FGFR1,1
renal cell carcinoma,PAZOPANIB,4,Completed,FGFR3,1
renal cell carcinoma,PAZOPANIB,4,Completed,FLT1,1
renal cell carcinoma,PAZOPANIB,4,Completed,FLT4,1
renal cell carcinoma,PAZOPANIB,4,Completed,ITK,1
renal cell carcinoma,PAZOPANIB,4,Completed,KDR,1
renal cell carcinoma,PAZOPANIB,4,Completed,KIT,1
renal cell carcinoma,PAZOPANIB,4,Completed,LCK,1
renal cell carcinoma,PAZOPANIB,4,Completed,PDGFRA,1
renal cell carcinoma,PAZOPANIB,4,Completed,PDGFRB,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,CSF1R,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,FGFR1,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,FGFR3,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,FLT1,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,FLT4,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,ITK,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,KDR,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,KIT,1
renal cell carcinoma,PAZOPANIB,4,Recruiting,LCK,1
renal cell carcinoma,PAZOPANIB,0,Completed,FGFR1,1
renal cell carcinoma,PAZOPANIB,0,Completed,CSF1R,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",PDGFRB,1
renal cell carcinoma,LENVATINIB,2,Recruiting,KDR,1
renal cell carcinoma,LENVATINIB,1,Completed,FLT4,1
renal cell carcinoma,LENVATINIB,1,Completed,KDR,1
renal cell carcinoma,LENVATINIB,1,Not yet recruiting,FLT1,1
renal cell carcinoma,LENVATINIB,1,Not yet recruiting,FLT4,1
renal cell carcinoma,LENVATINIB,1,Not yet recruiting,KDR,1
renal cell carcinoma,LENVATINIB,1,Terminated,FLT1,1
renal cell carcinoma,LENVATINIB,1,Terminated,FLT4,1
renal cell carcinoma,LENVATINIB,1,Terminated,KDR,1
renal cell carcinoma,LENVATINIB,2,Recruiting,FLT1,1
renal cell carcinoma,LENVATINIB,2,Recruiting,FLT4,1
renal cell carcinoma,LENVATINIB,3,Recruiting,FLT1,1
renal cell carcinoma,MK-2206,2,"Active, not recruiting",AKT1,1
renal cell carcinoma,LENVATINIB,3,Recruiting,FLT4,1
renal cell carcinoma,LENVATINIB,3,Recruiting,KDR,1
renal cell carcinoma,LINIFANIB,2,Completed,CSF1R,1
renal cell carcinoma,LINIFANIB,2,Completed,FLT1,1
renal cell carcinoma,LINIFANIB,2,Completed,FLT3,1
renal cell carcinoma,LINIFANIB,2,Completed,FLT4,1
renal cell carcinoma,LINIFANIB,2,Completed,KDR,1
renal cell carcinoma,LINIFANIB,2,Completed,PDGFRA,1
renal cell carcinoma,LINIFANIB,2,Completed,PDGFRB,1
renal cell carcinoma,LY-2584702,1,Terminated,RPS6KB1,1
renal cell carcinoma,LENVATINIB,1,Completed,FLT1,1
renal cell carcinoma,LENALIDOMIDE,1,Terminated,RBX1,1
renal cell carcinoma,LENALIDOMIDE,1,Terminated,DDB1,1
renal cell carcinoma,LENALIDOMIDE,1,Terminated,CUL4A,1
renal cell carcinoma,INTERFERON ALFA-2B,2,Terminated,IFNAR2,1
renal cell carcinoma,INTERFERON ALFA-2B,2,Unknown status,IFNAR1,1
renal cell carcinoma,INTERFERON ALFA-2B,2,Unknown status,IFNAR2,1
renal cell carcinoma,IODINE I 124 GIRENTUXIMAB,2,Completed,CA9,1
renal cell carcinoma,IPILIMUMAB,1,Unknown status,CTLA4,1
renal cell carcinoma,IPILIMUMAB,2,"Active, not recruiting",CTLA4,1
renal cell carcinoma,IPILIMUMAB,3,"Active, not recruiting",CTLA4,1
renal cell carcinoma,IPILIMUMAB,4,"Active, not recruiting",CTLA4,1
renal cell carcinoma,ISOTRETINOIN,1,Terminated,RARA,1
renal cell carcinoma,ISOTRETINOIN,1,Terminated,RARB,1
renal cell carcinoma,ISOTRETINOIN,1,Terminated,RARG,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB1,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB2A,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB2B,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB3,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB4A,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB4B,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB6,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB8,1
renal cell carcinoma,LENALIDOMIDE,1,Terminated,CRBN,1
renal cell carcinoma,MEDROXYPROGESTERONE ACETATE,3,Completed,PGR,1
renal cell carcinoma,MK-2206,2,"Active, not recruiting",AKT2,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",PDGFRA,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC7,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB8,1
renal cell carcinoma,PANITUMUMAB,2,Completed,EGFR,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC1,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC10,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC11,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC2,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC3,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC4,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC5,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC6,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC8,1
renal cell carcinoma,MK-2206,2,"Active, not recruiting",AKT3,1
renal cell carcinoma,PANOBINOSTAT,2,Completed,HDAC9,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",CSF1R,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",FGFR1,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",FGFR3,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",FLT1,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",FLT4,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",ITK,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",KDR,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",KIT,1
renal cell carcinoma,PAZOPANIB,0,"Active, not recruiting",LCK,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB6,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB4B,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB4A,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB3,1
renal cell carcinoma,MLN-1117,2,"Active, not recruiting",PIK3CA,1
renal cell carcinoma,MYCOPHENOLATE MOFETIL,1,"Active, not recruiting",IMPDH1,1
renal cell carcinoma,MYCOPHENOLATE MOFETIL,1,"Active, not recruiting",IMPDH2,1
renal cell carcinoma,NAPTUMOMAB ESTAFENATOX,2,Completed,TPBG,1
renal cell carcinoma,NINTEDANIB,2,"Active, not recruiting",FGFR1,1
renal cell carcinoma,NINTEDANIB,2,"Active, not recruiting",FGFR2,1
renal cell carcinoma,NINTEDANIB,2,"Active, not recruiting",FGFR3,1
renal cell carcinoma,NINTEDANIB,2,"Active, not recruiting",FGFR4,1
renal cell carcinoma,NINTEDANIB,2,"Active, not recruiting",FLT1,1
renal cell carcinoma,NINTEDANIB,2,"Active, not recruiting",FLT4,1
renal cell carcinoma,NINTEDANIB,2,"Active, not recruiting",KDR,1
renal cell carcinoma,NINTEDANIB,2,"Active, not recruiting",PDGFRA,1
renal cell carcinoma,NINTEDANIB,2,"Active, not recruiting",PDGFRB,1
renal cell carcinoma,NIVOLUMAB,1,Unknown status,PDCD1,1
renal cell carcinoma,NIVOLUMAB,2,Not yet recruiting,PDCD1,1
renal cell carcinoma,NIVOLUMAB,2,Withdrawn,PDCD1,1
renal cell carcinoma,NIVOLUMAB,3,"Active, not recruiting",PDCD1,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB1,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB2A,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB2B,1
renal cell carcinoma,GEMCITABINE,2,Withdrawn,POLE2,1
lupus nephritis,MYCOPHENOLIC ACID,2,Completed,IMPDH2,1
nephrotic syndrome,ALDESLEUKIN,2,Withdrawn,IL2RB,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB7,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA6,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA7,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA8,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA9,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAB1,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAF1,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAF2,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAF3,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAF4,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB1,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB10,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB11,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB2,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB3,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB4,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB5,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB6,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB7,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB8,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB9,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFC1,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFC2,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS1,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS2,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS3,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS4,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS5,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS6,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS7,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA5,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA4L2,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA4,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFV3,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB9,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFC1,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFC2,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFS1,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFS2,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFS3,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFS4,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFS5,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFS6,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFS7,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFS8,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFV1,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFV2,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,GPD2,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA3,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND1,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND2,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND3,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND4,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND4L,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND5,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND6,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA1,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA10,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA11,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA12,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA13,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA2,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS8,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFV1,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFV2,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE6B,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE10A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE1A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE1B,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE1C,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE2A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE3A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE3B,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE4A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE4B,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE4C,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE4D,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE5A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE6A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE6C,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,ADORA2A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE6D,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE6G,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE6H,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE7A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE7B,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE8A,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE8B,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,PDE9A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,ADORA2A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,ADORA2B,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE10A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE1A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE1B,1
chronic kidney disease,PENTOXIFYLLINE,2,Completed,ADORA2B,1
chronic kidney disease,PARICALCITOL,4,Unknown status,VDR,1
chronic kidney disease,METFORMIN,3,Not yet recruiting,NDUFV3,1
chronic kidney disease,MYCOPHENOLIC ACID,2,Unknown status,IMPDH1,1
chronic kidney disease,METHYLPREDNISOLONE,2,Terminated,NR3C1,1
chronic kidney disease,METHYLPREDNISOLONE,3,Completed,NR3C1,1
chronic kidney disease,METHYLPREDNISOLONE,4,Recruiting,NR3C1,1
chronic kidney disease,MYCOPHENOLATE MOFETIL,1,Unknown status,IMPDH1,1
chronic kidney disease,MYCOPHENOLATE MOFETIL,1,Unknown status,IMPDH2,1
chronic kidney disease,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH1,1
chronic kidney disease,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH2,1
chronic kidney disease,MYCOPHENOLATE MOFETIL,4,Recruiting,IMPDH1,1
chronic kidney disease,MYCOPHENOLATE MOFETIL,4,Recruiting,IMPDH2,1
chronic kidney disease,MYCOPHENOLIC ACID,1,Completed,IMPDH1,1
chronic kidney disease,MYCOPHENOLIC ACID,1,Completed,IMPDH2,1
chronic kidney disease,MYCOPHENOLIC ACID,2,Completed,IMPDH1,1
chronic kidney disease,MYCOPHENOLIC ACID,2,Completed,IMPDH2,1
chronic kidney disease,MYCOPHENOLIC ACID,2,Unknown status,IMPDH2,1
chronic kidney disease,PARICALCITOL,4,Terminated,VDR,1
chronic kidney disease,MYCOPHENOLIC ACID,3,Recruiting,IMPDH1,1
chronic kidney disease,MYCOPHENOLIC ACID,3,Recruiting,IMPDH2,1
chronic kidney disease,MYCOPHENOLIC ACID,4,Recruiting,IMPDH1,1
chronic kidney disease,MYCOPHENOLIC ACID,4,Recruiting,IMPDH2,1
chronic kidney disease,MYCOPHENOLIC ACID,4,Withdrawn,IMPDH1,1
chronic kidney disease,MYCOPHENOLIC ACID,4,Withdrawn,IMPDH2,1
chronic kidney disease,NALFURAFINE,1,Completed,OPRK1,1
chronic kidney disease,NIFEDIPINE,2,Unknown status,CACNA1C,1
chronic kidney disease,NIFEDIPINE,2,Unknown status,CACNA1D,1
chronic kidney disease,NIFEDIPINE,2,Unknown status,CACNA1F,1
chronic kidney disease,NIFEDIPINE,2,Unknown status,CACNA1S,1
chronic kidney disease,OBINUTUZUMAB,1,Completed,MS4A1,1
chronic kidney disease,OXYCODONE,4,Unknown status,OPRM1,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB8,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB6,1
chronic kidney disease,DROTRECOGIN ALFA (ACTIVATED),2,Completed,F8,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB5,1
chronic kidney disease,INSULIN PORK,4,Completed,INSR,1
chronic kidney disease,IRBESARTAN,2,Completed,AGTR1,1
chronic kidney disease,LAPATINIB,1,Completed,EGFR,1
chronic kidney disease,LAPATINIB,1,Completed,ERBB2,1
chronic kidney disease,LOSARTAN,3,Recruiting,AGTR1,1
chronic kidney disease,LUNACALCIPOL,2,Completed,VDR,1
chronic kidney disease,LUNACALCIPOL,2,Withdrawn,VDR,1
chronic kidney disease,LY2623091,1,Completed,NR3C2,1
chronic kidney disease,LY2623091,2,Completed,NR3C2,1
chronic kidney disease,METFORMIN,2,Recruiting,GPD2,1
chronic kidney disease,METFORMIN,2,Recruiting,MT-ND1,1
chronic kidney disease,METFORMIN,2,Recruiting,MT-ND2,1
chronic kidney disease,METFORMIN,2,Recruiting,MT-ND3,1
chronic kidney disease,METFORMIN,2,Recruiting,MT-ND4,1
chronic kidney disease,METFORMIN,2,Recruiting,MT-ND4L,1
chronic kidney disease,METFORMIN,2,Recruiting,MT-ND5,1
chronic kidney disease,METFORMIN,2,Recruiting,MT-ND6,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA1,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA10,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA11,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA12,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA13,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA2,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA3,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA4,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA4L2,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA5,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA6,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA7,1
chronic kidney disease,INSULIN HUMAN,4,Completed,INSR,1
chronic kidney disease,ILOPROST,2,Completed,PTGIR,1
chronic kidney disease,HYDROCHLOROTHIAZIDE,4,Recruiting,SLC12A3,1
chronic kidney disease,EPOETIN ALFA,3,Terminated,EPOR,1
chronic kidney disease,EFALIZUMAB,1,Terminated,ITGAL,1
chronic kidney disease,EMPAGLIFLOZIN,2,Recruiting,SLC5A2,1
chronic kidney disease,EMPAGLIFLOZIN,3,Recruiting,SLC5A2,1
chronic kidney disease,ENALAPRIL,1,Unknown status,ACE,1
chronic kidney disease,EPLERENONE,1,Completed,NR3C2,1
chronic kidney disease,EPLERENONE,2,Completed,NR3C2,1
chronic kidney disease,EPLERENONE,2,Unknown status,NR3C2,1
chronic kidney disease,EPLERENONE,3,Recruiting,NR3C2,1
chronic kidney disease,EPLERENONE,3,Terminated,NR3C2,1
chronic kidney disease,EPLERENONE,4,Completed,NR3C2,1
chronic kidney disease,EPOETIN ALFA,2,Completed,EPOR,1
chronic kidney disease,EPOETIN ALFA,2,Unknown status,EPOR,1
chronic kidney disease,EPOETIN ALFA,3,Recruiting,EPOR,1
chronic kidney disease,ERGOCALCIFEROL,3,Terminated,VDR,1
chronic kidney disease,HYDROCHLOROTHIAZIDE,4,Completed,SLC12A3,1
chronic kidney disease,ERGOCALCIFEROL,4,Not yet recruiting,VDR,1
chronic kidney disease,ESCITALOPRAM,2,Terminated,SLC6A4,1
chronic kidney disease,ETANERCEPT,2,Terminated,TNF,1
chronic kidney disease,EVEROLIMUS,2,Unknown status,FKBP1A,1
chronic kidney disease,EVEROLIMUS,3,Recruiting,FKBP1A,1
chronic kidney disease,EVEROLIMUS,3,Terminated,FKBP1A,1
chronic kidney disease,FLURANDRENOLIDE,3,Completed,NR3C1,1
chronic kidney disease,FOSINOPRIL,4,Unknown status,ACE,1
chronic kidney disease,FUROSEMIDE,4,Completed,SLC12A1,1
chronic kidney disease,FUROSEMIDE,4,Unknown status,SLC12A1,1
chronic kidney disease,GOSOGLIPTIN,1,Completed,DPP4,1
chronic kidney disease,HEPARIN SODIUM,4,Completed,SERPINC1,1
chronic kidney disease,HEPARIN SODIUM,4,Unknown status,SERPINC1,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA8,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFA9,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFAB1,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA6,1
chronic kidney disease,METFORMIN,2,Unknown status,MT-ND4L,1
chronic kidney disease,METFORMIN,2,Unknown status,MT-ND5,1
chronic kidney disease,METFORMIN,2,Unknown status,MT-ND6,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA1,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA10,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA11,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA12,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA13,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA2,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA3,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA4,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA4L2,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA5,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA7,1
chronic kidney disease,METFORMIN,2,Unknown status,MT-ND3,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA8,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFA9,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFAB1,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFAF1,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFAF2,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFAF3,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFAF4,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB1,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB10,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB11,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB2,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB3,1
chronic kidney disease,METFORMIN,2,Unknown status,NDUFB4,1
chronic kidney disease,METFORMIN,2,Unknown status,MT-ND4,1
chronic kidney disease,METFORMIN,2,Unknown status,MT-ND2,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFAF1,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB9,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFAF2,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFAF3,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFAF4,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB1,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB10,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB11,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB2,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB3,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB4,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB5,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB6,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB7,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFB8,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFC1,1
chronic kidney disease,METFORMIN,2,Unknown status,MT-ND1,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFC2,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFS1,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFS2,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFS3,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFS4,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFS5,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFS6,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFS7,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFS8,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFV1,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFV2,1
chronic kidney disease,METFORMIN,2,Recruiting,NDUFV3,1
chronic kidney disease,METFORMIN,2,Unknown status,GPD2,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE1C,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE2A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE3A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE3B,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,KCNK18,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,KCNK2,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,KCNK3,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,KCNK9,1
chronic kidney disease,SIMVASTATIN,3,Completed,HMGCR,1
chronic kidney disease,SIMVASTATIN,4,Unknown status,HMGCR,1
chronic kidney disease,SIPLIZUMAB,1,"Active, not recruiting",CD2,1
chronic kidney disease,SIPLIZUMAB,2,Completed,CD2,1
chronic kidney disease,SIROLIMUS,2,"Active, not recruiting",FKBP1A,1
chronic kidney disease,SIROLIMUS,2,Terminated,FKBP1A,1
chronic kidney disease,SIROLIMUS,3,Recruiting,FKBP1A,1
chronic kidney disease,SIROLIMUS,3,Terminated,FKBP1A,1
chronic kidney disease,SITAXENTAN,2,Unknown status,EDNRA,1
chronic kidney disease,SITAXENTAN,2,Unknown status,EDNRB,1
chronic kidney disease,SOMATROPIN,1,Completed,GHR,1
chronic kidney disease,SOMATROPIN,3,Completed,GHR,1
chronic kidney disease,SOMATROPIN,3,Terminated,GHR,1
chronic kidney disease,SOMATROPIN,4,Completed,GHR,1
chronic kidney disease,SOMATROPIN,4,Terminated,GHR,1
chronic kidney disease,SOMATROPIN,4,n/a,GHR,1
chronic kidney disease,SPIRONOLACTONE,2,"Active, not recruiting",NR3C2,1
chronic kidney disease,SPIRONOLACTONE,2,Completed,NR3C2,1
chronic kidney disease,SPIRONOLACTONE,3,Completed,NR3C2,1
chronic kidney disease,SPIRONOLACTONE,4,"Active, not recruiting",NR3C2,1
chronic kidney disease,SPIRONOLACTONE,4,Unknown status,NR3C2,1
chronic kidney disease,SPIRONOLACTONE,4,Withdrawn,NR3C2,1
chronic kidney disease,TABALUMAB,2,Completed,TNFSF13B,1
chronic kidney disease,TACROLIMUS,1,Unknown status,FKBP1A,1
chronic kidney disease,TACROLIMUS,2,Recruiting,FKBP1A,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,KCNK10,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GLRA1,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRQ,1
chronic kidney disease,SERELAXIN,1,Completed,RXFP2,1
chronic kidney disease,ROXADUSTAT,3,"Active, not recruiting",EGLN1,1
chronic kidney disease,ROXADUSTAT,3,"Active, not recruiting",EGLN2,1
chronic kidney disease,ROXADUSTAT,3,"Active, not recruiting",EGLN3,1
chronic kidney disease,ROXADUSTAT,3,"Active, not recruiting",P4HTM,1
chronic kidney disease,ROXADUSTAT,3,Recruiting,EGLN1,1
chronic kidney disease,ROXADUSTAT,3,Recruiting,EGLN2,1
chronic kidney disease,ROXADUSTAT,3,Recruiting,EGLN3,1
chronic kidney disease,ROXADUSTAT,3,Recruiting,P4HTM,1
chronic kidney disease,SAPROPTERIN,2,Completed,PAH,1
chronic kidney disease,SAPROPTERIN,2,Recruiting,PAH,1
chronic kidney disease,SAR-407899,1,Completed,ROCK1,1
chronic kidney disease,SAR-407899,1,Completed,ROCK2,1
chronic kidney disease,SERELAXIN,1,Completed,RXFP1,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRA1,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRP,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRA2,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRA3,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRA4,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRA5,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRA6,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRB1,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRB2,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRB3,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRD,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRE,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRG1,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRG2,1
chronic kidney disease,SEVOFLURANE,4,Recruiting,GABRG3,1
chronic kidney disease,TACROLIMUS,2,Terminated,FKBP1A,1
chronic kidney disease,TACROLIMUS,3,Completed,FKBP1A,1
chronic kidney disease,TACROLIMUS,3,Terminated,FKBP1A,1
clear cell renal carcinoma,AXITINIB,1,Suspended,FLT1,1
chronic kidney disease,VALSARTAN,2,Completed,AGTR1,1
chronic kidney disease,VALSARTAN,4,Unknown status,AGTR1,1
chronic kidney disease,VELCALCETIDE,1,Completed,CASR,1
chronic kidney disease,VONAPANITASE,2,Completed,ELN,1
clear cell renal carcinoma,ALDESLEUKIN,1,"Active, not recruiting",IL2RA,1
clear cell renal carcinoma,ALDESLEUKIN,1,"Active, not recruiting",IL2RB,1
clear cell renal carcinoma,ALDESLEUKIN,1,Recruiting,IL2RA,1
clear cell renal carcinoma,ALDESLEUKIN,1,Recruiting,IL2RB,1
clear cell renal carcinoma,ALDESLEUKIN,2,"Active, not recruiting",IL2RA,1
clear cell renal carcinoma,ALDESLEUKIN,2,"Active, not recruiting",IL2RB,1
clear cell renal carcinoma,AXITINIB,1,"Active, not recruiting",FLT1,1
clear cell renal carcinoma,AXITINIB,1,"Active, not recruiting",FLT4,1
clear cell renal carcinoma,AXITINIB,1,"Active, not recruiting",KDR,1
clear cell renal carcinoma,AXITINIB,1,Suspended,FLT4,1
chronic kidney disease,TOFACITINIB,1,Completed,TYK2,1
clear cell renal carcinoma,AXITINIB,1,Suspended,KDR,1
clear cell renal carcinoma,AXITINIB,3,Terminated,FLT1,1
clear cell renal carcinoma,AXITINIB,3,Terminated,FLT4,1
clear cell renal carcinoma,AXITINIB,3,Terminated,KDR,1
clear cell renal carcinoma,AZD-2014,2,Terminated,MTOR,1
clear cell renal carcinoma,BEVACIZUMAB,0,"Active, not recruiting",VEGFA,1
clear cell renal carcinoma,BEVACIZUMAB,1,"Active, not recruiting",VEGFA,1
clear cell renal carcinoma,BEVACIZUMAB,1,Recruiting,VEGFA,1
clear cell renal carcinoma,BEVACIZUMAB,3,Terminated,VEGFA,1
clear cell renal carcinoma,CABOZANTINIB,1,"Active, not recruiting",KDR,1
clear cell renal carcinoma,CABOZANTINIB,1,"Active, not recruiting",MET,1
clear cell renal carcinoma,CABOZANTINIB,2,"Active, not recruiting",KDR,1
clear cell renal carcinoma,CABOZANTINIB,2,"Active, not recruiting",MET,1
chronic kidney disease,URSODIOL,4,Unknown status,NR1H4,1
chronic kidney disease,TOFACITINIB,1,Completed,JAK3,1
chronic kidney disease,TACROLIMUS,4,Withdrawn,FKBP1A,1
chronic kidney disease,THEOPHYLLINE,4,Completed,ADORA2A,1
chronic kidney disease,TENAPANOR,2,Completed,SLC9A3,1
chronic kidney disease,TESTOSTERONE,3,Unknown status,AR,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,ADORA1,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,ADORA2A,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,ADORA2B,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,ADORA3,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,PDE3A,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,PDE3B,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,PDE4A,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,PDE4B,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,PDE4C,1
chronic kidney disease,THEOPHYLLINE,2,Recruiting,PDE4D,1
chronic kidney disease,THEOPHYLLINE,4,Completed,ADORA1,1
chronic kidney disease,THEOPHYLLINE,4,Completed,ADORA2B,1
chronic kidney disease,TOFACITINIB,1,Completed,JAK2,1
chronic kidney disease,THEOPHYLLINE,4,Completed,ADORA3,1
chronic kidney disease,THEOPHYLLINE,4,Completed,PDE3A,1
chronic kidney disease,THEOPHYLLINE,4,Completed,PDE3B,1
chronic kidney disease,THEOPHYLLINE,4,Completed,PDE4A,1
chronic kidney disease,THEOPHYLLINE,4,Completed,PDE4B,1
chronic kidney disease,THEOPHYLLINE,4,Completed,PDE4C,1
chronic kidney disease,THEOPHYLLINE,4,Completed,PDE4D,1
chronic kidney disease,TICAGRELOR,1,Completed,P2RY12,1
chronic kidney disease,TICAGRELOR,1,Recruiting,P2RY12,1
chronic kidney disease,TICAGRELOR,3,Completed,P2RY12,1
chronic kidney disease,TINZAPARIN SODIUM,4,Completed,SERPINC1,1
chronic kidney disease,TOCILIZUMAB,1,Completed,IL6R,1
chronic kidney disease,TOFACITINIB,1,Completed,JAK1,1
chronic kidney disease,RIVAROXABAN,4,Completed,F10,1
chronic kidney disease,RIVAROXABAN,1,Completed,F10,1
chronic kidney disease,RITUXIMAB,2,Completed,MS4A1,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE1B,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE6C,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE6D,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE6G,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE6H,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE7A,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE7B,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE8A,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE8B,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE9A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,ADORA2A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,ADORA2B,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE10A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE1A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE1C,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE6A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE2A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE3A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE3B,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE4A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE4B,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE4C,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE4D,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE5A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE6A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE6B,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE6C,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE6D,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE6G,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE6B,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE5A,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE7A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE8A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE4A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE4B,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE4C,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE4D,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE5A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE6A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE6B,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE6C,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE6D,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE6G,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE6H,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE7A,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE7B,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE8B,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE4D,1
chronic kidney disease,PENTOXIFYLLINE,2,Terminated,PDE9A,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,ADORA2A,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,ADORA2B,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE10A,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE1A,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE1B,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE1C,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE2A,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE3A,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE3B,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE4A,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE4B,1
chronic kidney disease,PENTOXIFYLLINE,3,Completed,PDE4C,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE6H,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE7B,1
chronic kidney disease,RITUXIMAB,1,"Active, not recruiting",MS4A1,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRA4,1
chronic kidney disease,PIOGLITAZONE,4,Unknown status,PPARG,1
chronic kidney disease,PITAVASTATIN,4,Recruiting,HMGCR,1
chronic kidney disease,PRASUGREL,3,Completed,P2RY12,1
chronic kidney disease,PRAVASTATIN,1,Terminated,HMGCR,1
chronic kidney disease,PRAVASTATIN,3,Completed,HMGCR,1
chronic kidney disease,PRAVASTATIN,4,"Active, not recruiting",HMGCR,1
chronic kidney disease,PRAVASTATIN,4,Terminated,HMGCR,1
chronic kidney disease,PREDNISOLONE,2,Unknown status,NR3C1,1
chronic kidney disease,PREDNISONE,2,Terminated,NR3C1,1
chronic kidney disease,PREDNISONE,4,Recruiting,NR3C1,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRA1,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRA2,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRA3,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRA5,1
chronic kidney disease,PIOGLITAZONE,4,Completed,PPARG,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRA6,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRB1,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRB2,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRB3,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRD,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRE,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRG1,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRG2,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRG3,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRP,1
chronic kidney disease,PROPOFOL,4,Recruiting,GABRQ,1
chronic kidney disease,RAMIPRIL,3,"Active, not recruiting",ACE,1
chronic kidney disease,RILONACEPT,4,Completed,IL1B,1
chronic kidney disease,PIOGLITAZONE,4,Recruiting,PPARG,1
chronic kidney disease,PIOGLITAZONE,2,Terminated,PPARG,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE8A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE4C,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE8B,1
chronic kidney disease,PENTOXIFYLLINE,4,Completed,PDE9A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,ADORA2A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,ADORA2B,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE10A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE1A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE1B,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE1C,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE2A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE3A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE3B,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE4A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE4B,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE4D,1
chronic kidney disease,PIOGLITAZONE,2,Completed,PPARG,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE5A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE6A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE6B,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE6C,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE6D,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE6G,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE6H,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE7A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE7B,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE8A,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE8B,1
chronic kidney disease,PENTOXIFYLLINE,4,Unknown status,PDE9A,1
chronic kidney disease,PERINDOPRIL,4,Unknown status,ACE,1
chronic kidney disease,ECULIZUMAB,2,Completed,C5,1
chronic kidney disease,DROTRECOGIN ALFA (ACTIVATED),2,Completed,F5,1
nephrotic syndrome,ALDESLEUKIN,2,Withdrawn,IL2RA,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA12,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS6,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS7,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS8,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFV1,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFV2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFV3,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,2,Not yet recruiting,SSTR1,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,2,Not yet recruiting,SSTR2,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,2,Not yet recruiting,SSTR3,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,2,Not yet recruiting,SSTR4,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,2,Not yet recruiting,SSTR5,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,3,Completed,SSTR1,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,3,Completed,SSTR2,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,3,Completed,SSTR3,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,3,Completed,SSTR4,1
Autosomal dominant polycystic kidney disease,OCTREOTIDE,3,Completed,SSTR5,1
Autosomal dominant polycystic kidney disease,PRAVASTATIN,3,Completed,HMGCR,1
Autosomal dominant polycystic kidney disease,SIROLIMUS,3,Completed,FKBP1A,1
Autosomal dominant polycystic kidney disease,SIROLIMUS,3,Recruiting,FKBP1A,1
Autosomal dominant polycystic kidney disease,SPIRONOLACTONE,3,Completed,NR3C2,1
Autosomal dominant polycystic kidney disease,TESEVATINIB,1,"Active, not recruiting",EGFR,1
Autosomal dominant polycystic kidney disease,TESEVATINIB,1,"Active, not recruiting",EPHB4,1
Autosomal dominant polycystic kidney disease,TESEVATINIB,1,"Active, not recruiting",ERBB2,1
Autosomal dominant polycystic kidney disease,TESEVATINIB,2,Terminated,EGFR,1
Autosomal dominant polycystic kidney disease,TESEVATINIB,2,Terminated,EPHB4,1
Autosomal dominant polycystic kidney disease,TESEVATINIB,2,Terminated,ERBB2,1
Autosomal dominant polycystic kidney disease,TOLVAPTAN,2,Not yet recruiting,AVPR2,1
Autosomal dominant polycystic kidney disease,TOLVAPTAN,3,"Active, not recruiting",AVPR2,1
Autosomal dominant polycystic kidney disease,TOLVAPTAN,3,Not yet recruiting,AVPR2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS5,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS4,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS3,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAF4,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA3,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA4,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA4L2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA5,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA6,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA7,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA8,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA9,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAB1,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAF1,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAF2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFAF3,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB1,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB10,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB11,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB3,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB4,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB5,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB6,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB7,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB8,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFB9,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFC1,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFC2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFS1,1
Churg-Strauss syndrome,AZATHIOPRINE,3,Completed,PPAT,1
Churg-Strauss syndrome,AZATHIOPRINE,4,Completed,PPAT,1
Churg-Strauss syndrome,AZATHIOPRINE,4,Unknown status,PPAT,1
Granulomatosis with Polyangiitis,RITUXIMAB,4,Terminated,MS4A1,1
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,3,Unknown status,IMPDH1,1
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,3,Unknown status,IMPDH2,1
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH1,1
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH2,1
Granulomatosis with Polyangiitis,PREDNISOLONE,2,Completed,NR3C1,1
Granulomatosis with Polyangiitis,PREDNISONE,2,Completed,NR3C1,1
Granulomatosis with Polyangiitis,PREDNISONE,3,Terminated,NR3C1,1
Granulomatosis with Polyangiitis,PREDNISONE,4,Completed,NR3C1,1
Granulomatosis with Polyangiitis,RITUXIMAB,1,Completed,MS4A1,1
Granulomatosis with Polyangiitis,RITUXIMAB,3,"Active, not recruiting",MS4A1,1
Granulomatosis with Polyangiitis,RITUXIMAB,3,Completed,MS4A1,1
Granulomatosis with Polyangiitis,RITUXIMAB,3,Recruiting,MS4A1,1
Granulomatosis with Polyangiitis,RITUXIMAB,4,Recruiting,MS4A1,1
Granulomatosis with Polyangiitis,RITUXIMAB,4,n/a,MS4A1,1
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,3,Terminated,IMPDH1,1
HIV-associated nephropathy,PREDNISONE,2,Completed,NR3C1,1
IGA glomerulonephritis,ALISKIREN,3,Completed,REN,1
IGA glomerulonephritis,ALISKIREN,4,Completed,REN,1
IGA glomerulonephritis,ATACICEPT,2,Recruiting,TNFSF13,1
IGA glomerulonephritis,ATACICEPT,2,Recruiting,TNFSF13B,1
IGA glomerulonephritis,ATORVASTATIN,2,Completed,HMGCR,1
IGA glomerulonephritis,AVACOPAN,2,Completed,C5AR1,1
IGA glomerulonephritis,AZATHIOPRINE,4,Completed,PPAT,1
IGA glomerulonephritis,BLISIBIMOD,2,Completed,TNFSF13B,1
IGA glomerulonephritis,BLISIBIMOD,3,Withdrawn,TNFSF13B,1
IGA glomerulonephritis,BUDESONIDE,2,Completed,NR3C1,1
IGA glomerulonephritis,CALCITRIOL,4,Completed,VDR,1
IGA glomerulonephritis,ENALAPRIL,2,Completed,ACE,1
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,3,Terminated,IMPDH2,1
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,1,Completed,IMPDH2,1
Churg-Strauss syndrome,MEPOLIZUMAB,1,Completed,IL5,1
Granulomatosis with Polyangiitis,ABATACEPT,1,Completed,CD86,1
Churg-Strauss syndrome,MEPOLIZUMAB,2,Completed,IL5,1
Churg-Strauss syndrome,MEPOLIZUMAB,3,"Active, not recruiting",IL5,1
Churg-Strauss syndrome,MEPOLIZUMAB,3,Completed,IL5,1
Churg-Strauss syndrome,METHOTREXATE,4,Completed,DHFR,1
Churg-Strauss syndrome,METHYLPREDNISOLONE,4,Completed,NR3C1,1
Churg-Strauss syndrome,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH1,1
Churg-Strauss syndrome,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH2,1
Churg-Strauss syndrome,PREDNISOLONE,3,"Active, not recruiting",NR3C1,1
Churg-Strauss syndrome,PREDNISONE,2,Terminated,NR3C1,1
Churg-Strauss syndrome,PREDNISONE,4,Completed,NR3C1,1
Churg-Strauss syndrome,RITUXIMAB,2,Terminated,MS4A1,1
Dense deposit disease,ECULIZUMAB,1,Completed,C5,1
Granulomatosis with Polyangiitis,ABATACEPT,1,Completed,CD80,1
Granulomatosis with Polyangiitis,ABATACEPT,3,Recruiting,CD80,1
Granulomatosis with Polyangiitis,MYCOPHENOLATE MOFETIL,1,Completed,IMPDH1,1
Granulomatosis with Polyangiitis,ABATACEPT,3,Recruiting,CD86,1
Granulomatosis with Polyangiitis,AZATHIOPRINE,3,"Active, not recruiting",PPAT,1
Granulomatosis with Polyangiitis,AZATHIOPRINE,3,Completed,PPAT,1
Granulomatosis with Polyangiitis,AZATHIOPRINE,3,Unknown status,PPAT,1
Granulomatosis with Polyangiitis,AZATHIOPRINE,4,Completed,PPAT,1
Granulomatosis with Polyangiitis,AZATHIOPRINE,4,Recruiting,PPAT,1
Granulomatosis with Polyangiitis,DACLIZUMAB,2,Completed,IL2RA,1
Granulomatosis with Polyangiitis,INFLIXIMAB,2,Completed,TNF,1
Granulomatosis with Polyangiitis,METHOTREXATE,3,Terminated,DHFR,1
Granulomatosis with Polyangiitis,METHOTREXATE,3,Unknown status,DHFR,1
Granulomatosis with Polyangiitis,METHOTREXATE,4,Completed,DHFR,1
Granulomatosis with Polyangiitis,METHYLPREDNISOLONE,3,Terminated,NR3C1,1
Granulomatosis with Polyangiitis,METHYLPREDNISOLONE,4,Completed,NR3C1,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA13,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA11,1
chronic kidney disease,DOPAMINE,4,Completed,ADRB1,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA10,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA6,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA7,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA8,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA9,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFAB1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFAF1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFAF2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFAF3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFAF4,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB10,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB11,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB4,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB5,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB6,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB7,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB8,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFB9,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFC1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFC2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFS1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFS2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFS3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFS4,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFS5,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFS6,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFS7,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA5,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA4L2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA4,1
Autosomal dominant polycystic kidney disease,LIXIVAPTAN,2,Recruiting,AVPR2,1
Alport syndrome,BARDOXOLONE METHYL,2,"Active, not recruiting",NFE2L2,1
Alport syndrome,BARDOXOLONE METHYL,2,"Active, not recruiting",PPARG,1
Alport syndrome,BENAZEPRIL,2,Completed,ACE,1
Alport syndrome,FLUVASTATIN,2,Completed,HMGCR,1
Alport syndrome,VALSARTAN,2,Completed,AGTR1,1
Autosomal dominant polycystic kidney disease,BOSUTINIB,2,Completed,ABL1,1
Autosomal dominant polycystic kidney disease,BOSUTINIB,2,Completed,HCK,1
Autosomal dominant polycystic kidney disease,BOSUTINIB,2,Completed,LYN,1
Autosomal dominant polycystic kidney disease,BOSUTINIB,2,Completed,SRC,1
Autosomal dominant polycystic kidney disease,CANDESARTAN,4,Unknown status,AGTR1,1
Autosomal dominant polycystic kidney disease,CANDESARTAN CILEXETIL,4,Unknown status,AGTR1,1
Autosomal dominant polycystic kidney disease,EVEROLIMUS,3,Completed,FKBP1A,1
Autosomal dominant polycystic kidney disease,EVEROLIMUS,4,Completed,FKBP1A,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",GPD2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",MT-ND1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",MT-ND2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",MT-ND3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",MT-ND4,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",MT-ND4L,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",MT-ND5,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",MT-ND6,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA10,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA11,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA12,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA13,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFA2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFS8,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFV1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFV2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFS6,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB4,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB5,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB6,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB7,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB8,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB9,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFC1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFC2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFS1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFS2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFS3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFS4,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFS5,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFS7,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFS8,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFV1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFV2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFV3,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,GPD2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND1,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND2,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND3,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND4,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND4L,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND5,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,MT-ND6,1
Autosomal dominant polycystic kidney disease,METFORMIN,3,Not yet recruiting,NDUFA1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB11,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,"Active, not recruiting",NDUFV3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,GPD2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,MT-ND1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,MT-ND2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,MT-ND3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,MT-ND4,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,MT-ND4L,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,MT-ND5,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,MT-ND6,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA10,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA11,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA12,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA13,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB10,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA4,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA4L2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA5,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA6,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA7,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA8,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFA9,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFAB1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFAF1,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFAF2,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFAF3,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFAF4,1
Autosomal dominant polycystic kidney disease,METFORMIN,2,Recruiting,NDUFB1,1
IGA glomerulonephritis,ENALAPRIL,4,Completed,ACE,1
IGA glomerulonephritis,FOSTAMATINIB,2,Completed,SYK,1
IGA glomerulonephritis,FOSTAMATINIB,2,Withdrawn,SYK,1
IGA glomerulonephritis,HYDROXYCHLOROQUINE,4,Completed,TLR7,1
chromophobe renal cell carcinoma,SORAFENIB,1,Completed,FLT4,1
chromophobe renal cell carcinoma,SORAFENIB,1,Completed,KDR,1
chromophobe renal cell carcinoma,SORAFENIB,1,Completed,KIT,1
chromophobe renal cell carcinoma,SORAFENIB,1,Completed,PDGFRB,1
chromophobe renal cell carcinoma,SORAFENIB,1,Completed,RAF1,1
chromophobe renal cell carcinoma,SORAFENIB,1,Completed,RET,1
chronic kidney disease,ALEMTUZUMAB,2,Completed,CD52,1
chronic kidney disease,ALFACALCIDOL,4,Withdrawn,VDR,1
chronic kidney disease,ALISKIREN,1,Completed,REN,1
chronic kidney disease,ALISKIREN,4,Terminated,REN,1
chronic kidney disease,ALLOPURINOL,1,Recruiting,XDH,1
chronic kidney disease,ALPROSTADIL,4,"Active, not recruiting",PTGER1,1
chronic kidney disease,ALPROSTADIL,4,"Active, not recruiting",PTGER2,1
chronic kidney disease,AMILORIDE,4,Completed,SCNN1A,1
chronic kidney disease,AMILORIDE,4,Recruiting,SCNN1A,1
chronic kidney disease,AMLODIPINE,4,Completed,CACNA1C,1
chronic kidney disease,AMLODIPINE,4,Completed,CACNA1D,1
chronic kidney disease,AMLODIPINE,4,Completed,CACNA1F,1
chronic kidney disease,AMLODIPINE,4,Completed,CACNA1S,1
chronic kidney disease,ANAKINRA,2,Completed,IL1R1,1
chronic kidney disease,ANAKINRA,2,Recruiting,IL1R1,1
chronic kidney disease,APIXABAN,1,Completed,F10,1
chronic kidney disease,APIXABAN,2,Completed,F10,1
chronic kidney disease,APIXABAN,4,Completed,F10,1
chronic kidney disease,ARGATROBAN,4,Completed,F2,1
chronic kidney disease,ASPIRIN,1,Unknown status,PTGS1,1
chronic kidney disease,ASPIRIN,1,Unknown status,PTGS2,1
chronic kidney disease,ASPIRIN,3,Unknown status,PTGS1,1
chronic kidney disease,ASPIRIN,3,Unknown status,PTGS2,1
chromophobe renal cell carcinoma,SORAFENIB,1,Completed,FLT3,1
chromophobe renal cell carcinoma,SORAFENIB,1,Completed,FLT1,1
chromophobe renal cell carcinoma,SORAFENIB,1,Completed,BRAF,1
acute kidney tubular necrosis,BASILIXIMAB,1,Unknown status,IL2RA,1
Von Hippel-Lindau disease,SUNITINIB,2,Completed,FLT4,1
Von Hippel-Lindau disease,SUNITINIB,2,Completed,KDR,1
Von Hippel-Lindau disease,SUNITINIB,2,Completed,KIT,1
Von Hippel-Lindau disease,SUNITINIB,2,Completed,PDGFRA,1
Von Hippel-Lindau disease,SUNITINIB,2,Completed,PDGFRB,1
Von Hippel-Lindau disease,SUNITINIB,2,Completed,RET,1
Von Hippel-Lindau disease,VATALANIB,2,Completed,CSF1R,1
Von Hippel-Lindau disease,VATALANIB,2,Completed,FLT1,1
Von Hippel-Lindau disease,VATALANIB,2,Completed,FLT4,1
Von Hippel-Lindau disease,VATALANIB,2,Completed,KDR,1
Von Hippel-Lindau disease,VATALANIB,2,Completed,KIT,1
Von Hippel-Lindau disease,VATALANIB,2,Completed,PDGFRA,1
Von Hippel-Lindau disease,VATALANIB,2,Completed,PDGFRB,1
acute kidney tubular necrosis,TACROLIMUS,1,Unknown status,FKBP1A,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,1
chromophobe renal cell carcinoma,BEVACIZUMAB,1,Completed,VEGFA,1
chromophobe renal cell carcinoma,CABOZANTINIB,2,Not yet recruiting,KDR,1
chromophobe renal cell carcinoma,CABOZANTINIB,2,Not yet recruiting,MET,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT1,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT4,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",ITK,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",KDR,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",KIT,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",LCK,1
chromophobe renal cell carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,1
chronic kidney disease,ASPIRIN,4,Withdrawn,PTGS1,1
chronic kidney disease,ASPIRIN,4,Withdrawn,PTGS2,1
chronic kidney disease,ATORVASTATIN,1,Completed,HMGCR,1
chronic kidney disease,DASATINIB,2,Recruiting,BLK,1
chronic kidney disease,CORTICOTROPIN,1,Terminated,MC2R,1
chronic kidney disease,CYCLOSPORINE,2,Terminated,PPIA,1
chronic kidney disease,CYCLOSPORINE,3,Completed,PPIA,1
chronic kidney disease,CYCLOSPORINE,3,Terminated,PPIA,1
chronic kidney disease,DABIGATRAN ETEXILATE,1,Completed,F2,1
chronic kidney disease,DACLIZUMAB,3,Completed,IL2RA,1
chronic kidney disease,DALTEPARIN SODIUM,3,Completed,SERPINC1,1
chronic kidney disease,DAPAGLIFLOZIN,3,Recruiting,SLC5A2,1
chronic kidney disease,DARBEPOETIN ALFA,2,Completed,EPOR,1
chronic kidney disease,DARBEPOETIN ALFA,3,"Active, not recruiting",EPOR,1
chronic kidney disease,DARBEPOETIN ALFA,3,Recruiting,EPOR,1
chronic kidney disease,DARBEPOETIN ALFA,4,n/a,EPOR,1
chronic kidney disease,DASATINIB,2,Recruiting,ABL1,1
chronic kidney disease,DASATINIB,2,Recruiting,EPHA2,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB6,1
chronic kidney disease,DASATINIB,2,Recruiting,FGR,1
chronic kidney disease,DASATINIB,2,Recruiting,FRK,1
chronic kidney disease,DASATINIB,2,Recruiting,FYN,1
chronic kidney disease,DASATINIB,2,Recruiting,HCK,1
chronic kidney disease,DASATINIB,2,Recruiting,KIT,1
chronic kidney disease,DASATINIB,2,Recruiting,LCK,1
chronic kidney disease,DASATINIB,2,Recruiting,LYN,1
chronic kidney disease,DASATINIB,2,Recruiting,PDGFRB,1
chronic kidney disease,DASATINIB,2,Recruiting,SRC,1
chronic kidney disease,DASATINIB,2,Recruiting,SRMS,1
chronic kidney disease,DASATINIB,2,Recruiting,YES1,1
chronic kidney disease,DEFLAZACORT,4,Completed,NR3C1,1
chronic kidney disease,DONEPEZIL,4,Completed,ACHE,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB8,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB4B,1
chronic kidney disease,ATORVASTATIN,3,Completed,HMGCR,1
chronic kidney disease,CALCITRIOL,4,Terminated,VDR,1
chronic kidney disease,ATORVASTATIN,4,Completed,HMGCR,1
chronic kidney disease,ATORVASTATIN,4,Recruiting,HMGCR,1
chronic kidney disease,ATORVASTATIN,4,Terminated,HMGCR,1
chronic kidney disease,AZATHIOPRINE,3,Completed,PPAT,1
chronic kidney disease,BASILIXIMAB,2,Unknown status,IL2RA,1
chronic kidney disease,BELATACEPT,3,Completed,CD80,1
chronic kidney disease,BELATACEPT,3,Completed,CD86,1
chronic kidney disease,BELATACEPT,4,Withdrawn,CD80,1
chronic kidney disease,BELATACEPT,4,Withdrawn,CD86,1
chronic kidney disease,BEVACIZUMAB,0,Unknown status,VEGFA,1
chronic kidney disease,BORTEZOMIB,3,Completed,PSMB5,1
chronic kidney disease,CALCITRIOL,3,Completed,VDR,1
chronic kidney disease,CALCITRIOL,4,Completed,VDR,1
chronic kidney disease,CALCITRIOL,4,Unknown status,VDR,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB4A,1
chronic kidney disease,CHLORTHALIDONE,4,"Active, not recruiting",SLC12A3,1
chronic kidney disease,CHOLECALCIFEROL,0,Completed,VDR,1
chronic kidney disease,CHOLECALCIFEROL,2,Unknown status,VDR,1
chronic kidney disease,CHOLECALCIFEROL,3,"Active, not recruiting",VDR,1
chronic kidney disease,CHOLECALCIFEROL,3,Completed,VDR,1
chronic kidney disease,CHOLECALCIFEROL,3,Terminated,VDR,1
chronic kidney disease,CLOPIDOGREL,1,Unknown status,P2RY12,1
chronic kidney disease,CLOPIDOGREL,3,Unknown status,P2RY12,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB1,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB2A,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB2B,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB3,1
Von Hippel-Lindau disease,SUNITINIB,2,Completed,FLT3,1
Von Hippel-Lindau disease,SUNITINIB,2,Completed,FLT1,1
Von Hippel-Lindau disease,SUNITINIB,2,Completed,CSF1R,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,POLE3,1
IGA glomerulonephritis,SPARSENTAN,3,Recruiting,AGTR1,1
IGA glomerulonephritis,SPARSENTAN,3,Recruiting,EDNRA,1
IGA glomerulonephritis,TACROLIMUS,2,Completed,FKBP1A,1
IGA glomerulonephritis,VALSARTAN,4,Recruiting,AGTR1,1
Kidney Medullary Carcinoma,DOXORUBICIN,2,Recruiting,TOP2A,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,POLA1,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,POLA2,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,POLD1,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,POLD2,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,POLD3,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,POLD4,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,POLE,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,POLE2,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,PRIM1,1
IGA glomerulonephritis,RITUXIMAB,4,Unknown status,MS4A1,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,PRIM2,1
Kidney Medullary Carcinoma,GEMCITABINE,2,Recruiting,RRM1,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT1,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT4,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",ITK,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",KDR,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",KIT,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",LCK,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,1
Kidney Medullary Carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,1
IGA glomerulonephritis,SIROLIMUS,2,Completed,FKBP1A,1
IGA glomerulonephritis,RITUXIMAB,4,Completed,MS4A1,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,3,Terminated,IMPDH1,1
IGA glomerulonephritis,HYDROXYCHLOROQUINE,4,Completed,TLR9,1
IGA glomerulonephritis,HYDROXYCHLOROQUINE,4,Recruiting,TLR7,1
IGA glomerulonephritis,HYDROXYCHLOROQUINE,4,Recruiting,TLR9,1
IGA glomerulonephritis,IRBESARTAN,3,"Active, not recruiting",AGTR1,1
IGA glomerulonephritis,IRBESARTAN,3,Recruiting,AGTR1,1
IGA glomerulonephritis,LOSARTAN,3,Completed,AGTR1,1
IGA glomerulonephritis,LOSARTAN,4,Completed,AGTR1,1
IGA glomerulonephritis,LOSARTAN,4,Unknown status,AGTR1,1
IGA glomerulonephritis,METHYLPREDNISOLONE,3,"Active, not recruiting",NR3C1,1
IGA glomerulonephritis,METHYLPREDNISOLONE HEMISUCCINATE,3,"Active, not recruiting",NR3C1,1
IGA glomerulonephritis,METHYLPREDNISOLONE HEMISUCCINATE,4,Completed,NR3C1,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,3,"Active, not recruiting",IMPDH1,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,3,"Active, not recruiting",IMPDH2,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,3,Terminated,IMPDH2,1
IGA glomerulonephritis,RAMIPRIL,4,Completed,ACE,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,3,Unknown status,IMPDH1,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,3,Unknown status,IMPDH2,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH1,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH2,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,4,Unknown status,IMPDH1,1
IGA glomerulonephritis,MYCOPHENOLATE MOFETIL,4,Unknown status,IMPDH2,1
IGA glomerulonephritis,PARICALCITOL,3,Withdrawn,VDR,1
IGA glomerulonephritis,PREDNISOLONE,2,Unknown status,NR3C1,1
IGA glomerulonephritis,PREDNISOLONE,3,Completed,NR3C1,1
IGA glomerulonephritis,PREDNISONE,2,Completed,NR3C1,1
IGA glomerulonephritis,PREDNISONE,3,"Active, not recruiting",NR3C1,1
IGA glomerulonephritis,PREDNISONE,3,Completed,NR3C1,1
IGA glomerulonephritis,PROBUCOL,4,Completed,ABCA1,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,1
Von Hippel-Lindau disease,SUNITINIB,1,Terminated,RET,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",LCK,1
Von Hippel-Lindau disease,DOVITINIB,2,Terminated,FLT4,1
Von Hippel-Lindau disease,DOVITINIB,2,Terminated,KDR,1
Von Hippel-Lindau disease,DOVITINIB,2,Terminated,KIT,1
Von Hippel-Lindau disease,DOVITINIB,2,Terminated,PDGFRA,1
Von Hippel-Lindau disease,DOVITINIB,2,Terminated,PDGFRB,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",CSF1R,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",FGFR1,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",FGFR3,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",FLT1,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",FLT4,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",ITK,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",KDR,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",KIT,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",PDGFRA,1
Von Hippel-Lindau disease,DOVITINIB,2,Terminated,FLT1,1
Von Hippel-Lindau disease,PAZOPANIB,2,"Active, not recruiting",PDGFRB,1
Von Hippel-Lindau disease,PEGAPTANIB SODIUM,1,Completed,VEGFA,1
Von Hippel-Lindau disease,PEGPLERANIB SODIUM,1,"Active, not recruiting",PDGFB,1
Von Hippel-Lindau disease,RANIBIZUMAB,1,"Active, not recruiting",VEGFA,1
Von Hippel-Lindau disease,RANIBIZUMAB,1,Completed,VEGFA,1
Von Hippel-Lindau disease,SUNITINIB,1,Terminated,CSF1R,1
Von Hippel-Lindau disease,SUNITINIB,1,Terminated,FLT1,1
Von Hippel-Lindau disease,SUNITINIB,1,Terminated,FLT3,1
Von Hippel-Lindau disease,SUNITINIB,1,Terminated,FLT4,1
Von Hippel-Lindau disease,SUNITINIB,1,Terminated,KDR,1
Von Hippel-Lindau disease,SUNITINIB,1,Terminated,KIT,1
Von Hippel-Lindau disease,SUNITINIB,1,Terminated,PDGFRA,1
Von Hippel-Lindau disease,SUNITINIB,1,Terminated,PDGFRB,1
Von Hippel-Lindau disease,DOVITINIB,2,Terminated,FLT3,1
Von Hippel-Lindau disease,DOVITINIB,2,Terminated,FGFR3,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",FLT1,1
Polyarteritis Nodosa,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH1,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",FLT4,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",ITK,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",KDR,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",KIT,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",LCK,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,1
Kidney Oncocytoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,1
MYH9-related disease,ELTROMBOPAG,2,Completed,MPL,1
Non-immunoglobulin-mediated membranoproliferative glomerulonephritis,AVACOPAN,2,Recruiting,C5AR1,1
Polyarteritis Nodosa,AZATHIOPRINE,4,Completed,PPAT,1
Polyarteritis Nodosa,AZATHIOPRINE,4,Unknown status,PPAT,1
Polyarteritis Nodosa,METHOTREXATE,4,Completed,DHFR,1
Polyarteritis Nodosa,METHYLPREDNISOLONE,4,Completed,NR3C1,1
Polyarteritis Nodosa,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH2,1
Von Hippel-Lindau disease,BEVACIZUMAB,0,Terminated,VEGFA,1
Polyarteritis Nodosa,PREDNISONE,4,Completed,NR3C1,1
Polycystic Kidney Disease,PIOGLITAZONE,2,"Active, not recruiting",PPARG,1
Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,AXITINIB,2,Recruiting,FLT1,1
Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,AXITINIB,2,Recruiting,FLT4,1
Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,AXITINIB,2,Recruiting,KDR,1
Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,NIVOLUMAB,2,Recruiting,PDCD1,1
Tuberous sclerosis,EVEROLIMUS,1,Completed,FKBP1A,1
Tuberous sclerosis,EVEROLIMUS,2,Completed,FKBP1A,1
Tuberous sclerosis,EVEROLIMUS,3,"Active, not recruiting",FKBP1A,1
Tuberous sclerosis,EVEROLIMUS,3,Completed,FKBP1A,1
Tuberous sclerosis,EVEROLIMUS,4,n/a,FKBP1A,1
Tuberous sclerosis,VIGABATRIN,2,Recruiting,ABAT,1
Unclassified Renal Cell Carcinoma,NIVOLUMAB,3,Recruiting,PDCD1,1
clear cell renal carcinoma,CABOZANTINIB,2,Recruiting,KDR,1
clear cell renal carcinoma,CABOZANTINIB,2,Recruiting,MET,1
clear cell renal carcinoma,CAROTUXIMAB,2,Completed,ENG,1
kidney failure,MYCOPHENOLATE MOFETIL,4,Unknown status,IMPDH2,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRB2,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRB3,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRD,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRE,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRG1,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRG2,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRG3,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRP,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRQ,1
kidney failure,SEVOFLURANE,1,Unknown status,GLRA1,1
kidney failure,SEVOFLURANE,1,Unknown status,KCNK10,1
kidney failure,SEVOFLURANE,1,Unknown status,KCNK18,1
kidney failure,SEVOFLURANE,1,Unknown status,KCNK2,1
kidney failure,SEVOFLURANE,1,Unknown status,KCNK3,1
kidney failure,SEVOFLURANE,1,Unknown status,KCNK9,1
kidney failure,SEVOFLURANE,2,Completed,GABRA1,1
kidney failure,SEVOFLURANE,2,Completed,GABRA2,1
kidney failure,SEVOFLURANE,2,Completed,GABRA3,1
kidney failure,SEVOFLURANE,2,Completed,GABRA4,1
kidney failure,SEVOFLURANE,2,Completed,GABRA5,1
kidney failure,SEVOFLURANE,2,Completed,GABRA6,1
kidney failure,SEVOFLURANE,2,Completed,GABRB1,1
kidney failure,SEVOFLURANE,2,Completed,GABRB2,1
kidney failure,SEVOFLURANE,2,Completed,GABRB3,1
kidney failure,SEVOFLURANE,2,Completed,GABRD,1
kidney failure,SEVOFLURANE,2,Completed,GABRE,1
kidney failure,SEVOFLURANE,2,Completed,GABRG1,1
kidney failure,SEVOFLURANE,2,Completed,GABRG2,1
kidney failure,SEVOFLURANE,2,Completed,GABRG3,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRB1,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRA6,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRA5,1
kidney failure,PROPOFOL,1,Unknown status,GABRB1,1
kidney failure,MYCOPHENOLIC ACID,3,Completed,IMPDH2,1
kidney failure,MYCOPHENOLIC ACID,4,Completed,IMPDH1,1
kidney failure,MYCOPHENOLIC ACID,4,Completed,IMPDH2,1
kidney failure,NAPROXCINOD,1,Completed,PTGS1,1
kidney failure,NAPROXCINOD,1,Completed,PTGS2,1
kidney failure,NESIRITIDE,2,Completed,NPR1,1
kidney failure,PARICALCITOL,4,Completed,VDR,1
kidney failure,PROPOFOL,1,Unknown status,GABRA1,1
kidney failure,PROPOFOL,1,Unknown status,GABRA2,1
kidney failure,PROPOFOL,1,Unknown status,GABRA3,1
kidney failure,PROPOFOL,1,Unknown status,GABRA4,1
kidney failure,PROPOFOL,1,Unknown status,GABRA5,1
kidney failure,PROPOFOL,1,Unknown status,GABRA6,1
kidney failure,PROPOFOL,1,Unknown status,GABRB2,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRA4,1
kidney failure,PROPOFOL,1,Unknown status,GABRB3,1
kidney failure,PROPOFOL,1,Unknown status,GABRD,1
kidney failure,PROPOFOL,1,Unknown status,GABRE,1
kidney failure,PROPOFOL,1,Unknown status,GABRG1,1
kidney failure,PROPOFOL,1,Unknown status,GABRG2,1
kidney failure,PROPOFOL,1,Unknown status,GABRG3,1
kidney failure,PROPOFOL,1,Unknown status,GABRP,1
kidney failure,PROPOFOL,1,Unknown status,GABRQ,1
kidney failure,RITUXIMAB,2,Terminated,MS4A1,1
kidney failure,ROSUVASTATIN,3,Completed,HMGCR,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRA1,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRA2,1
kidney failure,SEVOFLURANE,1,Unknown status,GABRA3,1
kidney failure,SEVOFLURANE,2,Completed,GABRP,1
kidney failure,SEVOFLURANE,2,Completed,GABRQ,1
kidney failure,SEVOFLURANE,2,Completed,GLRA1,1
kidney neoplasm,ALDESLEUKIN,1,Terminated,IL2RB,1
kidney failure,TACROLIMUS,4,Not yet recruiting,FKBP1A,1
kidney failure,TACROLIMUS,4,Recruiting,FKBP1A,1
kidney failure,THEOPHYLLINE,4,Completed,ADORA1,1
kidney failure,THEOPHYLLINE,4,Completed,ADORA2A,1
kidney failure,THEOPHYLLINE,4,Completed,ADORA2B,1
kidney failure,THEOPHYLLINE,4,Completed,ADORA3,1
kidney failure,THEOPHYLLINE,4,Completed,PDE3A,1
kidney failure,THEOPHYLLINE,4,Completed,PDE3B,1
kidney failure,THEOPHYLLINE,4,Completed,PDE4A,1
kidney failure,THEOPHYLLINE,4,Completed,PDE4B,1
kidney failure,THEOPHYLLINE,4,Completed,PDE4C,1
kidney failure,THEOPHYLLINE,4,Completed,PDE4D,1
kidney neoplasm,ALDESLEUKIN,1,Terminated,IL2RA,1
kidney neoplasm,AXITINIB,2,Completed,FLT1,1
kidney failure,TACROLIMUS,1,Completed,FKBP1A,1
kidney neoplasm,AXITINIB,2,Completed,FLT4,1
kidney neoplasm,AXITINIB,2,Completed,KDR,1
kidney neoplasm,AXITINIB,3,"Active, not recruiting",FLT1,1
kidney neoplasm,AXITINIB,3,"Active, not recruiting",FLT4,1
kidney neoplasm,AXITINIB,3,"Active, not recruiting",KDR,1
kidney neoplasm,AXITINIB,3,Completed,FLT1,1
kidney neoplasm,AXITINIB,3,Completed,FLT4,1
kidney neoplasm,AXITINIB,3,Completed,KDR,1
kidney neoplasm,CAPECITABINE,2,Completed,TYMS,1
kidney neoplasm,ETOPOSIDE,3,Not yet recruiting,TOP2A,1
kidney neoplasm,ETOPOSIDE,3,Not yet recruiting,TOP2B,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,POLA1,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,POLA2,1
kidney failure,TACROLIMUS,4,Completed,FKBP1A,1
kidney failure,SPIRONOLACTONE,4,Unknown status,NR3C2,1
kidney failure,SEVOFLURANE,2,Completed,KCNK10,1
kidney failure,SEVOFLURANE,4,Terminated,GABRD,1
kidney failure,SEVOFLURANE,2,Completed,KCNK18,1
kidney failure,SEVOFLURANE,2,Completed,KCNK2,1
kidney failure,SEVOFLURANE,2,Completed,KCNK3,1
kidney failure,SEVOFLURANE,2,Completed,KCNK9,1
kidney failure,SEVOFLURANE,4,Terminated,GABRA1,1
kidney failure,SEVOFLURANE,4,Terminated,GABRA2,1
kidney failure,SEVOFLURANE,4,Terminated,GABRA3,1
kidney failure,SEVOFLURANE,4,Terminated,GABRA4,1
kidney failure,SEVOFLURANE,4,Terminated,GABRA5,1
kidney failure,SEVOFLURANE,4,Terminated,GABRA6,1
kidney failure,SEVOFLURANE,4,Terminated,GABRB1,1
kidney failure,SEVOFLURANE,4,Terminated,GABRB2,1
kidney failure,SEVOFLURANE,4,Terminated,GABRB3,1
kidney failure,SEVOFLURANE,4,Terminated,GABRE,1
kidney failure,SIROLIMUS,2,Completed,FKBP1A,1
kidney failure,SEVOFLURANE,4,Terminated,GABRG1,1
kidney failure,SEVOFLURANE,4,Terminated,GABRG2,1
kidney failure,SEVOFLURANE,4,Terminated,GABRG3,1
kidney failure,SEVOFLURANE,4,Terminated,GABRP,1
kidney failure,SEVOFLURANE,4,Terminated,GABRQ,1
kidney failure,SEVOFLURANE,4,Terminated,GLRA1,1
kidney failure,SEVOFLURANE,4,Terminated,KCNK10,1
kidney failure,SEVOFLURANE,4,Terminated,KCNK18,1
kidney failure,SEVOFLURANE,4,Terminated,KCNK2,1
kidney failure,SEVOFLURANE,4,Terminated,KCNK3,1
kidney failure,SEVOFLURANE,4,Terminated,KCNK9,1
kidney failure,SIMVASTATIN,4,Completed,HMGCR,1
kidney failure,SIROLIMUS,1,Completed,FKBP1A,1
kidney failure,MYCOPHENOLIC ACID,3,Completed,IMPDH1,1
kidney failure,MYCOPHENOLATE MOFETIL,4,Unknown status,IMPDH1,1
clear cell renal carcinoma,CEDIRANIB,2,Terminated,FLT1,1
kidney failure,MYCOPHENOLATE MOFETIL,3,"Active, not recruiting",IMPDH2,1
kidney disease,SORAFENIB,1,Completed,FLT4,1
kidney disease,SORAFENIB,1,Completed,KDR,1
kidney disease,SORAFENIB,1,Completed,KIT,1
kidney disease,SORAFENIB,1,Completed,PDGFRB,1
kidney disease,SORAFENIB,1,Completed,RAF1,1
kidney disease,SORAFENIB,1,Completed,RET,1
kidney disease,TACROLIMUS,2,Completed,FKBP1A,1
kidney disease,TACROLIMUS,2,Unknown status,FKBP1A,1
kidney disease,TACROLIMUS,3,"Active, not recruiting",FKBP1A,1
kidney disease,THEOPHYLLINE,2,Unknown status,ADORA1,1
kidney disease,THEOPHYLLINE,2,Unknown status,ADORA2A,1
kidney disease,THEOPHYLLINE,2,Unknown status,ADORA2B,1
kidney disease,THEOPHYLLINE,2,Unknown status,ADORA3,1
kidney disease,THEOPHYLLINE,2,Unknown status,PDE3A,1
kidney disease,THEOPHYLLINE,2,Unknown status,PDE3B,1
kidney disease,THEOPHYLLINE,2,Unknown status,PDE4A,1
kidney disease,THEOPHYLLINE,2,Unknown status,PDE4B,1
kidney disease,THEOPHYLLINE,2,Unknown status,PDE4C,1
kidney disease,THEOPHYLLINE,2,Unknown status,PDE4D,1
kidney disease,TOLVAPTAN,2,Completed,AVPR2,1
kidney failure,ALEFACEPT,1,Terminated,CD2,1
kidney failure,ALEMTUZUMAB,1,Completed,CD52,1
kidney failure,ALEMTUZUMAB,4,Completed,CD52,1
kidney failure,ALFACALCIDOL,2,Completed,VDR,1
kidney failure,BELATACEPT,4,Recruiting,CD80,1
kidney failure,BELATACEPT,4,Recruiting,CD86,1
kidney failure,CYCLOSPORINE,3,"Active, not recruiting",PPIA,1
kidney failure,CYCLOSPORINE,3,Completed,PPIA,1
kidney failure,CYCLOSPORINE,4,Completed,PPIA,1
kidney disease,SORAFENIB,1,Completed,FLT3,1
kidney disease,SORAFENIB,1,Completed,FLT1,1
kidney disease,SORAFENIB,1,Completed,BRAF,1
kidney disease,PROPOFOL,4,Completed,GABRQ,1
kidney disease,PROPOFOL,4,Completed,GABRA3,1
kidney disease,PROPOFOL,4,Completed,GABRA4,1
kidney disease,PROPOFOL,4,Completed,GABRA5,1
kidney disease,PROPOFOL,4,Completed,GABRA6,1
kidney disease,PROPOFOL,4,Completed,GABRB1,1
kidney disease,PROPOFOL,4,Completed,GABRB2,1
kidney disease,PROPOFOL,4,Completed,GABRB3,1
kidney disease,PROPOFOL,4,Completed,GABRD,1
kidney disease,PROPOFOL,4,Completed,GABRE,1
kidney disease,PROPOFOL,4,Completed,GABRG1,1
kidney disease,PROPOFOL,4,Completed,GABRG2,1
kidney disease,PROPOFOL,4,Completed,GABRG3,1
kidney disease,PROPOFOL,4,Completed,GABRP,1
kidney disease,PROPRANOLOL,1,Completed,ADRB1,1
kidney disease,SIROLIMUS,4,Unknown status,FKBP1A,1
kidney disease,PROPRANOLOL,1,Completed,ADRB2,1
kidney disease,RAMIPRIL,2,Terminated,ACE,1
kidney disease,RITUXIMAB,0,Completed,MS4A1,1
kidney disease,RITUXIMAB,2,Completed,MS4A1,1
kidney disease,RITUXIMAB,2,Terminated,MS4A1,1
kidney disease,RITUXIMAB,3,"Active, not recruiting",MS4A1,1
kidney disease,ROSUVASTATIN,4,Completed,HMGCR,1
kidney disease,SARGRAMOSTIM,2,Terminated,CSF2RA,1
kidney disease,SIMVASTATIN,4,Completed,HMGCR,1
kidney disease,SIPLIZUMAB,1,Completed,CD2,1
kidney disease,SIROLIMUS,2,Unknown status,FKBP1A,1
kidney disease,SIROLIMUS,3,Completed,FKBP1A,1
kidney disease,SIROLIMUS,4,Completed,FKBP1A,1
kidney failure,DACLIZUMAB,4,Completed,IL2RA,1
kidney failure,DALTEPARIN SODIUM,4,Unknown status,SERPINC1,1
kidney failure,DESFLURANE,2,Completed,GABRA1,1
kidney failure,ISOFLURANE,4,Terminated,GABRE,1
kidney failure,HEPARIN SODIUM,1,Not yet recruiting,SERPINC1,1
kidney failure,HEPARIN SODIUM,4,Completed,SERPINC1,1
kidney failure,IMIQUIMOD,2,Recruiting,TLR7,1
kidney failure,ISOFLURANE,4,Terminated,GABRA1,1
kidney failure,ISOFLURANE,4,Terminated,GABRA2,1
kidney failure,ISOFLURANE,4,Terminated,GABRA3,1
kidney failure,ISOFLURANE,4,Terminated,GABRA4,1
kidney failure,ISOFLURANE,4,Terminated,GABRA5,1
kidney failure,ISOFLURANE,4,Terminated,GABRA6,1
kidney failure,ISOFLURANE,4,Terminated,GABRB1,1
kidney failure,ISOFLURANE,4,Terminated,GABRB2,1
kidney failure,ISOFLURANE,4,Terminated,GABRB3,1
kidney failure,ISOFLURANE,4,Terminated,GABRD,1
kidney failure,ISOFLURANE,4,Terminated,GABRG1,1
kidney failure,FUROSEMIDE,3,Terminated,SLC12A1,1
kidney failure,ISOFLURANE,4,Terminated,GABRG2,1
kidney failure,ISOFLURANE,4,Terminated,GABRG3,1
kidney failure,ISOFLURANE,4,Terminated,GABRP,1
kidney failure,ISOFLURANE,4,Terminated,GABRQ,1
kidney failure,ISOFLURANE,4,Terminated,GLRA1,1
kidney failure,ISOFLURANE,4,Terminated,KCNK10,1
kidney failure,ISOFLURANE,4,Terminated,KCNK18,1
kidney failure,ISOFLURANE,4,Terminated,KCNK2,1
kidney failure,ISOFLURANE,4,Terminated,KCNK3,1
kidney failure,ISOFLURANE,4,Terminated,KCNK9,1
kidney failure,MYCOPHENOLATE MOFETIL,1,Completed,IMPDH1,1
kidney failure,MYCOPHENOLATE MOFETIL,1,Completed,IMPDH2,1
kidney failure,MYCOPHENOLATE MOFETIL,3,"Active, not recruiting",IMPDH1,1
kidney failure,FUROSEMIDE,4,Withdrawn,SLC12A1,1
kidney failure,FUROSEMIDE,1,Completed,SLC12A1,1
kidney failure,DESFLURANE,2,Completed,GABRA2,1
kidney failure,DESFLURANE,2,Completed,GABRQ,1
kidney failure,DESFLURANE,2,Completed,GABRA3,1
kidney failure,DESFLURANE,2,Completed,GABRA4,1
kidney failure,DESFLURANE,2,Completed,GABRA5,1
kidney failure,DESFLURANE,2,Completed,GABRA6,1
kidney failure,DESFLURANE,2,Completed,GABRB1,1
kidney failure,DESFLURANE,2,Completed,GABRB2,1
kidney failure,DESFLURANE,2,Completed,GABRB3,1
kidney failure,DESFLURANE,2,Completed,GABRD,1
kidney failure,DESFLURANE,2,Completed,GABRE,1
kidney failure,DESFLURANE,2,Completed,GABRG1,1
kidney failure,DESFLURANE,2,Completed,GABRG2,1
kidney failure,DESFLURANE,2,Completed,GABRG3,1
kidney failure,DESFLURANE,2,Completed,GABRP,1
kidney failure,DESFLURANE,2,Completed,GLRA1,1
kidney failure,FENOLDOPAM,4,Withdrawn,DRD1,1
kidney failure,DESFLURANE,2,Completed,KCNK10,1
kidney failure,DESFLURANE,2,Completed,KCNK18,1
kidney failure,DESFLURANE,2,Completed,KCNK2,1
kidney failure,DESFLURANE,2,Completed,KCNK3,1
kidney failure,DESFLURANE,2,Completed,KCNK9,1
kidney failure,DESMOPRESSIN,4,Completed,AVPR1A,1
kidney failure,DESMOPRESSIN,4,Completed,AVPR1B,1
kidney failure,DESMOPRESSIN,4,Completed,AVPR2,1
kidney failure,EPOPROSTENOL,4,Completed,PTGIR,1
kidney failure,EVEROLIMUS,3,"Active, not recruiting",FKBP1A,1
kidney failure,EVEROLIMUS,3,Completed,FKBP1A,1
kidney failure,EVEROLIMUS,4,Completed,FKBP1A,1
kidney failure,FENOLDOPAM,3,Completed,DRD1,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,POLD1,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,POLD2,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,POLD3,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,POLD4,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE2A,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE3A,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE3B,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE4A,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE4B,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE4C,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE4D,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE5A,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE6A,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE6B,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE6C,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE6D,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE6G,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE6H,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE7A,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE7B,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE8A,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE8B,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE9A,1
lupus nephritis,PREDNISOLONE,3,Completed,NR3C1,1
lupus nephritis,PREDNISOLONE,3,Withdrawn,NR3C1,1
lupus nephritis,PREDNISONE,3,Withdrawn,NR3C1,1
lupus nephritis,RITUXIMAB,2,"Active, not recruiting",MS4A1,1
lupus nephritis,RITUXIMAB,3,Completed,MS4A1,1
lupus nephritis,RITUXIMAB,3,Terminated,MS4A1,1
lupus nephritis,RITUXIMAB,3,Withdrawn,MS4A1,1
lupus nephritis,RUPLIZUMAB,2,Completed,CD40LG,1
lupus nephritis,SIRUKUMAB,2,Completed,IL6,1
lupus nephritis,TACROLIMUS,2,Unknown status,FKBP1A,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE1C,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE1B,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE1A,1
lupus nephritis,MYCOPHENOLATE MOFETIL,2,"Active, not recruiting",IMPDH1,1
lupus nephritis,AZATHIOPRINE,3,Terminated,PPAT,1
lupus nephritis,AZATHIOPRINE,4,Completed,PPAT,1
lupus nephritis,BELIMUMAB,2,"Active, not recruiting",TNFSF13B,1
lupus nephritis,BELIMUMAB,3,"Active, not recruiting",TNFSF13B,1
lupus nephritis,CORTICOTROPIN,4,Recruiting,MC2R,1
lupus nephritis,CYCLOSPORINE,3,Withdrawn,PPIA,1
lupus nephritis,DIPHENHYDRAMINE,2,"Active, not recruiting",HRH1,1
lupus nephritis,DIPHENHYDRAMINE,3,Completed,HRH1,1
lupus nephritis,ETANERCEPT,2,Terminated,TNF,1
lupus nephritis,LEFLUNOMIDE,3,Terminated,DHODH,1
lupus nephritis,METHYLPREDNISOLONE,2,Completed,NR3C1,1
lupus nephritis,METHYLPREDNISOLONE,3,Completed,NR3C1,1
lupus nephritis,METHYLPREDNISOLONE,4,Completed,NR3C1,1
lupus nephritis,MYCOPHENOLATE MOFETIL,2,"Active, not recruiting",IMPDH2,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,PDE10A,1
lupus nephritis,MYCOPHENOLATE MOFETIL,2,Not yet recruiting,IMPDH1,1
lupus nephritis,MYCOPHENOLATE MOFETIL,2,Not yet recruiting,IMPDH2,1
lupus nephritis,MYCOPHENOLIC ACID,2,"Active, not recruiting",IMPDH1,1
lupus nephritis,MYCOPHENOLIC ACID,2,"Active, not recruiting",IMPDH2,1
lupus nephritis,MYCOPHENOLIC ACID,2,Completed,IMPDH1,1
Alport syndrome,BARDOXOLONE METHYL,2,"Active, not recruiting",KEAP1,1
lupus nephritis,MYCOPHENOLIC ACID,3,Terminated,IMPDH1,1
lupus nephritis,MYCOPHENOLIC ACID,3,Terminated,IMPDH2,1
lupus nephritis,MYCOPHENOLIC ACID,3,Withdrawn,IMPDH1,1
lupus nephritis,MYCOPHENOLIC ACID,3,Withdrawn,IMPDH2,1
lupus nephritis,OBINUTUZUMAB,2,"Active, not recruiting",MS4A1,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,ADORA2A,1
lupus nephritis,PENTOXIFYLLINE,3,Not yet recruiting,ADORA2B,1
lupus nephritis,TACROLIMUS,3,Terminated,FKBP1A,1
lupus nephritis,TACROLIMUS,3,Withdrawn,FKBP1A,1
lupus nephritis,TACROLIMUS,4,Recruiting,FKBP1A,1
nephrolithiasis,MIRABEGRON,4,Unknown status,ADRB3,1
nephritis,PREDNISONE,2,Withdrawn,NR3C1,1
nephrolithiasis,ACETAMINOPHEN,3,Recruiting,FAAH,1
nephrolithiasis,ACETAMINOPHEN,3,Recruiting,PTGS1,1
nephrolithiasis,ACETAMINOPHEN,3,Recruiting,PTGS2,1
nephrolithiasis,ACETAMINOPHEN,3,Recruiting,TRPV1,1
nephrolithiasis,ACETAMINOPHEN,4,Unknown status,FAAH,1
nephrolithiasis,ACETAMINOPHEN,4,Unknown status,PTGS1,1
nephrolithiasis,ACETAMINOPHEN,4,Unknown status,PTGS2,1
nephrolithiasis,ACETAMINOPHEN,4,Unknown status,TRPV1,1
nephrolithiasis,ALLOPURINOL,4,Completed,XDH,1
nephrolithiasis,HYDROCHLOROTHIAZIDE,3,Recruiting,SLC12A3,1
nephrolithiasis,KETOROLAC,3,Recruiting,PTGS1,1
nephrolithiasis,KETOROLAC,3,Recruiting,PTGS2,1
nephrolithiasis,OXYCODONE,3,Recruiting,OPRM1,1
membranous glomerulonephritis,TACROLIMUS,4,Unknown status,FKBP1A,1
nephrolithiasis,TADALAFIL,4,Enrolling by invitation,PDE5A,1
nephrolithiasis,TAMSULOSIN,4,Enrolling by invitation,ADRA1A,1
nephrolithiasis,TAMSULOSIN,4,Enrolling by invitation,ADRA1B,1
nephrolithiasis,TAMSULOSIN,4,Enrolling by invitation,ADRA1D,1
nephrolithiasis,TAMSULOSIN,4,Unknown status,ADRA1A,1
nephrolithiasis,TAMSULOSIN,4,Unknown status,ADRA1B,1
nephrolithiasis,TAMSULOSIN,4,Unknown status,ADRA1D,1
nephrolithiasis,TOLVAPTAN,1,Completed,AVPR2,1
nephrolithiasis,TRANEXAMIC ACID,4,Recruiting,PLG,1
nephrotic syndrome,ABATACEPT,2,Recruiting,CD80,1
nephrotic syndrome,ABATACEPT,2,Recruiting,CD86,1
nephrotic syndrome,ALDESLEUKIN,1,Completed,IL2RA,1
nephrotic syndrome,ALDESLEUKIN,1,Completed,IL2RB,1
nephritis,OMALIZUMAB,2,Withdrawn,IGHE,1
membranous glomerulonephritis,TACROLIMUS,3,Completed,FKBP1A,1
lupus nephritis,TACROLIMUS,4,Terminated,FKBP1A,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH1,1
malignant rhabdoid tumour,ABEMACICLIB,1,Recruiting,CDK4,1
malignant rhabdoid tumour,ABEMACICLIB,1,Recruiting,CDK6,1
malignant rhabdoid tumour,RIBOCICLIB,1,Terminated,CDK4,1
malignant rhabdoid tumour,RIBOCICLIB,1,Terminated,CDK6,1
membranous glomerulonephritis,BELIMUMAB,2,Completed,TNFSF13B,1
membranous glomerulonephritis,BELIMUMAB,2,Withdrawn,TNFSF13B,1
membranous glomerulonephritis,CORTICOTROPIN,1,Completed,MC2R,1
membranous glomerulonephritis,COSYNTROPIN,2,Completed,MC2R,1
membranous glomerulonephritis,CYCLOSPORINE,2,"Active, not recruiting",PPIA,1
membranous glomerulonephritis,CYCLOSPORINE,3,Unknown status,PPIA,1
membranous glomerulonephritis,CYCLOSPORINE,4,Recruiting,PPIA,1
membranous glomerulonephritis,METHYLPREDNISOLONE,2,Completed,NR3C1,1
membranous glomerulonephritis,METHYLPREDNISOLONE,3,Recruiting,NR3C1,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,2,Completed,IMPDH2,1
membranous glomerulonephritis,RITUXIMAB,3,Unknown status,MS4A1,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH1,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH2,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,3,Unknown status,IMPDH1,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,3,Unknown status,IMPDH2,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,4,Recruiting,IMPDH1,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,4,Recruiting,IMPDH2,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,4,Unknown status,IMPDH1,1
membranous glomerulonephritis,MYCOPHENOLATE MOFETIL,4,Unknown status,IMPDH2,1
membranous glomerulonephritis,PREDNISOLONE,3,Completed,NR3C1,1
membranous glomerulonephritis,PREDNISONE,2,Completed,NR3C1,1
membranous glomerulonephritis,RITUXIMAB,2,"Active, not recruiting",MS4A1,1
membranous glomerulonephritis,RITUXIMAB,2,Not yet recruiting,MS4A1,1
membranous glomerulonephritis,RITUXIMAB,3,Recruiting,MS4A1,1
lupus nephritis,AZATHIOPRINE,2,Recruiting,PPAT,1
lupus nephritis,ATACICEPT,2,Terminated,TNFSF13B,1
lupus nephritis,ATACICEPT,2,Terminated,TNFSF13,1
kidney stone,DOXAZOSIN,3,Unknown status,ADRA1A,1
kidney neoplasm,SUNITINIB,3,Completed,PDGFRB,1
kidney neoplasm,SUNITINIB,3,Completed,RET,1
kidney neoplasm,THALIDOMIDE,2,Completed,CRBN,1
kidney neoplasm,THALIDOMIDE,2,Completed,CUL4A,1
kidney neoplasm,THALIDOMIDE,2,Completed,DDB1,1
kidney neoplasm,THALIDOMIDE,2,Completed,RBX1,1
kidney stone,ALFUZOSIN,3,Unknown status,ADRA1A,1
kidney stone,ALFUZOSIN,3,Unknown status,ADRA1B,1
kidney stone,ALFUZOSIN,3,Unknown status,ADRA1D,1
kidney stone,ALFUZOSIN,3,Withdrawn,ADRA1A,1
kidney stone,ALFUZOSIN,3,Withdrawn,ADRA1B,1
kidney stone,ALFUZOSIN,3,Withdrawn,ADRA1D,1
kidney stone,ALLOPURINOL,2,Completed,XDH,1
kidney stone,DOXAZOSIN,3,Unknown status,ADRA1B,1
kidney neoplasm,SUNITINIB,3,Completed,KIT,1
kidney stone,DOXAZOSIN,3,Unknown status,ADRA1D,1
kidney stone,FEBUXOSTAT,2,Completed,XDH,1
kidney stone,INDAPAMIDE,2,Recruiting,SLC12A3,1
kidney stone,ISOPROTERENOL,2,Unknown status,ADRB1,1
kidney stone,ISOPROTERENOL,2,Unknown status,ADRB2,1
kidney stone,ISOPROTERENOL,2,Unknown status,ADRB3,1
kidney stone,KETOROLAC,4,Completed,PTGS1,1
kidney stone,KETOROLAC,4,Completed,PTGS2,1
kidney stone,LOSARTAN,4,Completed,AGTR1,1
kidney stone,MORPHINE,3,Completed,OPRM1,1
kidney stone,NIFEDIPINE,3,Unknown status,CACNA1C,1
kidney stone,NIFEDIPINE,3,Unknown status,CACNA1D,1
kidney stone,NIFEDIPINE,3,Unknown status,CACNA1F,1
kidney neoplasm,SUNITINIB,3,Completed,PDGFRA,1
kidney neoplasm,SUNITINIB,3,Completed,KDR,1
kidney stone,NIFEDIPINE,4,Unknown status,CACNA1C,1
kidney neoplasm,SORAFENIB,3,"Active, not recruiting",PDGFRB,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,POLE,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,POLE2,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,POLE3,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,PRIM1,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,PRIM2,1
kidney neoplasm,FLUDARABINE PHOSPHATE,1,Terminated,RRM1,1
kidney neoplasm,MUROMONAB-CD3,1,Terminated,CD3E,1
kidney neoplasm,SORAFENIB,3,"Active, not recruiting",BRAF,1
kidney neoplasm,SORAFENIB,3,"Active, not recruiting",FLT1,1
kidney neoplasm,SORAFENIB,3,"Active, not recruiting",FLT3,1
kidney neoplasm,SORAFENIB,3,"Active, not recruiting",FLT4,1
kidney neoplasm,SORAFENIB,3,"Active, not recruiting",KDR,1
kidney neoplasm,SORAFENIB,3,"Active, not recruiting",KIT,1
kidney neoplasm,SORAFENIB,3,"Active, not recruiting",RAF1,1
kidney neoplasm,SUNITINIB,3,Completed,FLT4,1
kidney neoplasm,SORAFENIB,3,"Active, not recruiting",RET,1
kidney neoplasm,SORAFENIB,3,Completed,BRAF,1
kidney neoplasm,SORAFENIB,3,Completed,FLT1,1
kidney neoplasm,SORAFENIB,3,Completed,FLT3,1
kidney neoplasm,SORAFENIB,3,Completed,FLT4,1
kidney neoplasm,SORAFENIB,3,Completed,KDR,1
kidney neoplasm,SORAFENIB,3,Completed,KIT,1
kidney neoplasm,SORAFENIB,3,Completed,PDGFRB,1
kidney neoplasm,SORAFENIB,3,Completed,RAF1,1
kidney neoplasm,SORAFENIB,3,Completed,RET,1
kidney neoplasm,SUNITINIB,3,Completed,CSF1R,1
kidney neoplasm,SUNITINIB,3,Completed,FLT1,1
kidney neoplasm,SUNITINIB,3,Completed,FLT3,1
kidney stone,NIFEDIPINE,3,Unknown status,CACNA1S,1
kidney stone,NIFEDIPINE,4,Unknown status,CACNA1D,1
lupus nephritis,ATACICEPT,1,Terminated,TNFSF13B,1
lupus nephritis,ABATACEPT,1,Completed,CD86,1
kidney stone,TOLTERODINE,2,Unknown status,CHRM2,1
kidney stone,TOLTERODINE,2,Unknown status,CHRM3,1
kidney stone,TRAMADOL,4,Completed,OPRM1,1
kidney stone,VERAPAMIL,4,Completed,CACNA1C,1
kidney stone,VERAPAMIL,4,Completed,CACNA1D,1
kidney stone,VERAPAMIL,4,Completed,CACNA1F,1
kidney stone,VERAPAMIL,4,Completed,CACNA1S,1
lipoid nephrosis,MYCOPHENOLIC ACID,4,Completed,IMPDH1,1
lipoid nephrosis,MYCOPHENOLIC ACID,4,Completed,IMPDH2,1
lipoid nephrosis,PREDNISOLONE,4,Completed,NR3C1,1
lipoid nephrosis,PREDNISOLONE,4,Recruiting,NR3C1,1
lipoid nephrosis,TACROLIMUS,4,Recruiting,FKBP1A,1
lupus nephritis,ABATACEPT,1,Completed,CD80,1
lupus nephritis,ABATACEPT,2,Completed,CD80,1
kidney stone,TAMSULOSIN,4,Unknown status,ADRA1B,1
lupus nephritis,ABATACEPT,2,Completed,CD86,1
lupus nephritis,ABATACEPT,3,Completed,CD80,1
lupus nephritis,ABATACEPT,3,Completed,CD86,1
lupus nephritis,ACETAMINOPHEN,2,"Active, not recruiting",FAAH,1
lupus nephritis,ACETAMINOPHEN,2,"Active, not recruiting",PTGS1,1
lupus nephritis,ACETAMINOPHEN,2,"Active, not recruiting",PTGS2,1
lupus nephritis,ACETAMINOPHEN,2,"Active, not recruiting",TRPV1,1
lupus nephritis,ACETAMINOPHEN,3,Completed,FAAH,1
lupus nephritis,ACETAMINOPHEN,3,Completed,PTGS1,1
lupus nephritis,ACETAMINOPHEN,3,Completed,PTGS2,1
lupus nephritis,ACETAMINOPHEN,3,Completed,TRPV1,1
lupus nephritis,ANIFROLUMAB,2,Recruiting,IFNAR1,1
lupus nephritis,ATACICEPT,1,Terminated,TNFSF13,1
kidney stone,TAMSULOSIN,4,Unknown status,ADRA1D,1
kidney stone,TAMSULOSIN,4,Unknown status,ADRA1A,1
kidney stone,NIFEDIPINE,4,Unknown status,CACNA1F,1
kidney stone,ROPIVACAINE,4,Completed,SCN2A,1
kidney stone,NIFEDIPINE,4,Unknown status,CACNA1S,1
kidney stone,OXYCODONE,3,Completed,OPRM1,1
kidney stone,PRAZOSIN,3,Unknown status,ADRA1A,1
kidney stone,PRAZOSIN,3,Unknown status,ADRA1B,1
kidney stone,PRAZOSIN,3,Unknown status,ADRA1D,1
kidney stone,PROGESTERONE,4,Unknown status,PGR,1
kidney stone,PROPANTHELINE,4,Unknown status,CHRM1,1
kidney stone,PROPANTHELINE,4,Unknown status,CHRM2,1
kidney stone,PROPANTHELINE,4,Unknown status,CHRM3,1
kidney stone,REMIFENTANIL,4,Completed,OPRM1,1
kidney stone,ROPIVACAINE,4,Completed,SCN10A,1
kidney stone,ROPIVACAINE,4,Completed,SCN11A,1
kidney stone,ROPIVACAINE,4,Completed,SCN1A,1
kidney stone,ROPIVACAINE,4,Completed,SCN3A,1
kidney stone,TAMSULOSIN,3,Withdrawn,ADRA1D,1
kidney stone,ROPIVACAINE,4,Completed,SCN4A,1
kidney stone,ROPIVACAINE,4,Completed,SCN5A,1
kidney stone,ROPIVACAINE,4,Completed,SCN7A,1
kidney stone,ROPIVACAINE,4,Completed,SCN8A,1
kidney stone,ROPIVACAINE,4,Completed,SCN9A,1
kidney stone,SILODOSIN,2,Completed,ADRA1A,1
kidney stone,SILODOSIN,3,Terminated,ADRA1A,1
kidney stone,SILODOSIN,3,Withdrawn,ADRA1A,1
kidney stone,TAMSULOSIN,3,Unknown status,ADRA1A,1
kidney stone,TAMSULOSIN,3,Unknown status,ADRA1B,1
kidney stone,TAMSULOSIN,3,Unknown status,ADRA1D,1
kidney stone,TAMSULOSIN,3,Withdrawn,ADRA1A,1
kidney stone,TAMSULOSIN,3,Withdrawn,ADRA1B,1
kidney disease,PROPOFOL,4,Completed,GABRA2,1
kidney disease,PROPOFOL,4,Completed,GABRA1,1
kidney disease,PROBUCOL,4,Completed,ABCA1,1
diabetic nephropathy,CLONIDINE,4,Unknown status,ADRA2C,1
clear cell renal carcinoma,SUNITINIB,2,Terminated,RET,1
clear cell renal carcinoma,TANDUTINIB,2,Completed,FLT3,1
clear cell renal carcinoma,TANDUTINIB,2,Completed,KIT,1
clear cell renal carcinoma,TANDUTINIB,2,Completed,PDGFRB,1
clear cell renal carcinoma,TEMSIROLIMUS,1,Completed,FKBP1A,1
clear cell renal carcinoma,TEMSIROLIMUS,2,Completed,FKBP1A,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EGFR,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHA1,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHA10,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHA2,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHA3,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHA4,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHA5,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHA6,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHA7,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHA8,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHB1,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHB2,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHB3,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHB4,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,EPHB6,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,ERBB2,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,ERBB3,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,ERBB4,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,FLT1,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,FLT4,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,KDR,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,PTK6,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,RET,1
clear cell renal carcinoma,SUNITINIB,2,Terminated,PDGFRB,1
clear cell renal carcinoma,SUNITINIB,2,Terminated,PDGFRA,1
clear cell renal carcinoma,SUNITINIB,2,Terminated,KIT,1
clear cell renal carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRB,1
clear cell renal carcinoma,SORAFENIB,1,Completed,FLT4,1
clear cell renal carcinoma,SORAFENIB,1,Completed,KDR,1
clear cell renal carcinoma,SORAFENIB,1,Completed,KIT,1
clear cell renal carcinoma,SORAFENIB,1,Completed,PDGFRB,1
clear cell renal carcinoma,SORAFENIB,1,Completed,RAF1,1
clear cell renal carcinoma,SORAFENIB,1,Completed,RET,1
clear cell renal carcinoma,SUNITINIB,2,"Active, not recruiting",CSF1R,1
clear cell renal carcinoma,SUNITINIB,2,"Active, not recruiting",FLT1,1
clear cell renal carcinoma,SUNITINIB,2,"Active, not recruiting",FLT3,1
clear cell renal carcinoma,SUNITINIB,2,"Active, not recruiting",FLT4,1
clear cell renal carcinoma,SUNITINIB,2,"Active, not recruiting",KDR,1
clear cell renal carcinoma,SUNITINIB,2,"Active, not recruiting",KIT,1
clear cell renal carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRA,1
clear cell renal carcinoma,SUNITINIB,2,"Active, not recruiting",RET,1
clear cell renal carcinoma,SUNITINIB,2,Terminated,KDR,1
clear cell renal carcinoma,SUNITINIB,2,Completed,CSF1R,1
clear cell renal carcinoma,SUNITINIB,2,Completed,FLT1,1
clear cell renal carcinoma,SUNITINIB,2,Completed,FLT3,1
clear cell renal carcinoma,SUNITINIB,2,Completed,FLT4,1
clear cell renal carcinoma,SUNITINIB,2,Completed,KDR,1
clear cell renal carcinoma,SUNITINIB,2,Completed,KIT,1
clear cell renal carcinoma,SUNITINIB,2,Completed,PDGFRA,1
clear cell renal carcinoma,SUNITINIB,2,Completed,PDGFRB,1
clear cell renal carcinoma,SUNITINIB,2,Completed,RET,1
clear cell renal carcinoma,SUNITINIB,2,Terminated,CSF1R,1
clear cell renal carcinoma,SUNITINIB,2,Terminated,FLT1,1
clear cell renal carcinoma,SUNITINIB,2,Terminated,FLT3,1
clear cell renal carcinoma,SUNITINIB,2,Terminated,FLT4,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,SRC,1
clear cell renal carcinoma,VANDETANIB,2,Terminated,TEK,1
clear cell renal carcinoma,VORINOSTAT,1,Completed,HDAC1,1
diabetic nephropathy,BARDOXOLONE METHYL,2,Completed,PPARG,1
diabetic nephropathy,ALPROSTADIL,4,Completed,PTGER2,1
diabetic nephropathy,AMLODIPINE,4,Unknown status,CACNA1C,1
diabetic nephropathy,AMLODIPINE,4,Unknown status,CACNA1D,1
diabetic nephropathy,AMLODIPINE,4,Unknown status,CACNA1F,1
diabetic nephropathy,AMLODIPINE,4,Unknown status,CACNA1S,1
diabetic nephropathy,ASPIRIN,4,Unknown status,PTGS1,1
diabetic nephropathy,ASPIRIN,4,Unknown status,PTGS2,1
diabetic nephropathy,ATENOLOL,4,Unknown status,ADRB1,1
diabetic nephropathy,ATRASENTAN,3,Terminated,EDNRA,1
diabetic nephropathy,AVOSENTAN,3,Terminated,EDNRA,1
diabetic nephropathy,BARDOXOLONE METHYL,2,Completed,IKBKB,1
diabetic nephropathy,BARDOXOLONE METHYL,2,Completed,KEAP1,1
diabetic nephropathy,BARDOXOLONE METHYL,2,Completed,NFE2L2,1
diabetic nephropathy,BARDOXOLONE METHYL,3,Recruiting,IKBKB,1
diabetic nephropathy,ALLOPURINOL,4,Terminated,XDH,1
diabetic nephropathy,BARDOXOLONE METHYL,3,Recruiting,KEAP1,1
diabetic nephropathy,BARDOXOLONE METHYL,3,Recruiting,NFE2L2,1
diabetic nephropathy,BARDOXOLONE METHYL,3,Recruiting,PPARG,1
diabetic nephropathy,BARICITINIB,2,Completed,JAK1,1
diabetic nephropathy,BARICITINIB,2,Completed,JAK2,1
diabetic nephropathy,CALCITRIOL,2,Terminated,VDR,1
diabetic nephropathy,CALCITRIOL,3,Recruiting,VDR,1
diabetic nephropathy,CALCITRIOL,4,Unknown status,VDR,1
diabetic nephropathy,CANAGLIFLOZIN,3,Recruiting,SLC5A2,1
diabetic nephropathy,CANDESARTAN CILEXETIL,4,Completed,AGTR1,1
diabetic nephropathy,CAPTOPRIL,2,Completed,ACE,1
diabetic nephropathy,CILOSTAZOL,4,Completed,PDE3A,1
diabetic nephropathy,CLONIDINE,4,Unknown status,ADRA2A,1
diabetic nephropathy,ALPROSTADIL,4,Completed,PTGER1,1
diabetic nephropathy,ALISKIREN,2,Completed,REN,1
clear cell renal carcinoma,VORINOSTAT,1,Completed,HDAC2,1
collecting duct carcinoma,CABOZANTINIB,2,Recruiting,KDR,1
clear cell renal carcinoma,VORINOSTAT,1,Completed,HDAC3,1
clear cell renal carcinoma,VORINOSTAT,1,Completed,HDAC6,1
clear cell sarcoma of the kidney,DALTEPARIN SODIUM,1,Completed,SERPINC1,1
clear cell sarcoma of the kidney,SUNITINIB,1,Completed,CSF1R,1
clear cell sarcoma of the kidney,SUNITINIB,1,Completed,FLT1,1
clear cell sarcoma of the kidney,SUNITINIB,1,Completed,FLT3,1
clear cell sarcoma of the kidney,SUNITINIB,1,Completed,FLT4,1
clear cell sarcoma of the kidney,SUNITINIB,1,Completed,KDR,1
clear cell sarcoma of the kidney,SUNITINIB,1,Completed,KIT,1
clear cell sarcoma of the kidney,SUNITINIB,1,Completed,PDGFRA,1
clear cell sarcoma of the kidney,SUNITINIB,1,Completed,PDGFRB,1
clear cell sarcoma of the kidney,SUNITINIB,1,Completed,RET,1
collecting duct carcinoma,BEVACIZUMAB,2,Recruiting,VEGFA,1
collecting duct carcinoma,CABOZANTINIB,2,Recruiting,MET,1
diabetic nephropathy,ALFACALCIDOL,4,Recruiting,VDR,1
collecting duct carcinoma,IPILIMUMAB,2,Recruiting,CTLA4,1
collecting duct carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT1,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT4,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",ITK,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",KDR,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",KIT,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",LCK,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,1
collecting duct carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,1
clear cell renal carcinoma,SORAFENIB,1,Completed,FLT3,1
clear cell renal carcinoma,SORAFENIB,1,Completed,FLT1,1
clear cell renal carcinoma,SORAFENIB,1,Completed,BRAF,1
clear cell renal carcinoma,HYDROXYCHLOROQUINE,1,"Active, not recruiting",TLR9,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC8,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC9,1
clear cell renal carcinoma,ENZALUTAMIDE,0,Recruiting,AR,1
clear cell renal carcinoma,ERLOTINIB,1,Completed,EGFR,1
clear cell renal carcinoma,EVEROLIMUS,1,"Active, not recruiting",FKBP1A,1
clear cell renal carcinoma,EVEROLIMUS,1,Completed,FKBP1A,1
clear cell renal carcinoma,EVEROLIMUS,1,Terminated,FKBP1A,1
clear cell renal carcinoma,EVEROLIMUS,2,Completed,FKBP1A,1
clear cell renal carcinoma,EVEROLIMUS,2,Terminated,FKBP1A,1
clear cell renal carcinoma,EVEROLIMUS,3,"Active, not recruiting",FKBP1A,1
clear cell renal carcinoma,EVEROLIMUS,3,Terminated,FKBP1A,1
clear cell renal carcinoma,GIRENTUXIMAB,2,Completed,CA9,1
clear cell renal carcinoma,HYDROXYCHLOROQUINE,1,"Active, not recruiting",TLR7,1
clear cell renal carcinoma,IMATINIB,1,Completed,ABL1,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC6,1
clear cell renal carcinoma,IMATINIB,1,Completed,KIT,1
clear cell renal carcinoma,IMATINIB,1,Completed,PDGFRB,1
clear cell renal carcinoma,IPILIMUMAB,0,"Active, not recruiting",CTLA4,1
clear cell renal carcinoma,IPILIMUMAB,1,Not yet recruiting,CTLA4,1
clear cell renal carcinoma,IPILIMUMAB,2,Withdrawn,CTLA4,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB1,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB2A,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB2B,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB3,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB4A,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB4B,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB6,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC7,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC5,1
clear cell renal carcinoma,LENVATINIB,2,"Active, not recruiting",FLT1,1
clear cell renal carcinoma,DOVITINIB,2,Unknown status,FGFR3,1
clear cell renal carcinoma,CEDIRANIB,2,Terminated,FLT4,1
clear cell renal carcinoma,CEDIRANIB,2,Terminated,KDR,1
clear cell renal carcinoma,CEDIRANIB,2,Terminated,KIT,1
clear cell renal carcinoma,CEDIRANIB,2,Terminated,PDGFRA,1
clear cell renal carcinoma,CEDIRANIB,2,Terminated,PDGFRB,1
clear cell renal carcinoma,DOVITINIB,1,Completed,FGFR3,1
clear cell renal carcinoma,DOVITINIB,1,Completed,FLT1,1
clear cell renal carcinoma,DOVITINIB,1,Completed,FLT3,1
clear cell renal carcinoma,DOVITINIB,1,Completed,FLT4,1
clear cell renal carcinoma,DOVITINIB,1,Completed,KDR,1
clear cell renal carcinoma,DOVITINIB,1,Completed,KIT,1
clear cell renal carcinoma,DOVITINIB,1,Completed,PDGFRA,1
clear cell renal carcinoma,DOVITINIB,1,Completed,PDGFRB,1
clear cell renal carcinoma,DOVITINIB,2,Unknown status,FLT1,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC4,1
clear cell renal carcinoma,DOVITINIB,2,Unknown status,FLT3,1
clear cell renal carcinoma,DOVITINIB,2,Unknown status,FLT4,1
clear cell renal carcinoma,DOVITINIB,2,Unknown status,KDR,1
clear cell renal carcinoma,DOVITINIB,2,Unknown status,KIT,1
clear cell renal carcinoma,DOVITINIB,2,Unknown status,PDGFRA,1
clear cell renal carcinoma,DOVITINIB,2,Unknown status,PDGFRB,1
clear cell renal carcinoma,DURVALUMAB,1,"Active, not recruiting",CD274,1
clear cell renal carcinoma,DURVALUMAB,1,Recruiting,CD274,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC1,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC10,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC11,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC2,1
clear cell renal carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC3,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB8,1
clear cell renal carcinoma,LENVATINIB,2,"Active, not recruiting",FLT4,1
clear cell renal carcinoma,PEMBROLIZUMAB,1,Recruiting,PDCD1,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,KIT,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",ITK,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",KDR,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",KIT,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",LCK,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,CSF1R,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,FGFR1,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,FGFR3,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,FLT1,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,FLT4,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,ITK,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,KDR,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,LCK,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT1,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,PDGFRA,1
clear cell renal carcinoma,PAZOPANIB,2,Recruiting,PDGFRB,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",CSF1R,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",FGFR1,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",FGFR3,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",FLT1,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",FLT4,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",ITK,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",KDR,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",KIT,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",LCK,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",PDGFRA,1
clear cell renal carcinoma,PAZOPANIB,3,"Active, not recruiting",PDGFRB,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT4,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,1
clear cell renal carcinoma,LENVATINIB,2,"Active, not recruiting",KDR,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC7,1
clear cell renal carcinoma,NIVOLUMAB,0,"Active, not recruiting",PDCD1,1
clear cell renal carcinoma,NIVOLUMAB,1,Completed,PDCD1,1
clear cell renal carcinoma,NIVOLUMAB,1,Not yet recruiting,PDCD1,1
clear cell renal carcinoma,NIVOLUMAB,2,Withdrawn,PDCD1,1
clear cell renal carcinoma,NIVOLUMAB,3,"Active, not recruiting",PDCD1,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC1,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC10,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC11,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC2,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC3,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC4,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC5,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC6,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC8,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,1
clear cell renal carcinoma,PANOBINOSTAT,1,Terminated,HDAC9,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,CSF1R,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,FGFR1,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,FGFR3,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,FLT1,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,FLT4,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,ITK,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,KDR,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,KIT,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,LCK,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,PDGFRA,1
clear cell renal carcinoma,PAZOPANIB,1,Recruiting,PDGFRB,1
clear cell renal carcinoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,1
diabetic nephropathy,CLONIDINE,4,Unknown status,ADRA2B,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB,1
kidney disease,PREDNISONE,4,Completed,NR3C1,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB1,1
focal segmental glomerulosclerosis,LOSARTAN,2,Completed,AGTR1,1
focal segmental glomerulosclerosis,LOSMAPIMOD,2,Completed,MAPK11,1
focal segmental glomerulosclerosis,LOSMAPIMOD,2,Completed,MAPK14,1
focal segmental glomerulosclerosis,MYCOPHENOLATE MOFETIL,2,Recruiting,IMPDH1,1
focal segmental glomerulosclerosis,MYCOPHENOLATE MOFETIL,2,Recruiting,IMPDH2,1
focal segmental glomerulosclerosis,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH1,1
focal segmental glomerulosclerosis,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH2,1
focal segmental glomerulosclerosis,PAMREVLUMAB,1,Terminated,CCN2,1
focal segmental glomerulosclerosis,PREDNISONE,2,Recruiting,NR3C1,1
focal segmental glomerulosclerosis,RITUXIMAB,1,Not yet recruiting,MS4A1,1
focal segmental glomerulosclerosis,RITUXIMAB,2,"Active, not recruiting",MS4A1,1
focal segmental glomerulosclerosis,RITUXIMAB,2,Completed,MS4A1,1
focal segmental glomerulosclerosis,ROSIGLITAZONE,1,Completed,PPARG,1
focal segmental glomerulosclerosis,SIROLIMUS,2,Completed,FKBP1A,1
focal segmental glomerulosclerosis,SPARSENTAN,2,"Active, not recruiting",AGTR1,1
focal segmental glomerulosclerosis,SPARSENTAN,2,"Active, not recruiting",EDNRA,1
focal segmental glomerulosclerosis,SPARSENTAN,3,Recruiting,AGTR1,1
focal segmental glomerulosclerosis,SPARSENTAN,3,Recruiting,EDNRA,1
focal segmental glomerulosclerosis,TACROLIMUS,2,Recruiting,FKBP1A,1
glomerular disease,PREDNISONE,4,Unknown status,NR3C1,1
kidney disease,ACETAMINOPHEN,1,Completed,FAAH,1
kidney disease,ACETAMINOPHEN,1,Completed,PTGS1,1
kidney disease,ACETAMINOPHEN,1,Completed,PTGS2,1
kidney disease,ACETAMINOPHEN,1,Completed,TRPV1,1
kidney disease,ACETAZOLAMIDE,2,Completed,CA1,1
kidney disease,ACETAZOLAMIDE,2,Completed,CA12,1
kidney disease,ACETAZOLAMIDE,2,Completed,CA2,1
kidney disease,ACETAZOLAMIDE,2,Completed,CA4,1
kidney disease,ALEMTUZUMAB,1,Completed,CD52,1
focal segmental glomerulosclerosis,ISOTRETINOIN,2,Completed,RARG,1
focal segmental glomerulosclerosis,ISOTRETINOIN,2,Completed,RARB,1
focal segmental glomerulosclerosis,ISOTRETINOIN,2,Completed,RARA,1
diabetic nephropathy,XL550,2,Completed,NR3C2,1
diabetic nephropathy,PROBUCOL,2,Completed,ABCA1,1
diabetic nephropathy,PROBUCOL,4,Completed,ABCA1,1
diabetic nephropathy,RAMIPRIL,3,Completed,ACE,1
diabetic nephropathy,RAMIPRIL,4,Unknown status,ACE,1
diabetic nephropathy,SELONSERTIB,1,Completed,MAP3K5,1
diabetic nephropathy,SELONSERTIB,2,Completed,MAP3K5,1
diabetic nephropathy,SIMVASTATIN,3,Completed,HMGCR,1
diabetic nephropathy,SIMVASTATIN,4,Unknown status,HMGCR,1
diabetic nephropathy,SPIRONOLACTONE,1,Terminated,NR3C2,1
diabetic nephropathy,SPIRONOLACTONE,4,Completed,NR3C2,1
diabetic nephropathy,SPIRONOLACTONE,4,Unknown status,NR3C2,1
diabetic nephropathy,TELMISARTAN,3,Completed,AGTR1,1
diabetic nephropathy,TELMISARTAN,4,Completed,AGTR1,1
focal segmental glomerulosclerosis,ADALIMUMAB,1,Completed,TNF,1
focal segmental glomerulosclerosis,IRBESARTAN,3,Recruiting,AGTR1,1
focal segmental glomerulosclerosis,ADALIMUMAB,2,Completed,TNF,1
focal segmental glomerulosclerosis,ATORVASTATIN,2,Completed,HMGCR,1
focal segmental glomerulosclerosis,BASILIXIMAB,2,Recruiting,IL2RA,1
focal segmental glomerulosclerosis,CORTICOTROPIN,4,Recruiting,MC2R,1
focal segmental glomerulosclerosis,CYCLOSPORINE,3,Completed,PPIA,1
focal segmental glomerulosclerosis,DAPAGLIFLOZIN,4,Completed,SLC5A2,1
focal segmental glomerulosclerosis,FRESOLIMUMAB,1,Completed,TGFB1,1
focal segmental glomerulosclerosis,FRESOLIMUMAB,1,Completed,TGFB2,1
focal segmental glomerulosclerosis,FRESOLIMUMAB,1,Completed,TGFB3,1
focal segmental glomerulosclerosis,FRESOLIMUMAB,2,Completed,TGFB1,1
focal segmental glomerulosclerosis,FRESOLIMUMAB,2,Completed,TGFB2,1
focal segmental glomerulosclerosis,FRESOLIMUMAB,2,Completed,TGFB3,1
focal segmental glomerulosclerosis,IRBESARTAN,2,"Active, not recruiting",AGTR1,1
kidney disease,ALISKIREN,2,Terminated,REN,1
kidney disease,ALISKIREN,4,Completed,REN,1
kidney disease,ALTEPLASE,4,Not yet recruiting,PLG,1
kidney disease,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH2,1
kidney disease,KETAMINE,4,Completed,GRIN2A,1
kidney disease,KETAMINE,4,Completed,GRIN2B,1
kidney disease,KETAMINE,4,Completed,GRIN2C,1
kidney disease,KETAMINE,4,Completed,GRIN2D,1
kidney disease,KETAMINE,4,Completed,GRIN3A,1
kidney disease,KETAMINE,4,Completed,GRIN3B,1
kidney disease,LOSARTAN,1,Completed,AGTR1,1
kidney disease,METHYLPREDNISOLONE,1,Completed,NR3C1,1
kidney disease,METHYLPREDNISOLONE,3,"Active, not recruiting",NR3C1,1
kidney disease,METHYLPREDNISOLONE,3,Completed,NR3C1,1
kidney disease,MYCOPHENOLATE MOFETIL,1,Completed,IMPDH1,1
kidney disease,MYCOPHENOLATE MOFETIL,1,Completed,IMPDH2,1
kidney disease,MYCOPHENOLATE MOFETIL,3,Completed,IMPDH1,1
kidney disease,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH1,1
kidney disease,HYDROCHLOROTHIAZIDE,2,Terminated,SLC12A3,1
kidney disease,MYCOPHENOLATE MOFETIL,4,Completed,IMPDH2,1
kidney disease,MYCOPHENOLATE MOFETIL,4,Terminated,IMPDH1,1
kidney disease,MYCOPHENOLATE MOFETIL,4,Terminated,IMPDH2,1
kidney disease,MYCOPHENOLIC ACID,3,Completed,IMPDH1,1
kidney disease,MYCOPHENOLIC ACID,3,Completed,IMPDH2,1
kidney disease,NITROGLYCERIN,4,Completed,GUCY1B1,1
kidney disease,NITROGLYCERIN,4,Completed,GUCY1B2,1
kidney disease,PARICALCITOL,3,Completed,VDR,1
kidney disease,PARICALCITOL,4,Terminated,VDR,1
kidney disease,PITAVASTATIN,4,Unknown status,HMGCR,1
kidney disease,PREDNISOLONE,3,Completed,NR3C1,1
kidney disease,PREDNISONE,1,Completed,NR3C1,1
kidney disease,PREDNISONE,3,Completed,NR3C1,1
kidney disease,KETAMINE,4,Completed,GRIN1,1
kidney disease,FUROSEMIDE,3,Withdrawn,SLC12A1,1
kidney disease,AMLODIPINE,4,Completed,CACNA1C,1
kidney disease,DESMOPRESSIN,4,Not yet recruiting,AVPR2,1
kidney disease,AMLODIPINE,4,Completed,CACNA1D,1
kidney disease,AMLODIPINE,4,Completed,CACNA1F,1
kidney disease,AMLODIPINE,4,Completed,CACNA1S,1
kidney disease,ATORVASTATIN,2,Completed,HMGCR,1
kidney disease,ATORVASTATIN,3,Unknown status,HMGCR,1
kidney disease,CAPTOPRIL,4,Completed,ACE,1
kidney disease,CORTICOTROPIN,4,Completed,MC2R,1
kidney disease,CORTICOTROPIN,4,Recruiting,MC2R,1
kidney disease,CYCLOSPORINE,4,Terminated,PPIA,1
kidney disease,CYCLOSPORINE,4,Unknown status,PPIA,1
kidney disease,DACLIZUMAB,1,Completed,IL2RA,1
kidney disease,DESMOPRESSIN,4,Not yet recruiting,AVPR1A,1
kidney disease,DESMOPRESSIN,4,Not yet recruiting,AVPR1B,1
kidney disease,DEXMEDETOMIDINE,4,Recruiting,ADRA2A,1
kidney disease,FUROSEMIDE,3,Unknown status,SLC12A1,1
kidney disease,DEXMEDETOMIDINE,4,Recruiting,ADRA2B,1
kidney disease,DEXMEDETOMIDINE,4,Recruiting,ADRA2C,1
kidney disease,DIPHENHYDRAMINE,1,Completed,HRH1,1
kidney disease,EMPAGLIFLOZIN,2,Recruiting,SLC5A2,1
kidney disease,ENOXAPARIN SODIUM,3,Completed,SERPINC1,1
kidney disease,ENZALUTAMIDE,1,Completed,AR,1
kidney disease,EPOPROSTENOL,3,Completed,PTGIR,1
kidney disease,EPROSARTAN,1,Completed,AGTR1,1
kidney disease,EVEROLIMUS,2,Terminated,FKBP1A,1
kidney disease,EVEROLIMUS,2,Unknown status,FKBP1A,1
kidney disease,EVEROLIMUS,4,Recruiting,FKBP1A,1
kidney disease,EVEROLIMUS,4,Terminated,FKBP1A,1
kidney disease,EZETIMIBE,4,Completed,NPC1L1,1
diabetic nephropathy,PF-04634817,2,Completed,CCR5,1
diabetic nephropathy,PF-04634817,2,Completed,CCR2,1
diabetic nephropathy,PF-03882845,1,Terminated,NR3C2,1
diabetic nephropathy,NISOLDIPINE,4,Completed,CACNA1C,1
diabetic nephropathy,IVABRADINE,3,Recruiting,HCN4,1
diabetic nephropathy,LIRAGLUTIDE,3,Completed,GLP1R,1
diabetic nephropathy,LIRAGLUTIDE,4,Completed,GLP1R,1
diabetic nephropathy,LOSARTAN,0,Completed,AGTR1,1
diabetic nephropathy,LOSARTAN,2,Terminated,AGTR1,1
diabetic nephropathy,LOSARTAN,3,Completed,AGTR1,1
diabetic nephropathy,LY-2382770,2,Terminated,TGFB1,1
diabetic nephropathy,MLN-1202,2,Withdrawn,CCR2,1
diabetic nephropathy,MOXONIDINE,4,Unknown status,NISCH,1
diabetic nephropathy,NIFEDIPINE,3,Completed,CACNA1C,1
diabetic nephropathy,NIFEDIPINE,3,Completed,CACNA1D,1
diabetic nephropathy,NIFEDIPINE,3,Completed,CACNA1F,1
diabetic nephropathy,NIFEDIPINE,3,Completed,CACNA1S,1
diabetic nephropathy,NISOLDIPINE,4,Completed,CACNA1D,1
diabetic nephropathy,IRBESARTAN,4,Recruiting,AGTR1,1
diabetic nephropathy,NISOLDIPINE,4,Completed,CACNA1F,1
diabetic nephropathy,NISOLDIPINE,4,Completed,CACNA1S,1
diabetic nephropathy,OLMESARTAN MEDOXOMIL,2,Completed,AGTR1,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,ADORA2A,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,ADORA2B,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE10A,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE1A,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE1B,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE1C,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE2A,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE3A,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE3B,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE4A,1
diabetic nephropathy,IRBESARTAN,4,Unknown status,AGTR1,1
diabetic nephropathy,IRBESARTAN,0,Unknown status,AGTR1,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE4C,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB4B,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB2A,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB2B,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB3,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB4A,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB4B,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB6,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB8,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB1,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB2A,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB2B,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB3,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB4A,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB6,1
diabetic nephropathy,INSULIN LISPRO,4,Unknown status,INSR,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB8,1
diabetic nephropathy,CORTICOTROPIN,2,Completed,MC2R,1
diabetic nephropathy,DOXAZOSIN,4,Unknown status,ADRA1A,1
diabetic nephropathy,DOXAZOSIN,4,Unknown status,ADRA1B,1
diabetic nephropathy,DOXAZOSIN,4,Unknown status,ADRA1D,1
diabetic nephropathy,ENALAPRIL,4,Completed,ACE,1
diabetic nephropathy,EPLERENONE,1,Recruiting,NR3C2,1
diabetic nephropathy,EPLERENONE,2,Completed,NR3C2,1
diabetic nephropathy,EXENATIDE,4,Unknown status,GLP1R,1
diabetic nephropathy,FOSINOPRIL,2,Completed,ACE,1
diabetic nephropathy,FUROSEMIDE,4,Unknown status,SLC12A1,1
diabetic nephropathy,HYDROCHLOROTHIAZIDE,4,Unknown status,SLC12A3,1
diabetic nephropathy,INSULIN HUMAN,4,Unknown status,INSR,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE4B,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE4D,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE9A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE4A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE7B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE8A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE8B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE9A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,ADORA2A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,ADORA2B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE10A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE1A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE1B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE1C,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE2A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE3A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE3B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE4B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE6H,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE4C,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE4D,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE5A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE6A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE6B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE6C,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE6D,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE6G,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE6H,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE7A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE7B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE8A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Not yet recruiting,PDE8B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE7A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE6G,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE5A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE10A,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE6A,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE6B,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE6C,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE6D,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE6G,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE6H,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE7A,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE7B,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE8A,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE8B,1
diabetic nephropathy,PENTOXIFYLLINE,2,Completed,PDE9A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,ADORA2A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,ADORA2B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE1A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE6D,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE1B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE1C,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE2A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE3A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE3B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE4A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE4B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE4C,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE4D,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE5A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE6A,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE6B,1
diabetic nephropathy,PENTOXIFYLLINE,4,Completed,PDE6C,1
type 2 diabetes nephropathy,TELMISARTAN,4,Withdrawn,AGTR1,1
